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Summary of findings {#CD012234-sec1-0001}
===================

Summary of findings for the main comparisonAll irrigation compared with no irrigation for prevention of surgical site infection**All irrigation compared with no irrigation for prevention of surgical site infectionPatient or population:** participants undergoing clean, clean‐contaminated, contaminated or dirty surgical procedures\
**Setting:** hospitals **Intervention:** irrigation of any type **Comparison:** no irrigation**OutcomesAnticipated absolute effects^\*^ (95% CI)Relative effect (95% CI)№ of participants (studies)Certainty of the evidence (GRADE)CommentsRisk with no irrigationRisk with irrigation**SSIStudy population: participants undergoing clean‐contaminated, contaminated\
or dirty surgical proceduresRR 0.87 (0.68 to 1.11)6106 (14 RCTs)⊕⊕⊝⊝ Low^1^On the basis of the included studies there is no clear difference between the intervention and comparison groups in the incidence of SSI.98 per 100085 per 1000 (67 to 108)**Risk difference:** 13 fewer SSI occur per 1000 with irrigation than with no irrigation (31 fewer to 10 more)Wound dehiscenceStudy population: participants undergoing clean procedures (split‐body design)RR 1.17 (0.44 to 3.06)30 (1 RCT)⊕⊕⊝⊝ Low^2^There is no clear difference between surgical sites treated with irrigation and those in the control condition. This is based on a single split‐body design with small numbers of participants.200 per 1000234 per 1000 (88 to 612)**Risk difference:** 34 more wound dehiscences occur per 1000 with irrigation than with no irrigation (112 fewer to 412 more)Adverse eventsStudy population: participants undergoing clean‐contaminated or dirty surgical proceduresRR 1.05 (0.76 to 1.44)403\
(3 RCTs)⊕⊕⊝⊝ Low^3^There is no clear difference in the number of adverse events between participants treated with irrigation and those in the control condition.247 per 1000259 per 1000 (187 to 355)**Risk difference:** 12 more per 1000 (from 59 fewer to 108 more)Adverse events: abscess formationStudy population: participants undergoing dirty or contaminated surgical proceduresRR 0.91 (0.54 to 1.54)331\
(3 RCTs)⊕⊕⊕⊝\
Moderate^4^There is no clear difference in the number of adverse events between participants treated with irrigation and those in the control condition.149 per 1000136 per 1000**Risk difference:** 13 fewer per 1000 (from 69 fewer to 80 more)\***The risk in the intervention group** (and its 95% confidence interval) is based on the assumed risk in the comparison group and the **relative effect** of the intervention (and its 95% CI). **CI:** confidence interval; **RR:** risk ratio; **SSI:** surgical site infection**GRADE Working Group grades of evidence** **High certainty:** we are very confident that the true effect lies close to that of the estimate of the effect **Moderate certainty:** we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different **Low certainty:** our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect **Very low certainty:** we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect[^2]

Summary of findings 2Irrigation with antibacterial solution compared with irrigation with non‐antibacterial solution for prevention of surgical site infection**Irrigation with antibacterial compared with non‐antibacterial solution for prevention of surgical site infectionPatient or population:** participants undergoing clean, clean‐contaminated, contaminated or dirty surgical procedures **Setting:** hospitals **Intervention:** irrigation with antibacterial solution (antiseptic or antibiotic) **Comparison:** irrigation with solution without antibacterial properties**OutcomesAnticipated absolute effects^\*^ (95% CI)Relative effect (95% CI)№ of participants (studies)Certainty of the evidence (GRADE)CommentsRisk with non‐antibacterialRisk with antibacterial**SSIStudy population: participants undergoing clean‐contaminated, contaminated or dirty surgical proceduresRR 0.57 (0.44 to 0.75)5141 (30 RCTs)⊕⊕⊝⊝ Low^1^The included studies found that there may be fewer SSIs in participants treated with antibacterial irrigation compared with those treated with non‐antibacterial irrigation.140 per 100080 per 1000 (62 to 105)**Risk difference:** 60 fewer SSI occur per 1000 with antibacterial irrigation than with non‐antibacterial (78 to 35 fewer)Wound dehiscenceStudy population: participants undergoing clean or clean‐contaminated surgical proceduresRR 1.26 (0.65 to 2.45)660 (3 RCTs)⊕⊝⊝⊝ Very low^2^The effect of antibacterial compared with non‐antibacterial irrigation on wound dehiscence is very uncertain.45 per 100056 per 1000 (29 to 109)**Risk difference:** 11 more wound dehiscences occur per 1000 with antibacterial irrigation than with non‐antibacterial (16 fewer to 64 more)Adverse eventsStudy population: participants undergoing clean, clean‐contaminated or dirty surgical proceduresRR 0.55 (0.22 to 1.34)178\
(3 RCTs)⊕⊕⊝⊝ Low^3^It is unclear whether there is a difference in the incidence of all adverse events between participants treated with antibacterial irrigation compared with those treated with non‐antibacterial irrigation.67 per 100037 per 1000 (15 to 90)**Risk difference:** 30 fewer adverse events occur per 1000 with antibacterial irrigation than with non‐antibacterial (53 fewer to 23 more)Adverse events: abscess formationStudy population: participants undergoing clean‐contaminated, contaminated or dirty surgical proceduresRR 0.82 (0.42 to 1.62)1309\
(9 RCTs)⊕⊝⊝⊝ Very low^4^The effect of antibacterial compared with non‐antibacterial irrigation on abscess formation is very uncertain31 per 100025 per 1000 (13 to 50)**Risk difference:** 6 fewer abscesses form per 1000 with antibacterial irrigation than with non‐antibacterial (18 fewer to 19 more)\***The risk in the intervention group** (and its 95% confidence interval) is based on the assumed risk in the comparison group and the **relative effect** of the intervention (and its 95% CI). **CI:** confidence interval; **RR:** risk ratio; **SSI:** surgical site infection**GRADE Working Group grades of evidence** **High certainty:** we are very confident that the true effect lies close to that of the estimate of the effect **Moderate quality:** we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different **Low quality:** our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect **Very low quality:** we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect[^3]

Summary of findings 3Standard irrigation compared with pulsatile irrigation for prevention of surgical site infection**Standard irrigation compared with pulsatile irrigation for prevention of surgical site infectionPatient or population:** participants undergoing clean, clean‐contaminated, contaminated or dirty surgical procedures **Setting:** hospital **Intervention:** standard irrigation with saline **Comparison:** pulsatile irrigation with saline**OutcomesAnticipated absolute effects^\*^ (95% CI)Relative effect (95% CI)№ of participants (studies)Certainty of the evidence (GRADE)CommentsRisk with standard irrigationRisk with pulsatile irrigation**SSIStudy population: participants undergoing clean or clean‐contaminated surgical proceduresRR 0.34 (0.19 to 0.62)484 (2 RCTs)⊕⊕⊝⊝ Low^1^Included studies show that there may be fewer SSIs in participants treated with pulsatile saline irrigation compared with standard techniques; the evidence is low certainty due to high risk of biases in the study contributing the majority of participants and weight to the analysis.165 per 100056 per 1000 (31 to 103)**Risk difference:** 109 fewer SSI occur per 1000 with pulsatile irrigation than with standard (134 fewer to 62 fewer)Wound dehiscenceStudy population: participants undergoing\
clean‐contaminated surgical proceduresRR 0.31 (0.01 to 7.55)128 (1 RCT)⊕⊕⊝⊝ Low^2^There is no clear difference in the incidence of wound dehiscence between groups treated with standard or pulsatile techniques of saline irrigation. Confidence intervals include both benefit and harm and are wide and fragile.16 per 10005 per 1000 (0 to 122)**Risk difference:** 11 fewer wound dehiscences occur per 1000 with pulsatile irrigation than with standard (16 fewer to 106 more)Adverse eventsStudy population: participants undergoing clean‐contaminated surgical proceduresRR 1.31 (0.87 to 1.97)128 (1 RCT)⊕⊕⊝⊝ Low^2^There is no clear difference in the incidence of adverse events between groups treated with standard or pulsatile techniques of saline irrigation. Confidence intervals include both benefit and harm and are wide and fragile.486 per 1000371 per 1000**Risk difference:** 115 fewer adverse events occur per 1000 with pulsatile irrigation (360 fewer to 48 more)Adverse events: abscess formationThere were no reported data on abscess formation\***The risk in the intervention group** (and its 95% confidence interval) is based on the assumed risk in the comparison group and the **relative effect** of the intervention (and its 95% CI). **CI:** confidence interval; **RR:** risk ratio; **SSI:** surgical site infection**GRADE Working Group grades of evidence** **High certainty:** we are very confident that the true effect lies close to that of the estimate of the effect **Moderate certainty:** we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different **Low certainty:** our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect **Very low certainty:** we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect[^4]

Background {#CD012234-sec1-0002}
==========

Description of the condition {#CD012234-sec2-0001}
----------------------------

Surgical site infections (SSIs) encompass a range of superficial to deep wound infections that can occur after an operative procedure. SSIs are a preventable complication, responsible for substantial financial burden to health services that can result in poorer patient outcomes, increased mortality, morbidity and reoperation rates. A 2006 prevalence survey in the UK National Health Service (NHS) indicated that approximately 8% of all patients (5743/75,694 patients over a four‐month period) admitted to hospital suffer healthcare‐associated infections, with 15% of these infections being SSIs ([@CD012234-bbs2-0185]). A US study found that in over 750,000 episodes of surgical hospitalisation, 1% resulted in a SSI, and similar estimates have been found in France ([@CD012234-bbs2-0146]; [@CD012234-bbs2-0153]). However, such values are known to underestimate the levels of SSI by not considering those that develop outside hospitals ([@CD012234-bbs2-0149]; [@CD012234-bbs2-0158]), as most SSIs present within the first 30 days following a procedure, although commonly between the fifth and tenth postoperative day ([@CD012234-bbs2-0172]). Patients who develop SSIs have longer hospital stays and incur higher treatment costs than other patients; in some types of surgery they also have higher mortality rates ([@CD012234-bbs2-0151]; [@CD012234-bbs2-0165]). Diagnosis with a SSI after hospital discharge is associated with a greater number of healthcare visits, higher resource use, and more readmissions ([@CD012234-bbs2-0175]). While more data are available for Western healthcare settings, SSI was the leading cause of hospital‐acquired infection in a systematic review of studies in low‐ and middle‐income countries ([@CD012234-bbs2-0144]). Surgical site infection can also contribute to wound dehiscence, which is also a primary outcome of this review; such wounds may then convert to healing by secondary intention with a resultant increased healing time and impact on the individual and on costs to the health service.

While the cause of SSIs is multifactorial, recognised risk factors include: length of hospital stay, obesity, patient co morbidities, duration and complexity of surgery, and degree of wound contamination ([@CD012234-bbs2-0145]; [@CD012234-bbs2-0150]; [@CD012234-bbs2-0155]; [@CD012234-bbs2-0168]; [@CD012234-bbs2-0174]). Using the classification system adopted by the Centers for Disease Control and Prevention (CDC; [@CD012234-bbs2-0159]), wounds can be classified by their level of contamination as follows.

Clean (Class 1): noninfective operative wounds in which no inflammation is encountered, with no involvement of respiratory, gastrointestinal, genitourinary tract, and oropharyngeal cavity.Clean‐contaminated (Class 2): operative wounds in which either the respiratory, gastrointestinal, or genitourinary tract is entered under controlled conditions and with only minor contamination. This category specifically includes wounds as a result of operations involving the biliary tract, appendix, and oropharynx, provided no evidence of infection or a major break in sterile technique is encountered.Contaminated (Class 3): fresh, accidental wounds, resulting from operations with major breaks in sterile technique or gross spillage from the gastrointestinal tract, and incisions in which acute, nonpurulent (free from pus) inflammation is encountered. This category includes traumatic lacerations.Dirty (Class 4): old traumatic wounds with retained devitalised tissue and those that involve existing clinical infection or perforated viscera. Organisms causing postoperative infection are likely to be present in the operative field before the operation.

The risk of developing a SSI is related to the level of contamination of the wound. Higher classifications of contamination are associated with higher risks of a SSI, as demonstrated in recent surveillance of surgical infections in NHS hospitals in England, which showed that gastrointestinal procedures, especially large bowel surgery, carry the highest risk of bacterial contamination (10.2%) ([@CD012234-bbs2-0176]). Conversely, hip and knee prosthesis surgeries were shown to carry the lowest risk of infection, with an occurrence rate of 0.7% and 0.6%, respectively ([@CD012234-bbs2-0176]).

Standard definitions of SSIs exist, as described by the CDC, the Surgical Site Infection Surveillance Service, the Southampton wound scoring system, and the ASEPSIS score ([@CD012234-bbs2-0147]; [@CD012234-bbs2-0163]; [@CD012234-bbs2-0178]; [@CD012234-bbs2-0189]). The most commonly applied definition by the CDC describes three levels of SSI ([@CD012234-bbs2-0163]). The lowest level of SSI can be defined as \'*superficial incisional*\' infections. These are limited to the skin and subcutaneous tissue. Such infections are identified by localised clinical (Celsian) signs such as redness, pain, heat, swelling, or the drainage of pus. \'*Deep incisional\'* infections affect the fascial and muscular layers and are identified by the presence of pus, abscess, fever, localised tenderness, or the separation of incision edges. Finally, \'cavity space\' infection is considered the most severe level of SSI. Such infections can be identified by the drainage of pus, formation of an abscess or histological, radiological, or visual signs during reoperation. These involve anatomical parts of the body that have been manipulated during a surgical procedure, for example, a joint cavity or the peritoneum. Visceral infection is not included within the scope of the CDC guidelines.

SSIs are not restricted to these definitions and are often accompanied by microbiological evidence from microscopy and culture of infection tissue and fluid. However, it is important to note that normal flora may colonise superficial skin sites, and therefore positive microbiological growth in the absence of clinical signs is rarely indicative of SSIs.

Description of the intervention {#CD012234-sec2-0002}
-------------------------------

Surgical wound irrigation is an intraoperative surgical technique, which may reduce the rate of SSIs by the removal of debris (dead or damaged tissue), metabolic waste, and wound exudate. It aims to create the optimal environment for wound healing, and is used with variable uptake among surgical practitioners ([@CD012234-bbs2-0148]). The theoretical advantage of surgical wound irrigation is to reduce the bacterial load in a surgical or traumatic wound by a combination of water pressure, dilution, or the application of antimicrobial agents. Usually, irrigation is undertaken at the end of an operative procedure, prior to wound closure, however postoperative wound irrigation may also be applied.

Intracavity lavage is another intraoperative surgical technique, which utilises similar principles to surgical wound irrigation with the aim of reducing SSI risk. It can be adopted during any operation that exposes a bodily cavity, but is most commonly used for procedures on the abdominal (peritoneal) cavity and during joint replacement surgery. Both wound irrigation and intracavity lavage can be altered by three basic variables: volume of irrigation fluid; mechanism/timing of delivery; or solution composition. We use the terms \'irrigation\' and \'lavage\' separately in this review, however they do not necessarily describe distinctly separate surgical techniques, and may often refer to similar methods of washout for a cavity or a wound.

How the intervention might work {#CD012234-sec2-0003}
-------------------------------

The aim of wound irrigation and lavage is to reduce the bacterial load in a surgical or traumatic wound by a combination of water pressure, dilution, or the application of antimicrobial agents. Usually, this is undertaken at the end of an operative procedure, prior to wound closure, to reduce the likelihood of the introduction of bacteria.

Both wound irrigation and intracavity lavage can be achieved using various solutions. Normal saline is commonly used along with antimicrobial agents for intracavity lavage. However, there is concern that antimicrobial agents may damage tissue and prevent normal healing. It is thought that the introduction of large volumes of fluid into a cavity or wound could wash away inflammatory cells vital to the host defence ([@CD012234-bbs2-0180]).

Why it is important to do this review {#CD012234-sec2-0004}
-------------------------------------

National Institute for Care and Health Excellence (NICE) guidelines reviewed evidence from 20 randomised controlled trials (RCTs) and concluded that the use of surgical wound irrigation or intracavity lavage could not be recommended to reduce the risk of SSIs ([@CD012234-bbs2-0172]). The search used to inform this guideline is now almost 10 years old, making it likely that a number of additional trials will be available. In some areas of surgical practice this is likely to lead to changes in conclusions; we are aware of a recent systematic review which found a benefit to intraoperative irrigation over no irrigation in abdominal surgery ([@CD012234-bbs2-0171]); this included both RCTs and studies that we consider to be quasi‐RCTs. A recent review restricted to prophylactic wound irrigation (excluding surgeries with high levels of contamination) has just been published ([@CD012234-bbs2-0152]), which informed recent WHO guidance ([@CD012234-bbs2-0188]) A recent expert consensus paper also identified the need for more evidence on several of the questions in this review ([@CD012234-bbs2-0148]). This review aims to update this evidence base.

Objectives {#CD012234-sec1-0003}
==========

To assess the effects of wound irrigation and intracavity lavage on the prevention of surgical site infection (SSI).

Methods {#CD012234-sec1-0004}
=======

Criteria for considering studies for this review {#CD012234-sec2-0005}
------------------------------------------------

### Types of studies {#CD012234-sec3-0001}

We included published and unpublished randomised controlled trials (RCTs), including cluster‐RCTs, irrespective of language of report. We excluded studies using quasi‐randomisation (i.e. a method of allocating participants to different forms of care that is not truly random, for example, allocation by date of birth, day of the week, medical record number, month of the year, or the order in which participants are included in the study (alternation)).

### Types of participants {#CD012234-sec3-0002}

All patients undergoing elective or emergency surgery, where surgery was defined as a procedure involving: (1) an incision being made into the skin forming an open wound; or (2) an operative procedure to treat an existing traumatic wound/injury. We included studies including either, or both, adults and children. Only studies focusing on wounds intended to heal by primary intention (i.e. where wound edges are held together after surgery) were included in this review. This included interventions for open fractures or operated traumatic wounds if the aim of the procedure was to heal the wound by primary intention. We excluded surgery intended to create wounds with planned healing by secondary intention (i.e. left open to heal through the formation of new tissues) or wounds healing by delayed primary/tertiary intention (wounds which are intentionally initially left open for a period of time, but then have the edges brought together for the rest of the healing process).

### Types of interventions {#CD012234-sec3-0003}

We included studies where the type or schedule of intraoperative washout (either wound irrigation or intracavity lavage) was the only systematic difference between study arms.

Surgical wound irrigation may occur as a singular event during wound closure, or involve the irrigation of a wound continuously/repeatedly during surgery, or in the postoperative period. Types of surgical wound irrigation may vary by volume of irrigation fluid, mechanism of delivery, or solution composition. We did not include studies where the irrigation was confined solely to the interior of internal organs (e.g.) the uterus, bowel or bladder, but did include studies in which (e.g.) the peritoneum was irrigated in addition to such procedures. We did not include studies of surgery in the oral or aural cavities or in the eyes.

Intracavity lavage may also occur as a singular event during surgery, which exposes a body cavity, or involve the irrigation of a cavity continuously/repeatedly during surgery, or in the postoperative period. Types of intracavity lavage again may vary by volume of irrigation fluid, mechanism of delivery, or solution composition.

In practice we found that the terms \'irrigation\' and \'lavage\' are often used interchangeably. We included all studies in which a washout procedure was conducted and we have used the term \'irrigation\' throughout the review. Where the term \'lavage\' was used in the included studies, this is reflected in the [Characteristics of included studies](#CD012234-sec2-0022){ref-type="sec"} tables; this section also details all available information on the point(s) at which irrigation occurred during surgery. We did not pre‐specify any subgrouping based on the use of irrigation or lavage or the level at which it was conducted; we have not conducted any post‐hoc analysis based on this but have followed the protocol and grouped all forms of intraoperative washout. The only exception was where one study used procedures which were so different from the other studies in the comparison that we treated this separately.

We anticipated that likely comparisons in this review may include:

comparison of wound irrigation/intracavity lavage with no washout;comparison of different solutions used for wound irrigation or intracavity lavage;comparison of different volumes of fluid used for wound irrigation or intracavity lavage;comparison of different mechanisms of delivery used for wound irrigation or intracavity lavage; andcomparison of different schedules/timings of wound irrigation or intracavity lavage.

### Types of outcome measures {#CD012234-sec3-0004}

We list primary and secondary outcome measures below. If a trial was otherwise eligible (correct study design, population, and intervention/comparator) but did not report a listed outcome, then we attempted to contact the study authors, in order to establish whether a relevant outcome was measured but not reported. However, we did not plan to exclude otherwise eligible studies solely on the basis of reported outcomes. In several instances author contact was not immediately successful and we recorded these studies as [Studies awaiting classification](#CD012234-bbs1-0003){ref-type="ref-list"}.

Where possible, we anticipated grouping outcomes by the following time points; the review authors used their judgement as to whether statistical pooling within these time categories was appropriate:

short‐term: 30 daysmedium‐term: more than 30 days to 12 monthslong‐term: more than 12 months.

In practice we found that the overwhelming majority of the data reported were for time points of between two and eight weeks postoperatively, with the majority being at either four or six weeks, sometimes with interim but unreported follow‐up points. We therefore decided that we would group all the data together for the outcomes reported; we did not consider dividing data reported at points that narrowly spanned 30 days to be informative.

#### Primary outcomes {#CD012234-sec4-0001}

Surgical site infection measured as: occurrence of postoperative surgical site infection (SSI) as defined by the CDC criteria ([@CD012234-bbs2-0164]), or the study authors\' definition of SSI. We did not differentiate between superficial and deep incisional infection. We planned to document septicaemia or septic shock under this outcome.Wound dehiscence within 30 days of operation. This included both superficial dehiscence (involving skin and subcutaneous tissues) or deep dehiscence (burst abdomen or dehiscence of fascia). Postoperative wound dehiscence refers to wound disruption resulting from poor wound healing. This may be caused by various factors, including infection, as well as the type of incision and patient characteristics, such as diabetes or smoking ([@CD012234-bbs2-0179]).

#### Secondary outcomes {#CD012234-sec4-0002}

30‐day mortality/in‐hospital mortalityProportion of participants with postoperative SSI using systemic antibiotics within 30 days of surgeryOccurrence of infections that show antibiotic resistanceAdverse events including postoperative abscess formation; we planned to include these, where reported, as total number of individuals with an adverse event in each intervention groupSurgical re‐intervention rates (including the placement of radiologically‐guided drains and joint revision surgery)Mean length of hospital stayNumber of hospital readmissions.

Search methods for identification of studies {#CD012234-sec2-0006}
--------------------------------------------

### Electronic searches {#CD012234-sec3-0005}

We searched the following electronic databases for randomised controlled trials:

the Cochrane Wounds Specialised Register (searched 1 February 2017);the Cochrane Central Register of Controlled Trials (CENTRAL; 2017, issue 1) in the Cochrane Library (searched 1 February 2017);Ovid MEDLINE (1946 to 1 February 2017);Ovid MEDLINE (In‐Process & Other Non‐Indexed Citations) (searched 1 February 2017);Ovid Embase (1974 to 1 February 2017);EBSCO CINAHL Plus (1937 to 1 February 2017).

The search strategies for the Cochrane Wounds Specialised Register, CENTRAL, Ovid MEDLINE, Ovid Embase and EBSCO CINAHL Plus are available in [Appendix 1](#CD012234-sec2-0016){ref-type="app"}. We combined the Ovid MEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity‐ and precision‐maximising version (2008 revision) ([@CD012234-bbs2-0169]). We combined the Embase search with the Ovid Embase randomised trials filter terms developed by the UK Cochrane Centre ([@CD012234-bbs2-0169]). We combined the CINAHL Plus searches with the randomised trials filter terms developed by the Scottish Intercollegiate Guidelines Network ([@CD012234-bbs2-0183]). We did not impose any restrictions with respect to language, date of publication, or study setting.

We also searched the following clinical trials registries for ongoing studies in March 2017:

[ClinicalTrials.gov](ClinicalTrials.gov) (searched 7 March 2017);[World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP)](World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP)) (searched 7 March 2017);[EU Clinical Trials Register](EU Clinical Trials Register) (searched 7 March 2017).

Search strategies for the clinical trials registries are available in [Appendix 1](#CD012234-sec2-0016){ref-type="app"}.

### Searching other resources {#CD012234-sec3-0006}

We sought to identify other potentially eligible trials or ancillary publications by searching the reference lists of retrieved included trials as well as relevant systematic reviews, meta‐analyses, and health‐technology assessment reports.

Data collection and analysis {#CD012234-sec2-0007}
----------------------------

### Selection of studies {#CD012234-sec3-0007}

Two review authors (CR and either TS or GN) independently assessed the titles and abstracts of the citations retrieved by the searches for relevance. After this initial assessment, we obtained full‐text copies of all studies considered to be potentially relevant. Two review authors (GN and either CR or TS) independently checked the full papers for eligibility; disagreements were resolved by discussion and, where required, the input of a third review author (CR, TS, JD or RA as appropriate). Where required and possible, we contacted study authors where the eligibility of a study was unclear. We recorded all reasons for exclusion of studies for which we had obtained full copies, where it was not immediately obvious that the study was ineligible after being ordered due to a very sparse citation record. We completed a PRISMA flowchart to summarise this process ([@CD012234-bbs2-0170]); [Figure 1](#CD012234-fig-0001){ref-type="fig"}.Figure 1Study flow diagram

Where studies were reported in multiple publications/reports, we obtained all publications. Whilst we included the study only once in the review, we extracted data from all reports to ensure maximal relevant data were obtained. Where it was unclear whether publications referred to the same study we attempted to contact the authors for clarification.

### Data extraction and management {#CD012234-sec3-0008}

We extracted and summarised details of the eligible studies using a data extraction sheet. Two review authors (two of CR,TS, GN, RA and AR) extracted data independently and resolved disagreements by discussion, drawing on a third review author (JD) where required. Where key data were missing from reports, we attempted to contact the study authors to obtain this information. Where a study with more than two intervention arms was included, we only extracted data from intervention and control groups that met the eligibility criteria.

We extracted the following data, where possible, by treatment group for the prespecified interventions and outcomes in this review. We planned to collect outcome data for relevant time points, as described in [Types of outcome measures](#CD012234-sec3-0004){ref-type="sec"}; in practice most studies reported only one time point.

Country of originType of wound and surgeryUnit of randomisation (e.g. participant or wound)Unit of analysis (e.g. participant or wound)Trial design (e.g. parallel; cluster)Number of participants/wounds randomised to each trial armEligibility criteria and key baseline participant dataDetails of treatment regimen received by each groupDuration of treatmentDetails of any co‐interventionsPrimary and secondary outcome(s) (with definitions and time points)Outcome data for primary and secondary outcomes (by group)Duration of follow‐up.Number of withdrawals (by group)Publication status of studySource of funding for trial.

### Assessment of risk of bias in included studies {#CD012234-sec3-0009}

Two review authors (two of CR, TS, GN, RA or AR) independently assessed included studies using the Cochrane approach for assessing risk of bias as detailed in the *Cochrane Handbook for Systematic Reviews of Interventions* ([@CD012234-bbs2-0161]). We resolved disagreements through discussion or by consulting a third review author (typically JD). The tool addresses specific domains: sequence generation, allocation concealment, blinding of participants and personnel, blinding of outcome assessors, incomplete data, selective outcome reporting, and other issues -- in this review we planned to record issues with unit of analysis, for example, where a cluster trial had been undertaken but analysed at the individual level in the study report ([Appendix 2](#CD012234-sec2-0017){ref-type="app"}). We recorded issues with adjustment for paired data in split‐body designs and with early stopping in this domain. We assessed blinding and completeness of outcome data for each of the review outcomes separately. In this review we anticipated that blinding of participants and personnel may not be possible. For this reason the assessment of the risk of detection bias focused on whether blinded outcome assessment was reported (because assessment of wound outcomes, such as breakdown and healing, can be subjective and at high risk of detection bias when outcome assessment is not blinded). We used blinding of outcome assessment to determine risk of bias from blinding in these instances. Although we recorded risk of bias from blinding of personnel and participants, we did not downgrade the certainty of the evidence for this alone, where the nature of the comparison made it highly likely. We presented our assessment of risk of bias using two \'Risk of bias\' summary figures; one that is a summary of bias for each item across all studies, and a second that shows a cross‐tabulation of each trial by all of the risk of bias items ([Figure 2](#CD012234-fig-0002){ref-type="fig"}; [Figure 3](#CD012234-fig-0003){ref-type="fig"}).Figure 2Risk of bias summary: review authors\' judgements about each risk of bias item for each included studyFigure 3Risk of bias graph: review authors\' judgements about each risk of bias item presented as percentages across all included studies

For trials using cluster‐randomisation, we also planned to consider the risk of bias considering: recruitment bias, baseline imbalance, loss of clusters, incorrect analysis, and comparability with individually randomised trials ([@CD012234-bbs2-0162]; [Appendix 3](#CD012234-sec2-0018){ref-type="app"}).

### Measures of treatment effect {#CD012234-sec3-0010}

For dichotomous outcomes, we calculated the risk ratio (RR) with 95% confidence intervals (CIs). For continuous outcomes we used the difference in means with 95% CIs, if all trials used the same or similar assessment scale. If trials had used different assessment scales, we planned to use the standardised difference in means with 95% CIs.

### Unit of analysis issues {#CD012234-sec3-0011}

If included studies had randomised at the participant level and measured outcomes at the wound level, we planned to treat the participant as the unit of analysis when the number of wounds assessed appeared equal to the number of participants (e.g. one wound per person).

Particular unit of analysis issues in wound care trials can occur when: (1) studies randomise at the participant level, use the allocated treatment on multiple wounds per participant, and then analyse outcomes per wound; or (2) studies undertake multiple assessments of an outcome over time per participant. These approaches should be treated as cluster trials, alongside more standard cluster designs -- such as delivery of interventions at an organisational level.

Where a cluster trial had been conducted and correctly analysed we planned to meta‐analyse effect estimates and their standard errors using the generic inverse‐variance method in Review Manager 5 ([@CD012234-bbs2-0177].

We planned to record where a cluster‐randomised trial had been conducted, but incorrectly analysed as part of the \'Risk of bias\' assessment. If possible, we planned to approximate the correct analyses based on guidance from the *Cochrane Handbook for Systematic Reviews of Interventions* ([@CD012234-bbs2-0162]), using information on:

the number of clusters (or groups) randomised to each intervention group; or the average (mean) size of each cluster;the outcome data ignoring the cluster design for the total number of individuals (for example, number or proportion of individuals with events, or means and standard deviations); andan estimate of the intra cluster (or intra class) correlation coefficient (ICC).

If we had been unable to analyse the study data correctly, we planned to extract and present outcome data but not analyse it further.

We did not identify any cluster randomised studies, but did identify a split‐body design in which two incisions on each participant were randomised to different treatment groups. This represented paired data and it was unclear that this had been adjusted for. Unadjusted paired data will generate confidence intervals wider than the true ones for the effect estimate. We presented the results of the single study with this design in narrative form, but did not include data from the study in any meta‐analysis.

### Dealing with missing data {#CD012234-sec3-0012}

It is common to have data missing from trial reports. Excluding participants post‐randomisation from the analysis, or ignoring those participants who are lost to follow‐up compromises the randomisation, and potentially introduces bias into the trial. Where there were missing data that we thought should be included in the analyses, or where data were unclear, we attempted to contact relevant study authors to request or clarify these data.

Where data remained missing for the proportion of participants with dehisced wounds or participants with SSI, we assumed that if randomised participants were not included in the results section of the paper, their wound did not show dehiscence or they did not have a SSI (i.e. in the analysis, missing participants were considered in the denominator but not the numerator). When appropriate, we planned to conduct a completed case analysis as a sensitivity analysis and also planned to explore alternative scenarios using different assumptions about missing cases. In the event only one trial had very substantive numbers of participants who were absent from the reported results and, because of clinical considerations we considered an ITT analysis non‐conservative. We therefore conducted a completed case analysis and conducted a sensitivity analysis to explore the impact of excluding this trial from the meta‐analysis.

For continuous variables, for example, length of hospital stay, and for all secondary outcomes, we presented available data from the study reports/study authors, but we did not impute missing data. Where measures of variance were missing, we planned to calculate these if this were possible. When calculation was not possible, we attempted to contact study authors. Where these measures of variation were not available, we excluded the study from any relevant meta‐analyses that we conducted.

### Assessment of heterogeneity {#CD012234-sec3-0013}

Assessment of heterogeneity can be a complex, multifaceted process. Firstly, we considered clinical and methodological heterogeneity: that is, the degree to which the included studies varied in terms of participant, intervention, outcome, and characteristics such as duration of follow‐up. We supplemented this assessment of clinical and methodological heterogeneity with information regarding statistical heterogeneity ‐ assessed using the Chi² test (we considered a significance level of P \< 0.10 to indicate statistically significant heterogeneity) in conjunction with the I² statistic ([@CD012234-bbs2-0160]). The I² statistic examines the percentage of total variation across RCTs that is due to heterogeneity rather than chance ([@CD012234-bbs2-0160]). In general, I² values of 25%, or less, can be interpreted as a low level of heterogeneity ([@CD012234-bbs2-0160]), and values of 75%, or more, indicate very high heterogeneity ([@CD012234-bbs2-0154]). However, these figures are only a guide, and it has been recognised that statistical tests and metrics may miss important heterogeneity ‐ thus, whilst these were assessed, the overall assessment of heterogeneity used these measures in combination with the methodological and clinical assessment of heterogeneity: see [Data synthesis](#CD012234-sec3-0015){ref-type="sec"} for further information about how we dealt with potential heterogeneity in the data analyses.

### Assessment of reporting biases {#CD012234-sec3-0014}

Reporting biases arise when the dissemination of research findings is influenced by the nature and direction of results. Publication bias is one of a number of possible causes of \'small study effects\', that is, a tendency for estimates of the intervention effect to be more beneficial in smaller RCTs. Funnel plots allow a visual assessment of whether small study effects may be present in a meta‐analysis. A funnel plot is a simple scatter plot of the intervention effect estimates from individual RCTs against some measure of each trial\'s size or precision ([@CD012234-bbs2-0186]). We presented funnel plots for meta‐analyses comprising 10 RCTs or more using Review Manager 5 ([@CD012234-bbs2-0177]). We also conducted Egger\'s test as a post‐hoc measure on the advice of peer reviewers.

### Data synthesis {#CD012234-sec3-0015}

We combined details of included studies in narrative review according to type of comparator and contamination level of wound. We planned to group outcomes by time period but in practice found that this was not helpful (see [Differences between protocol and review](#CD012234-sec1-0016){ref-type="notes"}). We considered clinical and methodological heterogeneity, and undertook pooling when studies appeared appropriately similar in terms of wound type, intervention type, duration of follow‐up, and outcome type.

In terms of meta‐analytical approach, our default approach was to use the random‐effects model. We planned to only use a fixed‐effect approach if clinical heterogeneity was thought to be minimal and statistical heterogeneity was not statistically significant for the Chi‐^2^ value and 0% for the I^2^ assessment ([@CD012234-bbs2-0167]). We adopted this approach as it is recognised that statistical assessments can miss potentially important between‐study heterogeneity in small samples, hence the preference for the more conservative random‐effects model ([@CD012234-bbs2-0166]). Since either clinical or statistical heterogeneity indicated that a random‐effects analysis was appropriate in all cases, we did not use any fixed‐effect analyses. Where clinical heterogeneity was thought to be acceptable, or of interest, we planned that we would meta‐analyse even when statistical heterogeneity was high, but would have attempted to interpret the causes behind this heterogeneity. We planned to consider using meta‐regression for that purpose, if possible ([@CD012234-bbs2-0187]). In the event, heterogeneity was not sufficiently high to require this approach but we used some exploratory subgroup analyses to confirm that lower levels of heterogeneity were not a consequence of particular differences between interventions.

We presented data using forest plots, where possible. For dichotomous outcomes, we presented the summary estimate as a RR with 95% CI. If continuous outcomes were measured in the same way across studies, we presented a pooled difference in means with 95% CI; we had planned to pool standardised difference in means estimates where studies measured the same outcome, but use different methods. However the studies that reported continuous data all used the same unit of measurement. For time to event data, we planned to plot (and, if appropriate, pool) estimates of hazard ratios and 95% CIs, as presented in the study reports, using the generic inverse variance method in Review Manager 5 ([@CD012234-bbs2-0177]), however no time‐to event data were reported in included studies.

We obtained pooled estimates of treatment effect using Cochrane Review Manager 5 software ([@CD012234-bbs2-0177]).

#### \'Summary of findings\' tables {#CD012234-sec4-0003}

We presented the main results of the review in \'Summary of findings\' tables. These tables present key information concerning the quality of the evidence, the magnitude of the effects of the interventions examined, and the sum of the available data for the main outcomes ([@CD012234-bbs2-0181]). The \'Summary of findings\' tables also include an overall grading of the evidence related to each of the main outcomes using the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach. The GRADE approach defines the quality of a body of evidence as the extent to which one can be confident that an estimate of effect or association is close to the true quantity of specific interest. The quality of a body of evidence involves consideration of within‐trial risk of bias (methodological quality), directness of evidence, heterogeneity, precision of effect estimates, and risk of publication bias ([@CD012234-bbs2-0182]). GRADE was undertaken for all outcomes where it was possible to calculate an estimate of effect. We planned to present the following primary outcomes in the \'Summary of findings\' tables:

surgical site infection (SSI);wound dehiscence within 30 days of operation.

In addition we also included adverse events in the \'Summary of findings\' tables; this was at the suggestion of peer reviewers as noted in [Differences between protocol and review](#CD012234-sec1-0016){ref-type="notes"}.

We did not produce a \'Summary of findings\' table for comparisons where the data were limited. Instead we summarised the specified outcomes together with their GRADE assessment in an additional table, [Table 8](#CD012234-tbl-0008){ref-type="table"}. This was done in order to make the \'Summary of findings\' tables manageable and improve the readability of the review.Table 1Summary of GRADE assessments for comparisons with limited data**ComparisonSurgeryParticipants (studies)SSI RR (95% CI)GRADE judgement: certainty of the evidenceReason for downgrading**Icodextrin vs Ringer\'s solutionClean‐contaminated\
(uterine)426 (1 RCT)\
[@CD012234-bbs2-0057]2.89 (0.30 to 27.56)LowDowngraded twice for very serious imprecisionPovidone iodine vs DermacynClean\
(cardiac)190 (1 RCT)\
[@CD012234-bbs2-0030]2.80 (1.05 to 7.47)LowDowngraded once for high risk of bias and once for imprecisionPovidone iodine vs chlorhexidineDirty\
(peritonitis)53 (1 RCT)^1^\
[@CD012234-bbs2-0058]1.13 (0.78 to 1.63)Very lowDowngraded twice for high risk of bias in multiple domains and once for imprecisionCepharin vs cefoxitinClean‐contaminated\
(caesarean section)132 (1 RCT)^1^\
[@CD012234-bbs2-0024]Not estimable\
(no events in either group)No assessment possible‐Epicillin vs lincomycinContaminated\
(appendicitis)162 (1 RCT)^1^\
[@CD012234-bbs2-0028]Not estimable\
(data not reported for groups)No assessment possible‐Gentamicin vs clindamycinClean\
(breast)51 (1 RCT)^1^\
[@CD012234-bbs2-0036]Not estimable\
(no events in either group)No assessment possible‐Cephapirin versus moxalactamClean‐contaminated\
(caesarean section)149 (total 360) (1 RCT)^2^\
[@CD012234-bbs2-0013]1.69 (0.29 to 9.84)LowDowngraded twice for very serious imprecisionCephapirin versus cefamandoleClean‐contaminated\
(caesarean section)134 (total 360) (1 RCT)^2^\
[@CD012234-bbs2-0013]1.37 (0.24 to 7.95)LowDowngraded twice for very serious imprecisionCephapirin versus ampicillinClean‐contaminated\
(caesarean section)140 (total 360) (1 RCT)^2^\
[@CD012234-bbs2-0013]7.00 (0.37 to 133.06)LowDowngraded twice for very serious imprecisionCefamandole versus moxalactamClean‐contaminated\
(caesarean section)143 (total 360) (1 RCT)^2^\
[@CD012234-bbs2-0013]1.23 (0.18 to 8.52)LowDowngraded twice for very serious imprecisionCefamandole versus ampicillinClean‐contaminated\
(caesarean section)134 (total 360) (1 RCT)^2^\
[@CD012234-bbs2-0013]5.46 (0.27 to 111.65)LowDowngraded twice for very serious imprecisionMoxalactam versus ampicillinClean‐contaminated\
(caesarean section)149 (total 360) (1 RCT)^2^\
[@CD012234-bbs2-0013]4.44 (0.22 to 90.88)LowDowngraded twice for very serious imprecisionCefazolin versus cefamandoleClean‐contaminated\
(caesarean section)207 (1 RCT)\
[@CD012234-bbs2-0038]4.58 (0.22 to 93.38)LowDowngraded twice for very serious imprecision[^5]

### Subgroup analysis and investigation of heterogeneity {#CD012234-sec3-0016}

Where feasible, we planned to explore the effects of interventions in children (aged under 18) and adults separately. We also planned in advance, and conducted (where possible) an exploration of the effects of interventions according to classification of wound contamination (clean, clean‐contaminated, contaminated, dirty). We used a post‐hoc exploratory sub‐group analysis to confirm the appropriateness of combining studies that used different types of lavage solution.

### Sensitivity analysis {#CD012234-sec3-0017}

Where possible, we planned and conducted sensitivity analyses to explore the effect of the following criteria:

studies at high risk of bias for any domain compared with other studies with no domain classed at high risk of bias;studies at high risk of detection bias compared with other studies.

**Elements of this Methods section are based on the standard Cochrane Wounds Protocol Template. The published protocol is archived in the Cochrane Library (**[@CD012234-bbs2-0190]**).**

Results {#CD012234-sec1-0005}
=======

Description of studies {#CD012234-sec2-0008}
----------------------

### Results of the search {#CD012234-sec3-0018}

The electronic searches identified 605 records. Of these we obtained 182 full‐text records. Citation searching identified a further 29 records, which were thoroughly assessed as full texts. An additional six records of relevant ongoing studies were identified from searches of trials registers. The results of the search and assessment process are shown in [Figure 1](#CD012234-fig-0001){ref-type="fig"}.

### Included studies {#CD012234-sec3-0019}

We included 59 RCTs reported in 64 publications and together involving 14,738 participants.

Most included studies assessed the following comparisons.

Use of irrigation compared with no irrigation (20 studies) ([@CD012234-bbs2-0003]; [@CD012234-bbs2-0006]; [@CD012234-bbs2-0009]; [@CD012234-bbs2-0012]; [@CD012234-bbs2-0014]; [@CD012234-bbs2-0015]; [@CD012234-bbs2-0017]; [@CD012234-bbs2-0020]; [@CD012234-bbs2-0027]; [@CD012234-bbs2-0035]; [@CD012234-bbs2-0037]; [@CD012234-bbs2-0039]; [@CD012234-bbs2-0046]; [@CD012234-bbs2-0050]; [@CD012234-bbs2-0051]; [@CD012234-bbs2-0053]; [@CD012234-bbs2-0054]; [@CD012234-bbs2-0055]; [@CD012234-bbs2-0056]; [@CD012234-bbs2-0059])Use of an antibacterial (antibiotic or antiseptic) solution compared with a non‐antibacterial irrigant such as saline (36 studies) ([@CD012234-bbs2-0001]; [@CD012234-bbs2-0002]; [@CD012234-bbs2-0003]; [@CD012234-bbs2-0005]; [@CD012234-bbs2-0007]; [@CD012234-bbs2-0008]; [@CD012234-bbs2-0010]; [@CD012234-bbs2-0011]; [@CD012234-bbs2-0013]; [@CD012234-bbs2-0016]; [@CD012234-bbs2-0018]; [@CD012234-bbs2-0021]; [@CD012234-bbs2-0022]; [@CD012234-bbs2-0023]; [@CD012234-bbs2-0024]; [@CD012234-bbs2-0025]; [@CD012234-bbs2-0026]; [@CD012234-bbs2-0028]; [@CD012234-bbs2-0029]; [@CD012234-bbs2-0031]; [@CD012234-bbs2-0032]; [@CD012234-bbs2-0035]; [@CD012234-bbs2-0036]; [@CD012234-bbs2-0034]; [@CD012234-bbs2-0040]; [@CD012234-bbs2-0041]; [@CD012234-bbs2-0042]; [@CD012234-bbs2-0043]; [@CD012234-bbs2-0044]; [@CD012234-bbs2-0045]; [@CD012234-bbs2-0046]; [@CD012234-bbs2-0048]; [@CD012234-bbs2-0049]; [@CD012234-bbs2-0052]; [@CD012234-bbs2-0056]; [@CD012234-bbs2-0058])Different methods of irrigation delivery (standard or pulsatile) compared (two studies) ([@CD012234-bbs2-0019]; [@CD012234-bbs2-0033])Different antibacterial irrigants compared (six studies) ([@CD012234-bbs2-0013]; [@CD012234-bbs2-0030]; [@CD012234-bbs2-0036]; [@CD012234-bbs2-0038]; [@CD012234-bbs2-0056]; [@CD012234-bbs2-0058])Different non‐antibacterial irrigants compared (three studies) ([@CD012234-bbs2-0004]; [@CD012234-bbs2-0047]; [@CD012234-bbs2-0057])

No studies compared an antibiotic solution with an antiseptic and no studies compared different volumes of irrigation.

There were eleven studies with more than two relevant arms ([@CD012234-bbs2-0003]; [@CD012234-bbs2-0013]; [@CD012234-bbs2-0015]; [@CD012234-bbs2-0024]; [@CD012234-bbs2-0026]; [@CD012234-bbs2-0028]; [@CD012234-bbs2-0035]; [@CD012234-bbs2-0036]; [@CD012234-bbs2-0056]; [@CD012234-bbs2-0046]; [@CD012234-bbs2-0058]); where appropriate to the comparison we combined data from two or more arms.

A majority of included studies enrolled adult participants. A small number ([@CD012234-bbs2-0021]; [@CD012234-bbs2-0022]; [@CD012234-bbs2-0023]; [@CD012234-bbs2-0051]) included only children, and in several others there were a mixture of adult and paediatric participants or it was unclear whether children, adults or a mixture were included. More information on study participants is given for each comparison (see [Effects of interventions](#CD012234-sec2-0010){ref-type="sec"}). Because of the nature of the surgeries assessed (e.g. caesarean sections), many studies enrolled only women.

A wide range of surgical operations and all classes of surgery (clean, clean‐contaminated, contaminated, dirty) were represented in the review. Use of prophylactic antibiotics varied but was, as anticipated, more likely to be reported for studies enrolling participants undergoing surgeries with higher levels of contamination. For further details of the operations and surgical category represented in each comparison (see [Effects of interventions](#CD012234-sec2-0010){ref-type="sec"}).

#### Ongoing or pending assessment studies {#CD012234-sec4-0004}

Five studies (reported in six publications) are pending assessment ([@CD012234-bbs2-0133]; [@CD012234-bbs2-0134]; [@CD012234-bbs2-0135]; [@CD012234-bbs2-0136]; [@CD012234-bbs2-0137]). In each case there were no relevant review outcomes reported; we have attempted to contact study authors without success to date in four cases. In the case of [@CD012234-bbs2-0133] a further publication with relevant data is pending but the corresponding author was unable to supply this in advance of publication. We were able to exclude a further study after author contact confirmed that the purpose of the study was outside the scope of this review and no relevant outcome data were available ([@CD012234-bbs2-0093]) (see [Excluded studies](#CD012234-sec3-0020){ref-type="sec"}).

Searching of trial registers identified six additional studies, which appeared to meet inclusion criteria but which were either still ongoing or which were completed but had no available outcome data or related publications. See [Ongoing studies](#CD012234-bbs1-0004){ref-type="ref-list"} for details of these trials.

### Excluded studies {#CD012234-sec3-0020}

We excluded 141 papers after appraisal of the full text. We ordered many of these because the initial records contained so little information, and upon obtaining full texts it was immediately evident that many studies were not eligible; others were reviews obtained solely in order to screen the bibliography. We noted more nuanced reasons for exclusion for 73 studies reported in 78 records; these studies are detailed here (see [Characteristics of excluded studies](#CD012234-sec2-0023){ref-type="sec"}).

We excluded studies for the following reasons: use of quasi‐randomisation (14 studies: [@CD012234-bbs2-0062]; [@CD012234-bbs2-0067]; [@CD012234-bbs2-0068]; [@CD012234-bbs2-0082]; [@CD012234-bbs2-0091]; [@CD012234-bbs2-0094]; [@CD012234-bbs2-0095]; [@CD012234-bbs2-0101]; [@CD012234-bbs2-0106]; [@CD012234-bbs2-0107]; [@CD012234-bbs2-0108]; [@CD012234-bbs2-0113]; [@CD012234-bbs2-0115]; [@CD012234-bbs2-0125]); or lack of randomisation only apparent after translation or study author contact (two studies: [@CD012234-bbs2-0126]; [@CD012234-bbs2-0130]); use of perioperative irrigation was not the only systematic difference between groups (20 studies: [@CD012234-bbs2-0061]; [@CD012234-bbs2-0065]; [@CD012234-bbs2-0066]; [@CD012234-bbs2-0069]; [@CD012234-bbs2-0072]; [@CD012234-bbs2-0073]; [@CD012234-bbs2-0077]; [@CD012234-bbs2-0078]; [@CD012234-bbs2-0080]; [@CD012234-bbs2-0086]; [@CD012234-bbs2-0096]; [@CD012234-bbs2-0103]; [@CD012234-bbs2-0112]; [@CD012234-bbs2-0116]; [@CD012234-bbs2-0118]; [@CD012234-bbs2-0120]; [@CD012234-bbs2-0122]; [@CD012234-bbs2-0127]; [@CD012234-bbs2-0129]; [@CD012234-bbs2-0131]); the study enrolled participants from a different patient population ‐ some or all participants did not undergo surgery (eight studies: [@CD012234-bbs2-0071]; [@CD012234-bbs2-0083]; [@CD012234-bbs2-0084]; [@CD012234-bbs2-0087]; [@CD012234-bbs2-0100]; [@CD012234-bbs2-0105]; [@CD012234-bbs2-0114]; [@CD012234-bbs2-0128]) or there was healing by delayed primary or secondary intention in some or all wounds (12 studies: [@CD012234-bbs2-0060]; [@CD012234-bbs2-0063]; [@CD012234-bbs2-0064]; [@CD012234-bbs2-0076]; [@CD012234-bbs2-0079]; [@CD012234-bbs2-0088]; [@CD012234-bbs2-0090]; [@CD012234-bbs2-0102]; [@CD012234-bbs2-0110]; [@CD012234-bbs2-0119]; [@CD012234-bbs2-0123]; [@CD012234-bbs2-0124]); the study assessed an ineligible intervention including irrigation conducted as a method of analgesia only, volumes of liquid used being too low to be considered irrigation, or irrigation was not the intervention of interest (17 studies: [@CD012234-bbs2-0070]; [@CD012234-bbs2-0074]; [@CD012234-bbs2-0075]; [@CD012234-bbs2-0081]; [@CD012234-bbs2-0085]; [@CD012234-bbs2-0089]; [@CD012234-bbs2-0092]; [@CD012234-bbs2-0093]; [@CD012234-bbs2-0097]; [@CD012234-bbs2-0098]; [@CD012234-bbs2-0099]; [@CD012234-bbs2-0104]; [@CD012234-bbs2-0109]; [@CD012234-bbs2-0111]; [@CD012234-bbs2-0117]; [@CD012234-bbs2-0121]; [@CD012234-bbs2-0132]).

Risk of bias in included studies {#CD012234-sec2-0009}
--------------------------------

A minority of studies were at high risk of avoidable bias in one or more domains. Many more were at risk of performance bias because of the nature of the comparison evaluated, and in more still there was a lack of clarity about the risk of bias across many or even all domains. The risk of bias for each study and a summary across all studies is shown in [Figure 2](#CD012234-fig-0002){ref-type="fig"} and [Figure 3](#CD012234-fig-0003){ref-type="fig"}.

### Allocation {#CD012234-sec3-0021}

About half of the included studies reported appropriate methods of generating a randomisation sequence. The others had an unclear risk of bias with the exception of one where it appeared that an otherwise acceptable method was likely not to have been implemented and the authors noted concern that randomisation may have been compromised ([@CD012234-bbs2-0054]). Fewer studies reported adequate concealment of allocation; in a majority this was unclear.

### Blinding {#CD012234-sec3-0022}

Many of the studies assessed a comparison between lavage/irrigation and no lavage/irrigation. In these cases personnel could not be blinded and the studies were therefore at high risk of performance bias. Because of this we focused on blinding of outcome assessment (risk of detection bias) when performing the GRADE assessment for these comparisons and did not downgrade because of high risk of performance bias. Where blinding was more feasible it often remained unclear whether personnel and participants were aware of the treatment groups. Blinding of outcome assessors was reported for a minority of studies. While only a few studies were clearly at high risk of detection bias many more had an unclear risk as the assessment was poorly described.

### Incomplete outcome data {#CD012234-sec3-0023}

Almost two‐thirds of studies were classed as being at low risk of bias for this domain. However a minority of studies were at high risk of bias with exclusions from analyses representing a serious threat to the validity of the result.

### Selective reporting {#CD012234-sec3-0024}

A minority of studies showed clear evidence of reporting bias. A somewhat greater number clearly reported full details of all specified outcomes, but many more were poorly reported and it was unclear whether all planned outcomes were fully reported.

### Other potential sources of bias {#CD012234-sec3-0025}

There were few additional sources of bias which were evident from the trial reports but many studies were poorly or very briefly reported and it was difficult to determine whether there were additional factors that we may have considered to pose a serious risk of bias.

Effects of interventions {#CD012234-sec2-0010}
------------------------

See: [Table 1](#CD012234-tbl-0001){ref-type="table"}; [Table 2](#CD012234-tbl-0002){ref-type="table"}; [Table 3](#CD012234-tbl-0003){ref-type="table"}

We assessed the following types of comparisons.

Comparison of irrigation with no irrigationComparisons of different types of irrigation solutionantibacterial (antibiotic or antiseptic) versus non‐antibacterialcomparisons of different antibacterial solutions ‐ either two antibiotics or two antisepticscomparisons of different non‐antibacterial solutionsComparisons of different methods of lavage delivery.

### Comparison 1: comparison of irrigation with no irrigation {#CD012234-sec3-0026}

[Table 1](#CD012234-tbl-0001){ref-type="table"}

Twenty studies (7192 participants) compared the use of some form of wound irrigation with no irrigation.

Types of surgery represented in this comparison include breast surgery (reduction), caesarean sections, appendicitis surgery, gastrectomy, uterine surgery, liver resection and various abdominal procedures and cover clean, clean‐contaminated, contaminated and dirty surgical classifications. One study was classed as clean ([@CD012234-bbs2-0039]); nine as clean‐contaminated ([@CD012234-bbs2-0003]; [@CD012234-bbs2-0012][@CD012234-bbs2-0015]; [@CD012234-bbs2-0017]; [@CD012234-bbs2-0020]; [@CD012234-bbs2-0027]; [@CD012234-bbs2-0053]; [@CD012234-bbs2-0055]; [@CD012234-bbs2-0059]); three as contaminated ([@CD012234-bbs2-0009]; [@CD012234-bbs2-0054]; [@CD012234-bbs2-0056]) and five as dirty ([@CD012234-bbs2-0006]; [@CD012234-bbs2-0035]; [@CD012234-bbs2-0037], [@CD012234-bbs2-0046]; [@CD012234-bbs2-0051]). Two studies included surgical procedures in several categories ([@CD012234-bbs2-0014]; [@CD012234-bbs2-0050]).

One of the studies enrolled only children ([@CD012234-bbs2-0051]); 11 enrolled only adults ([@CD012234-bbs2-0003]; [@CD012234-bbs2-0015]; [@CD012234-bbs2-0017]; [@CD012234-bbs2-0020]; [@CD012234-bbs2-0027]; [@CD012234-bbs2-0039]; [@CD012234-bbs2-0046]; [@CD012234-bbs2-0050]; [@CD012234-bbs2-0053]; [@CD012234-bbs2-0055]; [@CD012234-bbs2-0059]) and in eight studies the population was mixed or unclear ([@CD012234-bbs2-0006]; [@CD012234-bbs2-0009]; [@CD012234-bbs2-0012][@CD012234-bbs2-0014]; [@CD012234-bbs2-0035]; [@CD012234-bbs2-0037]; [@CD012234-bbs2-0054]; [@CD012234-bbs2-0056]).

The type of solution used for irrigation varied and included saline (15 studies, 2667 participants [@CD012234-bbs2-0003]; [@CD012234-bbs2-0006]; [@CD012234-bbs2-0009]; [@CD012234-bbs2-0012][@CD012234-bbs2-0017]; [@CD012234-bbs2-0020]; [@CD012234-bbs2-0035]; [@CD012234-bbs2-0037], [@CD012234-bbs2-0039]; [@CD012234-bbs2-0046]; [@CD012234-bbs2-0050]; [@CD012234-bbs2-0051]; [@CD012234-bbs2-0053]; [@CD012234-bbs2-0055]; [@CD012234-bbs2-0059]), an alternative without antibacterial properties (1 study, 131 participants [@CD012234-bbs2-0056]), different antiseptic solutions (4 studies, 4367 participants [@CD012234-bbs2-0014]; [@CD012234-bbs2-0027]; [@CD012234-bbs2-0054]; [@CD012234-bbs2-0056]), and solutions containing various antibiotics or combinations of antibiotics (4 studies, 501 participants [@CD012234-bbs2-0003]; [@CD012234-bbs2-0015]; [@CD012234-bbs2-0035]; [@CD012234-bbs2-0046]). Antiseptics used included povidone iodine, chlorhexidine and cetrimide (Savlon) and super‐oxidised water (Dermacyn); antibiotics used were cefoxitin, cefamandole, ampicillin or chloramphenicol. Doses and concentrations of both antibiotics and antiseptics varied; full details are given in [Characteristics of included studies](#CD012234-sec2-0022){ref-type="sec"}.

Three three‐arm studies randomised participants to no treatment, antibiotic irrigation or saline irrigation ([@CD012234-bbs2-0003]; [@CD012234-bbs2-0035]; [@CD012234-bbs2-0046]); another randomised participants to no treatment, antiseptic irrigation or sterile water irrigation ([@CD012234-bbs2-0056]). In each case we combined the antibiotic or antiseptic and non‐antibacterial interventions and compared them with \'no irrigation\'. One four‐arm study ([@CD012234-bbs2-0015]) used a factorial design to assess antibiotic irrigation and intravenous antibiotics; we combined the arms that used antibiotic irrigation and compared them with the combined arms that used no irrigation.

One study [@CD012234-bbs2-0006] compared additional postoperative irrigation with no additional treatment following intraoperative irrigation in both arms. We considered this intervention to be substantively different from the comparisons assessed in the other studies and did not include it in the meta‐analyses conducted. One study ([@CD012234-bbs2-0039]) used a \'split‐body\' or intra‐individual design, where the two operative sites on each participant were randomised to the two intervention groups. We also excluded this study from the meta‐analysis because it was unclear whether the analysis adjusted for the use of paired data.

#### Primary outcome: SSI {#CD012234-sec4-0005}

Fifteen studies with 6297 participants reported analysable data for the outcome of SSI, which was variously defined (some studies did not provide a definition) ([@CD012234-bbs2-0009]; [@CD012234-bbs2-0012]; [@CD012234-bbs2-0014]; [@CD012234-bbs2-0015]; [@CD012234-bbs2-0017]; [@CD012234-bbs2-0020]; [@CD012234-bbs2-0027]; [@CD012234-bbs2-0035]; [@CD012234-bbs2-0037]; [@CD012234-bbs2-0039]; [@CD012234-bbs2-0046]; [@CD012234-bbs2-0050]; [@CD012234-bbs2-0053]; [@CD012234-bbs2-0054]; [@CD012234-bbs2-0055]). [@CD012234-bbs2-0056] did not report the number of events in each group and [@CD012234-bbs2-0039] was not included in the analysis because of the split‐body design employed. Details for all studies are given in [Table 9](#CD012234-tbl-0009){ref-type="table"}.Table 2Summary of primary outcome data: surgical site infection (SSI) and wound dehiscence**StudySurgical category/typeParticipantsInterventionsDefinition of SSIFollow‐upSSI eventsRisk ratio (95% CI)Wound dehiscence risk ratio (95% CI)Comparison of irrigation compared with no irrigation**[@CD012234-bbs2-0003]Clean‐contaminated\
Caeasarean section223Antibiotic irrigation/saline irrigation\
No irrigationNR[@CD012234-bbs2-0006]Dirty\
Perforated appendicitis35Saline postoperative irrigation\
No postoperative irrigationTemperature \> 38.5C for \> 24 h plus localised, drainage‐confirmed accumulation of fluid6 weeks9/39\
2/445.08 (1.17 to 22.09)\
Not included in pooled analysis ‐ intervention too differentNR[@CD012234-bbs2-0009]Contaminated\
Appendicitis283Saline irrigation\
No irrigationCollection of pus or positive bacteriologic culture from wound discharge4 weeks11/127\
39/1560.25 (0.19 to 0.65)NR[@CD012234-bbs2-0012]Clean‐contaminated\
Gastrectomy34Saline irrigation\
No irrigationCenters for Disease Control and Prevention criteria2 weeks1/17\
3/170.33 (0.04 to 2.89)NR[@CD012234-bbs2-0014]Mixed\
Abdominal/inguinal hernia592Antiseptic irrigation\
No irrigationPurulent discharge seen within 4 weeks or culturing of fluid from the wound was positive4 weeks36/279\
39/2790.92 (0.61 to 1.41)NR[@CD012234-bbs2-0015]^1^Clean‐contaminated\
Caeasarean section158Antibiotic irrigation\
No irrigationNR6 weeks0/80\
1/780.33 (0.01 to 7.86)NR[@CD012234-bbs2-0017]Clean‐contaminated\
Caeasarean section520Saline irrigation\
No irrigationWound drained purulent material/serosanguineous fluid plus induration, warmth and tenderness6 weeks17/260\
19/2600.89 (0.48 to 1.68)NR[@CD012234-bbs2-0020]Clean‐contaminated\
Caeasarean section196Saline irrigation\
No irrigationUndue tenderness, erythema, discharge, or separation of the incision accompanying feverNR1/97\
2/990.51 (0.05 to 5.54)NR[@CD012234-bbs2-0027]Clean‐contaminated\
Caeasarean section3270Antiseptic irrigation\
No irrigationAbscess or wound draining pus or sero‐sanguinous fluid, or redness, induration, warmth and tenderness or general practitioner prescribed antibiotics4 weeks144/1520\
147/15070.97 (0.78 to 1.21)NR[@CD012234-bbs2-0035]Dirty\
Perforated appendicitis33Antibiotic irrigation/saline irrigation\
No irrigationNRMean 8 d (5‐16)5/20\
4/100.63 (0.21 to 1.83)NR[@CD012234-bbs2-0037]Dirty\
Perforated appendicitis14Saline irrigation\
No irrigationNRNR2/7\
0/75.00 (0.28 to 88.53)NR[@CD012234-bbs2-0039]Clean\
Breast30Saline irrigation\
No irrigationWound discharge, invasive infection8 weeks0/30\
0/30Not estimable\
Not included in pooled analysis ‐ split‐body design1.15 (0.44 to 3.06)[@CD012234-bbs2-0046]Dirty\
Abdominal infection87Saline irrigation/ Antibiotic irrigation\
No irrigationDischarge of pus2 weeks10/58\
6/290.83 (0.34 to 2.07)NR[@CD012234-bbs2-0050]Mixed\
Appendix83Saline irrigation\
No irrigationNR6 weeks0/40\
0/41Not estimableNR[@CD012234-bbs2-0051]Dirty\
Appendix220Saline irrigation\
No irrigationNRNR[@CD012234-bbs2-0053]Clean‐contaminated\
Liver resection193Saline irrigation\
No irrigationIncisional or organ/space infection\
Incisional infection: clinically apparent cellulitis, induration, or purulent discharge.\
Organ/space infection: radiologic evidence of fluid collection necessitating drainage or antibiotic therapy4 weeks21/96\
13/971.63 (0.87 to 3.07)NR[@CD012234-bbs2-0054]Contaminated\
Appendix374Antiseptic irrigation\
No irrigationCollection of pus that emptied itself spontaneously or after incision2 weeks13/128\
12/1241.05 (0.50 to 2.21)NR[@CD012234-bbs2-0055]Clean‐contaminated\
Caeasarean section430Saline irrigation\
No irrigationPartial or total separation of incision, plus purulent or serous wound discharge with induration, warmth, and tendernessNR1/215\
2/2150.50 (0.05 to 5.47)NR[@CD012234-bbs2-0056]Contaminated\
Appendix131Antiseptic irrigation\
No irrigation\
Non‐antibacterial irrigationPrescence of pus either spontaneously or on probing. All infections confirmed bacteriologicallyNR17/131 Results are not given by intervention group; no effect estimate calculableNR[@CD012234-bbs2-0059]Clean‐contaminated\
Caeasarean section236Saline irrigation\
No irrigationNRNR**Comparison of antibacterial irrigationwith non‐antibacterial irrigation**[@CD012234-bbs2-0001]Mixed\
Appendicits254Antibiotic\
SalinePurulent discharge in wound, regardless of culture results, or occurrence of serous discharge with positive culture1 month1/120\
7/1340.16 (0.02 to 1.28)NR[@CD012234-bbs2-0002]Clean‐contaminated\
Colorectal330Antiseptic\
SalineSpontaneous or incisional discharge from wound, pus or serous fluid, with infective organism identified on culture6 weeks17/150\
17/1501.00 (0.53 to 1.88)NR[@CD012234-bbs2-0003]Clean‐contaminated\
Caeasarean section223Antibiotic irrigation\
Saline irrigation\
(No irrigation)NRNR[@CD012234-bbs2-0005]Dirty\
Peritonitis35Antiseptic irrigation\
Saline irrigationNRNR[@CD012234-bbs2-0007]Clean‐contaminated40Antibiotic\
SalineNR4‐6 weeks1/20\
1/201.00 (0.07 to 14.90)NR[@CD012234-bbs2-0008]Clean\
Breast54Antibiotic\
SalineNR6 weeks0/23\
1/300.43 (0.02 to 10.11)0.43 (0.02 to 10.11)[@CD012234-bbs2-0010]Clean\
Spinal244Antiseptic\
SalineSuperficial (above lumbosacral fascia) or deep (below lumbosacral fascia), early onset (within 2 weeks) or late onset (otherwise). Deep infections confirmed by laboratory parameters: erythrocyte sedimentation rate, level of C‐reactive protein, and positive biopsy culture2 weeks, long‐term follow‐up to 19 months0/120\
6/1240.08 (0.00 to 1.40)\
Only included in sensitivity analysis due to suspected data overlap with [@CD012234-bbs2-0011]0.52 (0.05 to 5.62)[@CD012234-bbs2-0011]Clean\
Spinal417Antiseptic\
SalineUnusual pain, tenderness, erythema, induration, fever, or wound drainage; investigated with erythrocyte sedimentation rate, C‐reactive protein, and bacteriological cultures from operative site or blood2 weeks\', long‐term follow‐up to mean 15.5 months0/208\
7/2060.07 (0.00 to 1.015)NR[@CD012234-bbs2-0013]Clean‐contaminated\
Caesarean3604 antibiotics\
SalineWound breakdown with positive culture or presence of cellulitisNR7/283\
3/770.63 (0.17 to 2.40)NR[@CD012234-bbs2-0016]Mixed\
Colorectal129Antibiotic\
SalineDischarge of pus from the wound \"wound sepsis\"1 month15/64\
18/650.85 (0.47 to 1.53)NR[@CD012234-bbs2-0018]Mixed\
Appendicitis192Antiseptic\
SalineWound discharging pus4 weeks18/99\
29/930.58 (0.35 to 0.98)NR[@CD012234-bbs2-0021]Clean\
Orthopaedic162Antiseptic\
SalinePositive bacteriological examination6 weeks then mean 7.8 (2‐4) months0/89\
2/730.16 (0.01 to 3.37)NR[@CD012234-bbs2-0022]Dirty\
Perforated appendicitis16Antiseptic\
SalineNRNR1/8\
4/80.25 (0.04 to 1.77)NR[@CD012234-bbs2-0023]Dirty\
Perforated appendicitis44Antiseptic\
SalineInfection at operation site, up to 30 d after surgery; confirmed causative pathogen(s) identical to those of appendicitis30 d0/24\
4/200.09 (0.01 to 1.64)NR[@CD012234-bbs2-0024]Clean‐contaminated\
Caeasarean section1282 Antibiotics\
SalinePurulent wound discharge with or without wound separation8 weeks0/85\
3/430.07 (0.00 to 1.38)NR[@CD012234-bbs2-0025]Mixed\
Gastrointestinal/colorectal200Antibiotic\
SalineNRNR3/100\
9/1000.33 (0.09 to 1.20)NR[@CD012234-bbs2-0026]Clean‐contaminated\
Caeasarean section100Antibiotic\
SalineHyperemic skin incision and fluctuant mass which when opened contained purulent materialNR2/50\
4/500.50 (0.10 to 0.50)NR[@CD012234-bbs2-0028]Contaminated\
Appendicitis1622 Antibiotics\
SalineSeptic complications with spontaneous or induced purulent discharge4 d; longer follow‐up unclearResults are not given by intervention group; no effect estimate calculableNR[@CD012234-bbs2-0029]Clean‐contaminated\
Cholecystectomy102Antibiotic\
SalineErythema, induration, tenderness, warmth, suppurative discharge6 weeks6/51\
6/511.00 (0.35 to 2.89)NR[@CD012234-bbs2-0031]Clean‐contaminated\
Abdominal260Antibiotic\
SalineNR, wounds were monitored with daily photographsUntil discharge12/124\
23/1160.49 (0.25 to 0.94)NR[@CD012234-bbs2-0032]Clean‐contaminated\
Colorectal197Antiseptic\
Non‐antibacterialNRNR19/101\
22/960.82 (0.48 to 1.42)NR[@CD012234-bbs2-0034]Mixed\
General surgery540Antiseptic\
SalineNRNR16/267\
15/2731.09 (0.55 to 2.16)NR[@CD012234-bbs2-0035]Dirty\
Perforated appendicitis33Antibiotic irrigation\
Saline irrigation\
No irrigationNRmean 8 d (5‐16)3/10\
2/101.50 (0.32 to 3.09)NR[@CD012234-bbs2-0036]Clean\
Breast512 Antibiotics\
SalineNRNR0/34\
0/17Not estimableNR[@CD012234-bbs2-0040]Dirty\
Peritonitis94Antibiotic\
SalineNRNR11/44\
13/500.96 (0.48 to 1.92)NR[@CD012234-bbs2-0041]Clean‐contaminated\
Colorectal128Antibiotic\
SalineNRNR6/64\
27/640.22 (0.10 to 0.50)NR[@CD012234-bbs2-0042]Clean‐contaminated\
Colorectal108Antibiotic\
SalinePresence of purulent discharge, confirmed with microbiologic culture30 d2/52\
7/510.29 (0.06 to 1.31)NR[@CD012234-bbs2-0043]Clean\
Breast40Antibiotic\
SalineNR2 weeks0/20\
0/20Not estimableNR[@CD012234-bbs2-0044]Clean‐contaminated\
Colorectal106Antibiotic\
SalineNR30 d2/52\
7/520.20 (0.05 to 1.87)NR[@CD012234-bbs2-0045]Clean‐contaminated\
Bariatric surgery80Antibiotic\
SalineNR30 d after dischargeNRNR[@CD012234-bbs2-0046]Dirty\
Abdominal infection87Antibiotic\
Saline\
(No irrigation)Discharge of pus2 weeks5/29\
5/29\
(6/29)1.00 (0.32 to 3.09)NR[@CD012234-bbs2-0048]Mixed\
Gastrointestinal/colorectal159Antibiotic\
SalineDischarge of pus6 weeks10/85\
24/740.36 (0.19 to 0.71)NR[@CD012234-bbs2-0049]Mixed\
General Surgery500Antiseptic\
SalinePus discharged within 12 weeks or serous drainage from questionable wounds plus positive culture12 weeks7/242\
39/2580.19 (0.09 to 0.42)NR[@CD012234-bbs2-0052]Clean‐contaminated\
Colorectal400Antiseptic\
SalineNational Nosocomial Infections Surveillance system30 d (total 3 months)19/180\
29/1830.67 (0.39 to 1.14)1.44 (0.71 to 2.93)[@CD012234-bbs2-0056]Contaminated\
Appendix131Antiseptic irrigation\
Non‐antibacterial irrigation\
(No irrigation)Prescence of pus either spontaneously or on probing. All infections confirmed bacteriologicallyNR7/131 Results are not given by intervention group; No effect estimate calculableNR[@CD012234-bbs2-0058]Dirty\
Peritonitis532 Antiseptics\
SalinePus in wound, sero‐sanguinous discharge, Inflammation or induration1 month23/29\
10/160.61 (0.40 to 0.92)NR**Comparisons of two different agents in the same class**[@CD012234-bbs2-0004]Clean‐contaminated\
Uterine4492 non‐antibacterials\
Icodextrin\
Ringer\'s solutionNR clearly; data on infection ambiguousNR[@CD012234-bbs2-0013]Clean‐contaminated\
Caesarean3604 antibiotics\
(Saline)\
Cephapirin\
Cefamandole\
Moxalactam\
AmpicillinWound breakdown with positive culture or presence of cellulitisNR3/70\
2/64\
2/79\
0/70Cephapirin: cefamandole\
1.37 (0.24 to 7.95)\
Cephapirin: moxalactam\
1.69 (0.29 to 9.84)\
Cephapirin: ampicillin\
7.00 (0.37 to 133.06)\
Cefamandole: moxalactam\
1.23 (0.18 to 8.52)\
Cefamandole: ampicillin\
5.46 (0.27 to 111.65)\
Moxalactam: ampicillin\
4.44 (0.22 to 90.88)NR[@CD012234-bbs2-0024];Clean‐contaminated\
Caesarean1282 antibiotics\
(Saline)\
Cephapirin\
cefoxitinPurulent wound discharge with or without wound separation8 weeks0/44\
0/41Not estimable; zero eventsNR[@CD012234-bbs2-0028]Contaminated\
Appendicitis1622 antibiotics\
(Saline)\
Epicillin\
LincomycinSeptic complications with spontaneous or induced purulent discharge4 d; longer follow‐up unclearNot estimable; number of participants and events per group not reportedNR[@CD012234-bbs2-0030];Clean\
Cardiac1902 antiseptics\
Povidone iodine\
DermacynCenters for Disease Control and Prevention criteria6 weeks14/90\
5/882.80 (1.05 to 7.47)NR[@CD012234-bbs2-0036]Clean\
Breast512 antibiotics\
Clindamycin\
GentamicinNRNR0/17\
0/17Not estimable; zero eventsNR[@CD012234-bbs2-0038]Clean‐contaminated\
Caesarean207\
113 in relevant groups2 antibiotics\
Cefazolin\
CefamandolePresence of cellulitis and/or purulent exudate\> 2 weeks2/59\
0/544.58 (0.22 to 93.38)NR[@CD012234-bbs2-0047]Clean\
Brain202 non‐antibacterials\
Saline\
Artificial CSFNRNR[@CD012234-bbs2-0057]Clean‐contaminated\
Uterine4982 non‐antibacterials\
Icodextrin\
Ringer\'s solutionNR4‐16 weeks3/217\
1/2092.89 (0.30 to 27.56)NR[@CD012234-bbs2-0058]Dirty\
Peritonitis532 antiseptics\
(Saline)\
Povidone iodine\
ChlorhexidinePus in wound, sero‐sanguinous discharge, Inflammation or induration1 month4/16\
4/131.13 (95% CI 0.78 to 1.63)NR**Comparison of pulsatile versus standard irrigation delivery**[@CD012234-bbs2-0019]Clean\
Orthopaedic356Pulsatile saline\
Standard salineNosocomial Infection National Surveillance Survey30 days or discharge9/164\
30/1920.35 (0.17 to 0.72)NR[@CD012234-bbs2-0033]Clean‐contaminated\
Abdominal137Pulsatile saline\
Standard salinePurulent drainage, with or without laboratory confirmation; organisms isolated from aseptically obtained culture of fluid or tissue; at least 1 of the following: pain or tenderness, localised swelling, redness, or heat and incision is deliberately opened by surgeon, unless incision is culture‐negative; diagnosis of superficial incisional SSI by surgeon or attending physician1 month4/66\
12/620.31 (0.11 to 0.92)0.31 (0.01 to 7.55)[^6]

There is, on average, no clear difference in the incidence of SSI between groups treated with irrigation of any type and those not treated with irrigation. The overall RR was 0.87 (95% CI 0.68 to 1.11; I^2^ = 28%) [Analysis 1.1](#CD012234-fig-00101){ref-type="fig"}. This was based on 14 trials with 6106 participants. This was low‐certainty evidence downgraded once for risk of bias across various domains in studies that contributed almost half the weight of the analysis, and once for imprecision because confidence intervals included both no effect and values suggesting both harm and benefit. In absolute terms this equates to 13 fewer SSIs per 1000 with irrigation than with no irrigation, with 95% CI from 31 fewer to 10 more SSIs.

We assessed whether the analysis may be affected by publication bias; it was not clear that this was the case although we considered it to be possible, but did not downgrade for this ([Figure 4](#CD012234-fig-0004){ref-type="fig"}).Figure 4Funnel plot of comparison 1: all irrigation versus no irrigation, outcome: 1.1 surgical site infection

We conducted planned subgroup analysis based on the category of surgery, grouping the studies with a mixture of surgery categories ([@CD012234-bbs2-0014]; [@CD012234-bbs2-0050]) with the most high‐risk category represented; in this case, this was dirty surgery. There was only one study of participants undergoing clean surgery, [@CD012234-bbs2-0039], which was excluded from the analysis due to the \'split‐body\' design used. There were also only three studies of participants undergoing dirty surgery, one of which was extremely small ([@CD012234-bbs2-0037]; 14 participants). Because of this, we decided to group clean and clean‐contaminated studies together, and similarly to group contaminated, dirty and mixed studies together. The RR for SSI for the clean‐contaminated sub‐group was 1.00 (95% CI 0.82 to 1.21). The RR for SSI for contaminated or dirty surgeries was 0.74 (95% CI 0.47 to 1.16). Category of surgery may explain some differences between estimates of effect in the included studies; the I^2^ for subgroup differences was 29.1%.

We could not carry out planned subgroup analysis for this comparison, based on whether participants were adults or children, as only one study ([@CD012234-bbs2-0051]) enrolled only children, and it did not report SSI data.

We undertook an exploratory post‐hoc subgroup analysis of the type of irrigation solution (non‐antibacterial, antiseptic, antibiotic) to test the rationale for combining all studies comparing irrigation with no irrigation in the same comparison. This analysis did not explain the heterogeneity (I^2^ for subgroup differences = 0%), supporting the analysis plan employed. The results of this exploratory analysis are shown in [Table 10](#CD012234-tbl-0010){ref-type="table"}.Table 3Summary of subgroup analyses**ComparisonSubgroup basisPre‐specified or exploratorySubgroups usedSubgroup results RR (95% CI)I^2^ & Chi^2^ subgroup differencesI^2^ & Chi^2^ overall**Irrigation vs no irrigationSurgical classificationPre‐specifiedClean‐contaminated\
Contaminated/Dirty/Mixed1.00 (0.82, 1.21)\
0.74 (0.47 to 1.16)I^2^ = 29.1%.\
Chi^2^ = 1.41I^2^ = 28%\
Chi^2^ = 16.58Irrigation vs no irrigationType of irrigationExploratoryNon‐antibacterial\
Antiseptic\
Antibiotic0.80 (0.46 to 1.41)\
0.97 (0.81 to 1.17)\
0.92 (0.42 to 1.99)I^2^ = 0%\
Chi^2^ = 0.39I^2^ = 28%\
Chi^2^ = 16.58Antibacterial vs non‐antibacterialSurgical classificationPre‐specifiedClean\
Clean‐contaminated\
Contaminated/Dirty/Mixed0.17 (0.03 to 0.89)\
0.57 (0.40 to 0.79)\
0.61 (0.40 to 0.92)I^2^= 9.7%\
Chi^2^ = 2.21I^2^ = 53%\
Chi^2^ = 56.94Antibacterial vs non‐antibacterialType of irrigationExploratoryAntiseptic\
Antibiotic0.63 (0.40 to 0.95)\
0.57 (0.44 to 0.75)I^2^= 0%\
Chi^2^ = 0.38I^2^ = 53%\
Chi^2^ = 56.94[^7]

We conducted a planned sensitivity analysis excluding studies at high risk of bias. All studies were at high risk of bias for blinding of personnel so we excluded studies at high risk of bias in additional domains. Excluding five studies gave an overall effect estimate of RR 0.94 (95% CI 0.77 to 1.16), which is not materially different to the main analysis. Results for the two subgroups were, respectively, clean‐contaminated: RR 0.95 (95% CI 0.77 to 1.19) and contaminated/dirty/mixed: RR 0.82 (95% CI 0.42 to 1.61). We conducted another planned sensitivity analysis excluding studies at high risk of detection bias; this excluded only one study in the clean‐contaminated group and also did not materially change the estimate of effect RR 0.79 (95% CI 0.61 to 1.04); the RR for the clean‐contaminated group was 0.95 (95% CI 0.76 to 1.17).

We had decided to exclude [@CD012234-bbs2-0039] from the analysis because of the split‐body design; however the study reported no events in either arm so no estimate of effect could be calculated and no weight would have been contributed to the analysis. In one study ([@CD012234-bbs2-0014]), there was more than one wound per person in some cases and wounds rather than participants were the unit of analysis. There were also a substantial number of post‐randomisation exclusions due to death or need for reoperation. Because we were uncertain about the number of wounds in the excluded participants, and because the reasons for exclusion made an assumption that these participants did not have an SSI doubtful, we have reported the completed case analysis for this study and examined the impact of excluding it from the meta‐analysis in a post‐hoc sensitivity analysis. Excluding [@CD012234-bbs2-0014] made little difference to the estimate of effect, either overall (RR 0.84, 95% CI 0.62 to 1.14) or in the subgroup of contaminated, dirty or mixed surgeries (RR 0.69, 95% CI 0.38 to 1.25).

[@CD012234-bbs2-0006] compared additional postoperative irrigation with no additional treatment following intraoperative irrigation in both arms in 83 participants with generalised peritonitis; we analysed this trial separately as a substantively different clinical comparison and showed an increased rate of SSI in the group given additional postoperative irrigation: RR of 5.08 (95% CI 1.17 to 22.09). This was low‐certainty evidence, which was downgraded twice for imprecision due to small numbers of participants and very wide confidence intervals.

#### Primary outcome: wound dehiscence {#CD012234-sec4-0006}

Only [@CD012234-bbs2-0039] reported data on wound dehiscence. This split‐body design study conducted in 30 women undergoing clean breast surgery did not clearly adjust for the use of paired data; unadjusted paired data may produce wider confidence intervals than should be the case. There may be little or no difference in the incidence of wound dehiscence (RR 1.17, 95% CI 0.44 to 3.06). This was low‐certainty evidence downgraded twice for imprecision due to small numbers, wide confidence intervals and uncertainty about the analysis.

#### Secondary outcome: adverse events {#CD012234-sec4-0007}

Three studies reported analysable data on overall adverse events ([@CD012234-bbs2-0020]; [@CD012234-bbs2-0037]; [@CD012234-bbs2-0053]). Three other studies focused specifically on abscess formation, which we had prespecified as a specific event of interest ([@CD012234-bbs2-0035]; [@CD012234-bbs2-0050]; [@CD012234-bbs2-0051]); [@CD012234-bbs2-0037] reported one abscess but did not state in which group it occurred. Other studies reported only specific additional complications ([@CD012234-bbs2-0003]; [@CD012234-bbs2-0015]) or information that was not group‐specific ([@CD012234-bbs2-0009]). Current trial evidence shows that, on average, there is no clear difference in the total number of adverse events between groups treated with irrigation and those treated with no irrigation (RR 1.05, 95% CI 0.76 to 1.44, I^2^ = 0%; 403 participants) (low‐certainty evidence downgraded once for imprecision and once for high risk of detection bias in the study with 78% of the analysis weight) [Analysis 1.2](#CD012234-fig-00102){ref-type="fig"}. There is also no clear difference in the number of participants with abscess formation (RR 0.91, 95% CI 0.54 to 1.54, I^2^ = 0%, 331 participants) (moderate‐certainty evidence downgraded once for imprecision) [Analysis 1.3](#CD012234-fig-00103){ref-type="fig"}.

#### Secondary outcome: mortality {#CD012234-sec4-0008}

Two studies reported data on mortality explicitly ([@CD012234-bbs2-0046]; [@CD012234-bbs2-0053]). On average, there is no clear difference in mortality between the irrigation and no irrigation groups in these studies; the confidence intervals are wide and likely to be fragile, they also span both benefit and harm (RR 0.86, 95% CI 0.36 to 2.04, I^2^ = 0%, 280 participants). This was low‐certainty evidence downgraded twice for imprecision [Analysis 1.4](#CD012234-fig-00104){ref-type="fig"}.

#### Secondary outcome: hospital stay {#CD012234-sec4-0009}

Nine studies with 1949 participants reported some data on hospital stay. Seven (1597 participants) reported data on mean length of stay ([@CD012234-bbs2-0003]; [@CD012234-bbs2-0015]; [@CD012234-bbs2-0017]; [@CD012234-bbs2-0020]; [@CD012234-bbs2-0046]; [@CD012234-bbs2-0051]; [@CD012234-bbs2-0053]) and three (352 participants) reported median length of stay ([@CD012234-bbs2-0035]; [@CD012234-bbs2-0050]; [@CD012234-bbs2-0059]). There is, on average, little or no difference in the length of stay between the irrigation and no irrigation groups; the difference in means was ‐0.13 days (95% CI ‐0.38 to 0.12; I^2^ = 82%) [Analysis 1.5](#CD012234-fig-00105){ref-type="fig"}. This was moderate‐certainty evidence, downgraded once for risk of bias in one or more domains (other than performance bias) in studies accounting for more than 50% of the analysis weight. The studies reporting medians did not demonstrate differences between the groups either ([Table 11](#CD012234-tbl-0011){ref-type="table"}).Table 4Summary of secondary outcomes**Study**\
**Surgical category/typeParticipants (N)**\
**Follow‐upInterventionsMortality RR (95% CI)Systemic antibiotics RR (95% CI)Antibiotic resistance RR (95% CI)Adverse events RR (95% CI)Reoperation RR (95% CI)Readmission RR (95% CI)Length of stay (days (95% CI))Irrigation compared with no irrigation**[@CD012234-bbs2-0003]\
Clean‐contaminated\
Caeasarean section223\
6 weeksAntibiotic irrigation/Saline irrigation\
No irrigation‐‐‐Specific complication\
only‐‐Difference in means ‐0.46 (‐0.64 to ‐0.29)[@CD012234-bbs2-0006]\
Dirty\
Perforated appendicitis85\
6 weeksSaline postoperative irrigation\
No postoperative irrigation‐‐‐‐‐‐Medians\
5 (3‐11) vs 5 (4‐12)[@CD012234-bbs2-0009]\
Contaminated\
Appendicitis283\
4 weeksSaline irrigation\
No irrigation‐‐‐No group data‐‐‐[@CD012234-bbs2-0012]\
Clean‐contaminated\
Gastrectomy34\
2 weeks (primary outcome)Saline irrigation\
No irrigationNo secondary outcomes were reported[@CD012234-bbs2-0014]\
Mixed\
Abdominal/inguinal hernia592\
4 weeks (primary outcome)Antiseptic irrigation\
No irrigationNo secondary outcomes were reported[@CD012234-bbs2-0015]^1^\
Clean‐contaminated\
Caeasarean section158\
6 weeksAntibiotic irrigation\
No irrigation‐‐‐Specific complication\
only‐‐Difference in means\
‐0.20 (‐0.57 to 0.17)[@CD012234-bbs2-0017]\
Clean‐contaminated\
Caeasarean section520\
6 weeksSaline irrigation\
No irrigation‐‐‐‐‐‐Difference in means 0.01 (‐0.03 to 0.05)[@CD012234-bbs2-0020]\
Clean‐contaminated\
Caeasarean section196\
NRSaline irrigation\
No irrigation‐‐‐Overall\
RR 1.10 (0.55 to 2.22)‐‐Difference in means 0.10 (‐0.17 to 0.37)[@CD012234-bbs2-0027]\
Clean‐contaminated\
Caeasarean section3270\
4 weeksAntiseptic irrigation\
No irrigation‐‐‐‐RR 0.77 (0.29 to 2.07)RR 1.29 (0.81 to 2.06)‐[@CD012234-bbs2-0035]\
Dirty\
Perforated appendicitis33\
mean 8 days (5‐16)Antibiotic irrigation/Saline irrigation\
No irrigation‐‐‐Abscess\
RR 0.17 (0.01 to 3.94)‐‐Medians\
14 (8‐22) vs 13 (9‐22)[@CD012234-bbs2-0037]\
Dirty\
Perforated appendicitis14\
NRSaline irrigation\
No irrigation‐‐‐Overall\
RR 1.00 (0.08 to 13.02)\
Abscess but no group data‐‐‐[@CD012234-bbs2-0039]\
Clean\
Breast30\
8 weeksSaline irrigation\
No irrigation‐‐‐‐‐‐‐[@CD012234-bbs2-0046]\
Dirty\
Abdominal infection87\
2 weeksSaline irrigation\
Antibiotic irrigation\
No irrigationRR 0.75 (0.30 to 1.90)‐‐‐‐‐Difference in means not estimable\
11.5 vs 13[@CD012234-bbs2-0050]\
Mixed\
Appendix83\
6 weeksSaline irrigation\
No irrigation‐‐‐Abscess RR 1.02 (0.15 to 6.93)‐‐Medians\
2.0 (1‐3) vs 2.0 (1‐2.25)[@CD012234-bbs2-0051]\
Dirty\
Appendix220\
2‐4 weeksSaline irrigation\
No irrigation‐‐‐Abscess\
RR 0.95 (0.55 to 1.65)RR 0.33 (0.01 to 8.09)RR 0.14 (0.01 to 2.73)Difference in means ‐0.10 (‐0.85 to 0.65)[@CD012234-bbs2-0053]\
Clean‐contaminated\
Liver resection193\
4 weeksSaline irrigation\
No irrigationRR 2.02 (0.36 to 2.04)‐‐Overall\
RR 1.04 (0.72 to 1.49)‐‐Difference in means 0.00 (‐3.74 to 3.74)[@CD012234-bbs2-0054]\
Contaminated\
Appendix374\
2 weeksAntiseptic irrigation\
No irrigationNo secondary outcomes were reported[@CD012234-bbs2-0055]\
Clean‐contaminated\
Caeasarean section430\
NRSaline irrigation\
No irrigationNo secondary outcomes were reported[@CD012234-bbs2-0056]\
Contaminated\
Appendix131\
NRAntiseptic irrigation\
No irrigation\
Non‐antibacterial irrigation‐53/131 participants \"distributed evenly across the groups\"‐‐‐‐No group data[@CD012234-bbs2-0059]\
Clean‐contaminated\
Caeasarean section236\
NRSaline irrigation\
No irrigation‐‐‐‐‐‐Median discharge\
day: 3 in both groups**Antibacterial irrigation vs non‐antibacterial irrigation**[@CD012234-bbs2-0001]\
Mixed\
Appendicits254\
1 monthAntibiotic\
Saline‐‐‐Abscess\
RR not estimable 0 eventsNo group data[@CD012234-bbs2-0002]\
Clean‐contaminated\
Colorectal330\
6 weeksAntiseptic\
SalineRR 1.00 (0.25 to 3.92)‐‐Abscess RR 2.0 (0.18 to 21.82)No group data[@CD012234-bbs2-0003]\
Clean‐contaminated\
Caeasarean section223\
6 weeksAntibiotic irrigation\
Saline irrigation\
(No irrigation)‐‐‐Specific complication\
only‐‐Difference in means ‐1.08 (‐1.25 to ‐0.92)[@CD012234-bbs2-0005]\
Dirty\
Peritonitis35\
NRAntiseptic irrigation\
Saline irrigationRR 7.39 (0.41 to 133.24)‐‐‐‐[@CD012234-bbs2-0007]\
Clean‐contaminated\
Caeasarean section40\
4‐6 weeksAntibiotic\
Saline‐‐‐‐‐[@CD012234-bbs2-0008]\
Clean\
Breast54\
6 weeksAntibiotic\
Saline‐‐‐‐‐[@CD012234-bbs2-0010]\
Clean\
Spinal244\
2 weeks, long‐term follow‐up to 19 monthsAntiseptic\
Saline‐All 6 participants with SSI received these; all in saline group5/6 infections positive for MRSA‐‐[@CD012234-bbs2-0011]\
Clean\
Spinal417\
2 weeks long ‐term follow ‐up to mean 15.5 monthsAntiseptic\
Saline‐‐‐‐‐[@CD012234-bbs2-0013]\
Clean‐contaminated\
Caeasarean section360\
NR4 antibiotics\
Saline‐‐‐Abscess\
RR not estimable 0 events‐[@CD012234-bbs2-0016]\
Mixed\
Colorectal129\
1 monthAntibiotic\
SalineNo secondary outcomes were reported[@CD012234-bbs2-0018]\
Mixed\
Appendicitis192\
4 weeksAntiseptic\
Saline‐‐‐‐Difference in means not estimable (6.4 vs 6.6)[@CD012234-bbs2-0021]\
Clean\
Orthopaedic162\
mean 7‐8 months (range 2‐14 months) (primary outcome)Antiseptic\
SalineNo secondary outcomes were reported‐[@CD012234-bbs2-0022]\
Dirty\
Perforated appendicitis16\
NRAntiseptic\
Saline‐‐‐Abscess RR 0.33 (0.02 to 7.14)Difference in means ‐10.60 (‐19.06 to ‐2.14)[@CD012234-bbs2-0023]\
Dirty\
Perforated appendicitis44\
30 daysAntiseptic\
Saline‐‐‐Abscess\
RR 0.83 (0.06 to 12.49)Difference in means ‐0.70 (‐3.31 to 1.91)[@CD012234-bbs2-0024]\
Clean‐contaminated\
Caeasarean section128\
8 weeksAntibiotic\
Saline‐‐‐Specific complication\
onlyDifference in means ‐0.35 (‐1.06 to 0.36)[@CD012234-bbs2-0025]\
Mixed\
Gastrointestinal/colorectal200\
NRAntibiotic\
SalineRR 1.67 (0.41 to 6.79)‐Specific organismsSpecific complication\
only‐[@CD012234-bbs2-0026]\
Clean‐contaminated\
Caeasarean section100\
NRAntibiotic\
Saline‐‐‐Specific complication\
only‐[@CD012234-bbs2-0028]\
Contaminated\
Appendicitis162\
4 days; longer follow‐up unclearAntibiotic\
Saline‐‐‐Specific complication\
only‐[@CD012234-bbs2-0029]\
Clean‐contaminated\
Cholecystectomy102\
6 weeksAntibiotic\
SalineNo secondary outcomes were reported[@CD012234-bbs2-0031]\
Clean‐contaminated\
Abdominal260\
Until dischargeAntibiotic\
Saline‐‐Kanamycin resistance\
Kanamycin: 12/12\
Saline: \"over half\" of 23Specific complication\
only‐[@CD012234-bbs2-0032]\
Clean‐contaminated\
Colorectal197\
NRAntiseptic\
SalineNo secondary outcomes were reported[@CD012234-bbs2-0034]\
Mixed\
General surgery540\
NRAntiseptic\
SalineNo secondary outcomes were reported‐[@CD012234-bbs2-0035]\
Dirty\
Perforated appendicitis33\
Mean 8 days (5‐16Antibiotic irrigation\
Saline irrigation\
No irrigation‐‐‐Abscess\
RR not estimable 0 eventsMedians 13 (9‐20\
13 (10‐22)[@CD012234-bbs2-0036]\
Clean\
Breast51\
NRAntibiotic 1/ Antibiotic 2\
SalineRR not estimable, 0 events‐‐‐Medians 3 (1‐3)\
3 (1‐3)[@CD012234-bbs2-0040]\
Dirty\
Peritonitis94\
NRAntibiotic\
SalineRR 0.71 (0.25 to 2.01)‐Specific organismsAbscess grouped with another event ‐ not estimable‐[@CD012234-bbs2-0041]\
Clean‐contaminated\
Colorectal128\
NRAntibiotic\
SalineNo secondary outcomes were reported[@CD012234-bbs2-0042]\
Clean‐contaminated\
Colorectal108\
30 daysAntibiotic\
SalineRR 0.50 (0.05 to 5.35)‐‐Abscess RR 0.14 (0.01 to 2.65)Medians 6 (5‐32)\
6.5 (5‐14)[@CD012234-bbs2-0043]\
Clean\
Breast40\
2 weeksAntibiotic\
SalineRR not estimable, 0 events‐‐Overall RR not estimable 0 eventsMedians\
3 (1‐3)\
3 (1‐3)[@CD012234-bbs2-0044]\
Clean‐contaminated\
Colorectal106\
30 daysAntibiotic\
SalineRR 1.00 (0.06 to 15.57)‐‐Specific complication\
onlyMedians\
6.5 (5‐14)\
6 (5‐32)[@CD012234-bbs2-0045]\
Clean‐contaminated\
Bariatric surgery80\
30 daysAntibiotic\
SalineRR 0.33 (0.01 to 7.95)‐‐Overall RR 0.50 (0.05 to 5.30)‐[@CD012234-bbs2-0046]\
Dirty\
Abdominal infection87\
2 weeksAntibiotic\
SalineRR 0.50 (0.14 to 1.81)‐‐Overall RR 0.56 (0.21 to 1.46)\
Abscess RR 0.33 (0.01 to 7.86)Difference in means not estimable 10 vs 13[@CD012234-bbs2-0048]\
Mixed\
Gastrointestinal/colorectal159\
6 weeksAntibiotic\
Saline‐‐‐Abscess RR 0.96 (0.43 to 2.13)\
Specific additional complicationRR 6.10 (0.32 to 116.28)‐[@CD012234-bbs2-0049]\
Mixed\
General Surgery500\
12 weeksAntiseptic\
SalineNo secondary outcomes were reported[@CD012234-bbs2-0052]\
Clean‐contaminated\
Colorectal400\
30 days (total 3 months)Antiseptic\
Saline‐‐MRSA\
4/14 vs 8/24 MSSA\
0/14 vs 3/24‐‐[@CD012234-bbs2-0056]\
Contaminated\
Appendix131\
NRAntiseptic\
Non‐antibacterial\
(No irrigation)‐53/131 participants \"distributed evenly across the groups\"‐‐‐‐No group data[@CD012234-bbs2-0058]\
Dirty\
Peritonitis53\
1 monthAntiseptic\
SalineRR 0.61 (0.17 to 2.16)‐‐‐Difference in means ‐0.70 (‐3.32 to 1.92)**Comparisons of two different agents in the same class**[@CD012234-bbs2-0004]\
Clean‐contaminated\
Uterine449\
28‐56 days2 non‐antibacterials\
Icodextrin\
Ringer\'s solutionRR not estimable ‐ 0 events‐‐Total: RR 0.99 (0.96 to 1.02)\
Treatment‐related RR 1.42 (0.98 to 2.05)\
Serious RR 1.20 (0.80 to 1.78)\
Serious treatment‐related RR 0.71 (0.29 to 1.73)‐‐‐[@CD012234-bbs2-0013]\
Clean‐contaminated\
Caeasarean section360\
NR4 antibiotics\
(Saline)\
Cephapirin\
Cefamandole\
Moxalactam\
Ampicillin‐‐‐Abscess: no effect estimate calculable ‐ 0 events\
Other specific events‐‐‐[@CD012234-bbs2-0024]\
Clean‐contaminated\
Caeasarean section128\
8 weeks2 antibiotics\
(Saline)\
Cephapirin\
Cefoxitin‐‐‐Specific event data only‐‐Difference in means 0.10 (‐0.78 to 0.58)[@CD012234-bbs2-0028]\
Contaminated\
Appendicitis162\
4 days; longer follow‐up unclear2 antibiotics\
(Saline)\
Epicillin\
Lincomycin‐‐‐1 abscess in antibiotic groups; no group data‐‐‐[@CD012234-bbs2-0030]\
Clean\
Cardiac190\
6 weeks2 antiseptics\
Povidone iodine\
Dermacyn4 deaths but no group data; group data for composite outcome with reopening of chest‐‐‐RR 8.80 (0.48 to 161.11)‐‐[@CD012234-bbs2-0036]\
Clean\
Breast51\
NR2 antibiotics\
Clindamycin\
GentamicinRR not estimable, 0 events‐‐‐‐‐Median 3 (1‐3) in each group[@CD012234-bbs2-0038]\
Clean‐contaminated\
Caeasarean section207\
113 in relevant groups\
2 weeks + (primary outcome)2 antibiotics\
Cefazolin\
CefamandoleNo secondary outcomes were reported[@CD012234-bbs2-0047]\
Clean\
Brain20\
10 days2 non‐antibacterials\
Saline\
Artificial CSF‐‐‐2 participants in each group, included MRI data. RR not calculated‐‐‐‐[@CD012234-bbs2-0057]\
Clean‐contaminated\
Uterine498\
4‐16 weeks2 non‐antibacterials\
Icodextrin\
Ringer\'s solutionRR not estimable ‐ 0 events‐Total: RR 0.95 (0.73 to 1.24)\
Treatment‐related RR 1.16 (0.60 to 2.23)‐‐‐[@CD012234-bbs2-0058]\
Dirty\
Peritonitis53\
1 month2 antiseptics\
(Saline)\
Povidone iodine\
ChlorhexidineRR 0.45 (0.05 to 3.90) within 4 days, no group data for later events‐‐‐‐‐Difference in means 3.30 (0.53 to 3.90)**Comparison of pulsatile versus standard irrigationdelivery**[@CD012234-bbs2-0019]\
Clean\
Orthopaedic356\
30 days or dischargePulsatile saline\
Standard salineNo group data‐No group data \"half\" SSI positive for MRSA‐‐‐‐[@CD012234-bbs2-0033]\
Clean‐contaminated\
Abdominal137\
1 monthPulsatile saline\
Standard saline‐No group data: 14/16 SSI treatedQualitative data on organisms isolatedComplications, not wound infections RR 1.31 (0.87 to 1.97)RR 0.56 (0.14 to 2.26)RR 1.41 (0.53 to 3.73)Median\
9 (5 ‐45)\
9 (4‐71)[^8]

The study that we considered too clinically dissimilar to be included in meta‐analysis ([@CD012234-bbs2-0006]) reported median length of stay as 5 days in both groups with ranges of 3 to 11 days with postoperative irrigation compared with 4 to 12 days without.

#### Secondary outcome: reoperation (return to theatre) {#CD012234-sec4-0010}

One large study, [@CD012234-bbs2-0027], reported the proportion of participants returned to theatre after irrigation with povidone iodine compared with no irrigation in women undergoing caesarean sections; a smaller study reported this in children with appendicitis and used saline irrigation compared with no irrigation ([@CD012234-bbs2-0051]). There were a total of 3490 randomised participants but a completed case analysis was reported for [@CD012234-bbs2-0027] so 3247 were analysed. Event rates were low and evidence from these studies was that, on average, there is no clear difference between the groups (RR 0.72, 95% CI 0.28 to 1.84; I^2^ = 0%) [Analysis 1.6](#CD012234-fig-00106){ref-type="fig"}. This was low‐certainty evidence downgraded twice for imprecision due to the very low event rates that led to wide confidence intervals, which included both no effect and values suggesting both harm and benefit.

#### Secondary outcome: readmission to hospital {#CD012234-sec4-0011}

[@CD012234-bbs2-0027] and [@CD012234-bbs2-0051] (total of 3490 randomised participants with 3247 included in the completed case analysis) reported the proportion of participants re‐admitted to hospital. From these studies it is uncertain whether there is a difference between the groups on this measure: RR 0.70 (95% CI 0.10 to 4.90 ; I^2^ = 53%) [Analysis 1.7](#CD012234-fig-00107){ref-type="fig"}. This was very low certainty evidence downgraded twice for imprecision due to the low event rates, which led to wide confidence intervals (despite including 3247 participants) and because the 95% CIs span both benefit and harm as well as no effect, and once for inconsistency between the study estimates.

#### Secondary outcome: systemic antibiotics within 30 days {#CD012234-sec4-0012}

Only [@CD012234-bbs2-0056] reported this outcome and the data were not reported by treatment group so no estimate of effect was possible and no full GRADE assessment could be performed ([Table 11](#CD012234-tbl-0011){ref-type="table"}); the certainty of this evidence is affected by risk of bias as well as imprecision.

#### Other secondary outcomes {#CD012234-sec4-0013}

No studies reported the occurrence of wound infections with antibiotic resistance.

#### Summary of comparison {#CD012234-sec4-0014}

Twenty studies assessed a comparison of irrigation and no intervention; 15 of these, with over 6000 participants, reported SSI outcome data. Based on the included trial evidence there is currently no clear difference in incidence of SSI between participant groups treated with irrigation and those given no irrigation. Planned subgroup analysis found that this was the case in each of the surgical contamination subgroups we were able to assess (clean‐contaminated versus contaminated or dirty). Exploratory analysis supported our clinical opinion that it was reasonable to group irrigation solutions with different antibacterial properties together. This was low‐certainty evidence, which was downgraded once due to relevant risks of bias and once due to imprecision. There were no studies included in the analysis that had been conducted in clean surgeries therefore the results may be only indirectly relevant to these operations. A single, small, split‐body design study in clean surgery was the only study to report wound dehiscence: this single study provides low‐certainty evidence reporting no clear difference between groups; downgrading was due to very serious imprecision.

### Comparison 2: comparison of antibacterial irrigation with non‐antibacterial irrigation {#CD012234-sec3-0027}

[Table 2](#CD012234-tbl-0002){ref-type="table"}

Thirty‐six studies (6163 participants) compared the use of an antibacterial irrigation with non‐antibacterial irrigation solution.

The specific surgery types represented included appendicitis surgery, including perforated appendices; breast surgery (mastectomy or other); cardiac (pacemaker pocket) surgery; gastrointestinal and colorectal surgeries; caesarean sections; surgery for peritonitis; spinal surgery; orthopaedic (hip, pelvic and femoral) surgery; various abdominal procedures; uterine surgery; and general (mixed) surgical populations. All categories of surgery (clean, clean‐contaminated, contaminated, dirty) were represented. We classed eight studies as clean ([@CD012234-bbs2-0008]; [@CD012234-bbs2-0010]; [@CD012234-bbs2-0011]; [@CD012234-bbs2-0013]; [@CD012234-bbs2-0021]; [@CD012234-bbs2-0026]; [@CD012234-bbs2-0036]; [@CD012234-bbs2-0043]); 12 as clean‐contaminated ([@CD012234-bbs2-0003]; [@CD012234-bbs2-0002]; [@CD012234-bbs2-0007]; [@CD012234-bbs2-0024]; [@CD012234-bbs2-0029]; [@CD012234-bbs2-0031]; [@CD012234-bbs2-0032]; [@CD012234-bbs2-0041]; [@CD012234-bbs2-0042]; [@CD012234-bbs2-0044]; [@CD012234-bbs2-0045]; [@CD012234-bbs2-0052]); three as contaminated ([@CD012234-bbs2-0001]; [@CD012234-bbs2-0028]; [@CD012234-bbs2-0056]) and six as dirty ([@CD012234-bbs2-0005]; [@CD012234-bbs2-0022]; [@CD012234-bbs2-0023]; [@CD012234-bbs2-0035]; [@CD012234-bbs2-0040]; [@CD012234-bbs2-0046]). Seven studies included surgeries in several categories ([@CD012234-bbs2-0016]; [@CD012234-bbs2-0018]; [@CD012234-bbs2-0025]; [@CD012234-bbs2-0034]; [@CD012234-bbs2-0048]; [@CD012234-bbs2-0049]; [@CD012234-bbs2-0058]). We grouped these with the most contaminated class represented in each study (dirty in each case).

Three of the studies enrolled only children ([@CD012234-bbs2-0021]; [@CD012234-bbs2-0022]; [@CD012234-bbs2-0023]); 19 enrolled only adults [@CD012234-bbs2-0002]; [@CD012234-bbs2-0003]; [@CD012234-bbs2-0007]; [@CD012234-bbs2-0008]; [@CD012234-bbs2-0013]; [@CD012234-bbs2-0010]; [@CD012234-bbs2-0011]; [@CD012234-bbs2-0024]; [@CD012234-bbs2-0025]; [@CD012234-bbs2-0026]; [@CD012234-bbs2-0029]; [@CD012234-bbs2-0036]; [@CD012234-bbs2-0042]; [@CD012234-bbs2-0043]; [@CD012234-bbs2-0044]; [@CD012234-bbs2-0045]; [@CD012234-bbs2-0046]; [@CD012234-bbs2-0048]; [@CD012234-bbs2-0052]) and in 13 studies the population was mixed or unclear ([@CD012234-bbs2-0001]; [@CD012234-bbs2-0005]; [@CD012234-bbs2-0016]; [@CD012234-bbs2-0028]; [@CD012234-bbs2-0031]; [@CD012234-bbs2-0032]; [@CD012234-bbs2-0034]; [@CD012234-bbs2-0035]; [@CD012234-bbs2-0040]; [@CD012234-bbs2-0041]; [@CD012234-bbs2-0049]; [@CD012234-bbs2-0056]; [@CD012234-bbs2-0058]).

In all except two studies the non‐antibacterial irrigant was saline; one study used sterile water ([@CD012234-bbs2-0056]) and one used Ringer\'s solution ([@CD012234-bbs2-0032]). Fourteen studies (3261 participants) used an antiseptic solution ([@CD012234-bbs2-0002]; [@CD012234-bbs2-0005]; [@CD012234-bbs2-0010]; [@CD012234-bbs2-0011]; [@CD012234-bbs2-0018]; [@CD012234-bbs2-0021]; [@CD012234-bbs2-0022]; [@CD012234-bbs2-0023]; [@CD012234-bbs2-0032]; [@CD012234-bbs2-0034]; [@CD012234-bbs2-0049]; [@CD012234-bbs2-0052]; [@CD012234-bbs2-0056]; [@CD012234-bbs2-0058]). [@CD012234-bbs2-0058] was a three‐armed study that randomised participants to saline or one of two different antiseptic solutions; for this comparison we combined the two antiseptic groups and compared them with saline; the comparison between the two antiseptics is assessed in comparison 5. Antiseptic agents used included povidone iodine (Betadine), chlorhexidine, polyhexanide, taurolidine (Taurolin), and acidic electrolysed water. Twenty‐two studies (2902 participants) used an antibiotic solution ([@CD012234-bbs2-0001]; [@CD012234-bbs2-0003]; [@CD012234-bbs2-0007]; [@CD012234-bbs2-0008]; [@CD012234-bbs2-0013]; [@CD012234-bbs2-0016]; [@CD012234-bbs2-0024]; [@CD012234-bbs2-0025]; [@CD012234-bbs2-0026]; [@CD012234-bbs2-0028]; [@CD012234-bbs2-0029]; [@CD012234-bbs2-0031]; [@CD012234-bbs2-0035]; [@CD012234-bbs2-0036]; [@CD012234-bbs2-0040]; [@CD012234-bbs2-0041]; [@CD012234-bbs2-0042]; [@CD012234-bbs2-0043]; [@CD012234-bbs2-0044]; [@CD012234-bbs2-0045]; [@CD012234-bbs2-0046]; [@CD012234-bbs2-0048]). [@CD012234-bbs2-0024]; [@CD012234-bbs2-0028] and [@CD012234-bbs2-0036] were all three‐arm trials assessing saline and two different antibiotic solutions; for this comparison we combined the two antibiotic groups and compared them with saline. [@CD012234-bbs2-0026] used a factorial design to also assess skin preparation regimens; we combined arms as appropriate. [@CD012234-bbs2-0013] was a five‐arm trial assessing saline and four different antibiotic solutions; we combined the antibiotic groups here. Comparisons between the different antibiotics are assessed in comparison 5. Antibiotics used included: gentamicin, clindamycin (alone or in combination), ampicillin, tetracycline, cefotetan, cephapirin or cefoxitin, cefazolin, kanamycin, epicillin or lincomycine, cephalothin, chloramphenicol, cefamandole and moxalactam. Doses and concentrations of both antibiotics and antiseptics varied; full details are given in [Characteristics of included studies](#CD012234-sec2-0022){ref-type="sec"}. [@CD012234-bbs2-0003]; [@CD012234-bbs2-0035] and [@CD012234-bbs2-0056] were three‐arm studies that also randomised participants to no irrigation; these groups are included in comparison 1.

In one case we were unsure whether two study reports included some of the same participants ([@CD012234-bbs2-0010]; [@CD012234-bbs2-0011]). Attempts to contact the authors for clarification were unsuccessful so we have included only data from the larger of the two studies ([@CD012234-bbs2-0011]) in our an analysis for the primary outcome of SSI and conducted a sensitivity analysis to explore the impact of including both data sets independently; only one of these studies reported secondary outcomes so the issue did not impact these analyses.

#### Primary outcome: SSI {#CD012234-sec4-0015}

Thirty‐one studies (5141 randomised participants) reported analysable data for the outcome of SSI, which was variously defined (some studies did not provide a definition) ([@CD012234-bbs2-0001]; [@CD012234-bbs2-0002]; [@CD012234-bbs2-0007]; [@CD012234-bbs2-0008]; [@CD012234-bbs2-0010]; [@CD012234-bbs2-0011]; [@CD012234-bbs2-0013]; [@CD012234-bbs2-0016]; [@CD012234-bbs2-0018]; [@CD012234-bbs2-0021]; [@CD012234-bbs2-0022]; [@CD012234-bbs2-0023]; [@CD012234-bbs2-0024]; [@CD012234-bbs2-0025]; [@CD012234-bbs2-0026]; [@CD012234-bbs2-0029]; [@CD012234-bbs2-0031]; [@CD012234-bbs2-0032]; [@CD012234-bbs2-0034]; [@CD012234-bbs2-0035]; [@CD012234-bbs2-0036]; [@CD012234-bbs2-0040]; [@CD012234-bbs2-0041]; [@CD012234-bbs2-0042]; [@CD012234-bbs2-0043]; [@CD012234-bbs2-0044]; [@CD012234-bbs2-0046]; [@CD012234-bbs2-0048]; [@CD012234-bbs2-0049]; [@CD012234-bbs2-0052]; [@CD012234-bbs2-0058]). Details for all studies are given in [Table 9](#CD012234-tbl-0009){ref-type="table"}. However, [@CD012234-bbs2-0010] was included only for a sensitivity analysis (see below). Two studies ([@CD012234-bbs2-0028]; [@CD012234-bbs2-0056]) reported data which could not be included in the analysis as events were not attributable to groups.

There may be, on average, a benefit to the use of some form of antibacterial irrigation compared with non‐antibacterial irrigation. The pooled RR for SSI was 0.57 (95% CI 0.44 to 0.75; I^2^ = 53%) [Analysis 2.1](#CD012234-fig-00201){ref-type="fig"}. This was low‐certainty evidence downgraded once because 54% of the analysis weight was contributed by studies at high risk of bias in one or more domains, and once because publication bias was considered likely to have affected the result ([Figure 5](#CD012234-fig-0005){ref-type="fig"}). We conducted an exploratory post‐hoc Egger test on the advice of peer‐reviewers. The P value for small study effects was 0.073. The RR equates to an absolute difference in risk of 60 (95% CI 35 to 78) fewer SSIs per 1000 participants with antibacterial irrigation than with non‐antibacterial irrigation.Figure 5Funnel plot of comparison 2: antibacterial versus non‐antibacterial irrigation, outcome: 2.1 surgical site infection

We also undertook planned subgroup analysis based on the category of surgery. Because only one study that we classed as contaminated reported analysable data, we grouped this together with the studies of dirty or mixed surgical populations. The estimates of effect for the groups were as follows: clean RR 0.16 (95% CI 0.03 to 0.89); clean‐contaminated RR 0.57 (95% CI 0.40 to 0.79) and contaminated, dirty or mixed RR 0.61 (95% CI 0.40 to 0.92). It was not clear that these subgroupings explained much of the heterogeneity between studies; the I^2^ for between‐group differences was 9.7%. The result for the clean subgroup is fragile as it is based on very low event rates in small studies, with a zero event rate in one intervention group.

We did not carry out planned subgroup analysis for the comparison of antibacterial and non‐antibacterial irrigants for adults and children; only three studies ([@CD012234-bbs2-0021]; [@CD012234-bbs2-0022]; [@CD012234-bbs2-0023]), representing 3% of the analysis weight, enrolled only children, so meaningful results were unlikely. One of these studies enrolled children undergoing clean, orthopaedic surgeries ([@CD012234-bbs2-0021]); this reported 0 out of 79 participants with SSI in the antibacterial group compared with 2 out of 83 in the non‐antibacterial group.

The other two studies ([@CD012234-bbs2-0022]; [@CD012234-bbs2-0023]) enrolled children undergoing surgeries for appendicitis, classed as dirty. The two studies reported a total of 1 out of 32 participants with SSI in the antibacterial groups compared with 8 out of 28 in the non‐antibacterial group; both studies were at high risk of bias in one domain.

We undertook an exploratory post‐hoc subgroup analysis of the type of antibacterial irrigation (antiseptic or antibiotic) to test the rationale for combining all studies comparing irrigation with no irrigation in the same comparison. This analysis did not explain the heterogeneity, supporting the analysis plan employed, also based on clinical assessment. The results of this exploratory analysis are shown in [Table 10](#CD012234-tbl-0010){ref-type="table"}.

As noted we were unsure whether two study reports included some of the same participants ([@CD012234-bbs2-0010]; [@CD012234-bbs2-0011]). Attempts to contact the study authors for clarification were unsuccessful so we have included only data from the larger of the two studies ([@CD012234-bbs2-0011]) in our an analysis. A sensitivity analysis to explore the impact of including both data sets independently did not materially change the estimate of effect (RR 0.56, 95% CI 0.43 to 0.74; I^2^ = 51%).

We conducted a planned sensitivity analysis to look at the impact of excluding studies at high risk of bias in one or more domains. This had the effect of excluding half of the studies and the majority of participants with reported data and produced a larger estimate of effect than the main analysis (RR 0.38 95% CI 0.25 to 0.58). Because so many participants were excluded we do not place any emphasis on this analysis. No studies were at high risk of detection bias so we did not perform this planned sensitivity analysis.

#### Primary outcome: wound dehiscence {#CD012234-sec4-0016}

Three studies ([@CD012234-bbs2-0008]; [@CD012234-bbs2-0010]; [@CD012234-bbs2-0052]) with 660 participants reported wound dehiscence and the impact of antibacterial irrigation on dehiscence is very uncertain (RR 1.26; 95% CI 0.65 to 2.45, I^2^ = 0%) [Analysis 2.2](#CD012234-fig-00202){ref-type="fig"}. This was very low‐certainty evidence downgraded once for risk of bias in the study with the great majority of weight in the analysis, once for imprecision and once for inconsistency.

#### Secondary outcome: adverse events {#CD012234-sec4-0017}

Three studies with 202 participants reported analysable data on overall adverse events that could be clearly determined to represent all participants with an adverse event ([@CD012234-bbs2-0043]; [@CD012234-bbs2-0045]; [@CD012234-bbs2-0046]). There is no clear difference between the groups (RR 0.55, 95% CI 0.22 to 1.34, I^2^ = 0%; 178 participants); this was low‐certainty evidence downgraded twice for imprecision [Analysis 2.3](#CD012234-fig-00203){ref-type="fig"}.

Ten studies focused specifically on abscess formation, which we had prespecified as a specific event of interest ([@CD012234-bbs2-0001]; [@CD012234-bbs2-0002]; [@CD012234-bbs2-0013]; [@CD012234-bbs2-0022]; [@CD012234-bbs2-0023]; [@CD012234-bbs2-0035]; [@CD012234-bbs2-0040]; [@CD012234-bbs2-0042]; [@CD012234-bbs2-0046]; [@CD012234-bbs2-0048]). [@CD012234-bbs2-0040] grouped abscesses together with another type of event so could not be included in the analysis. Therefore nine studies were included in the analysis, three of which reported no events in either arm ([@CD012234-bbs2-0001]; [@CD012234-bbs2-0013]; [@CD012234-bbs2-0035]). It is uncertain whether there is a difference in abscess formation between antibacterial and non‐antibacterial irrigation; the pooled RR was 0.82, 95% CI 0.42 to 1.62, I^2^ = 0%; 1309 participants); this is very low‐certainty evidence downgraded once for risk of bias and twice for imprecision [Analysis 2.4](#CD012234-fig-00204){ref-type="fig"}.

A further eight studies reported additional specific types of adverse events that we had not prespecified, such as respiratory distress or endometritis, or made general non‐group specific statements about events ([@CD012234-bbs2-0003]; [@CD012234-bbs2-0024]; [@CD012234-bbs2-0025]; [@CD012234-bbs2-0026]; [@CD012234-bbs2-0028]; [@CD012234-bbs2-0031]; [@CD012234-bbs2-0044]; [@CD012234-bbs2-0048]); several of the studies included in analyses of abscess also specified such events. Details are provided in [Characteristics of included studies](#CD012234-sec2-0022){ref-type="sec"} but these data are not further analysed.

#### Secondary outcome: mortality {#CD012234-sec4-0018}

Eleven studies (1121 participants) reported data on mortality for antibacterial vs. non‐antibacterial irrigation ([@CD012234-bbs2-0002]; [@CD012234-bbs2-0005]; [@CD012234-bbs2-0025]; [@CD012234-bbs2-0036]; [@CD012234-bbs2-0040]; [@CD012234-bbs2-0042]; [@CD012234-bbs2-0043]; [@CD012234-bbs2-0044]; [@CD012234-bbs2-0045]; [@CD012234-bbs2-0046]; [@CD012234-bbs2-0058]). It is uncertain whether there is a difference in mortality between the treatment groups (RR 0.81, 95% CI 0.48 to 1.36) [Analysis 2.5](#CD012234-fig-00205){ref-type="fig"}. This was very low‐certainty evidence downgraded once for risk of bias in studies contributing 64% of the weight in the analysis and twice for imprecision.

#### Secondary outcome: hospital stay {#CD012234-sec4-0019}

Fifteen studies reported some data on length of hospital stay ([@CD012234-bbs2-0001]; [@CD012234-bbs2-0002]; [@CD012234-bbs2-0003]; [@CD012234-bbs2-0018]; [@CD012234-bbs2-0022]; [@CD012234-bbs2-0023]; [@CD012234-bbs2-0024]; [@CD012234-bbs2-0035]; [@CD012234-bbs2-0036]; [@CD012234-bbs2-0042]; [@CD012234-bbs2-0043]; [@CD012234-bbs2-0044]; [@CD012234-bbs2-0046]; [@CD012234-bbs2-0056]; [@CD012234-bbs2-0058]). Three studies did not report data separately for the intervention groups ([@CD012234-bbs2-0001]; [@CD012234-bbs2-0002]; [@CD012234-bbs2-0056]). Seven studies reported mean length of stay although two ([@CD012234-bbs2-0018]; [@CD012234-bbs2-0046]) did not report measures of variance. There may, on average, be a very slightly shorter length of stay in participants treated with antibacterial irrigation. The difference in means was ‐0.85 days (95% CI ‐1.60 to ‐0.09; I^2^ = 55%; 635 participants) [Analysis 2.6](#CD012234-fig-00206){ref-type="fig"}. Five studies reported median length of stay ([@CD012234-bbs2-0035]; [@CD012234-bbs2-0036]; [@CD012234-bbs2-0042]; [@CD012234-bbs2-0043]; [@CD012234-bbs2-0044]); in each case the median lengths of stay were very similar for the two groups. This was low‐certainty evidence downgraded for risks of bias across multiple domains.

#### Secondary outcome: systemic antibiotics {#CD012234-sec4-0020}

Two studies with a total of 375 participants reported some data on use of systemic antibiotics ([@CD012234-bbs2-0010]; [@CD012234-bbs2-0056]). [@CD012234-bbs2-0056] did not report the data based on treatment group allocation (they noted 53 of 131 participants receiving antibiotics \"distributed evenly across the groups\"); while [@CD012234-bbs2-0010] reported that all six of the participants with SSI received systemic antibiotics up to six weeks postoperatively (there were no infections in the povidone iodine group). Calculating an RR for this outcome would not produce a meaningful result since the data merely duplicate the results for the primary outcome of SSI; consequently no independent GRADE assessment is possible.

#### Secondary outcome: antibiotic‐resistant infection {#CD012234-sec4-0021}

Five studies with 1198 participants reported some information about antibiotic resistance in organisms sampled ([@CD012234-bbs2-0010]; [@CD012234-bbs2-0025]; [@CD012234-bbs2-0031]; [@CD012234-bbs2-0040]; [@CD012234-bbs2-0052]). [@CD012234-bbs2-0010] reported that 5 out of 6 infections in participants treated with saline tested positive for methicillin‐resistant *Staphylococcus aureus* (MRSA) (there were no infections in the povidone iodine group). [@CD012234-bbs2-0052] also focused on *S. Aureus* resistance and reported data for a majority of the participants with infection; however, the data could not be linked to the proportion of participants with or without resistance. Both studies used antiseptic rather than antibiotic irrigations. [@CD012234-bbs2-0031] reported tests for resistance to kanamycin (the antibiotic used in the study) in all wound cultures but provided specific results on the proportion with resistance for only one group. [@CD012234-bbs2-0025] and [@CD012234-bbs2-0040] reported data for resistance for specific organisms but these data were incomplete and could not be linked to participant‐level infections. We were not able to calculate any meaningful estimate of effect for the proportion of participants with antibiotic‐resistant infection and therefore no GRADE assessment was possible.

#### Secondary outcome: reoperation {#CD012234-sec4-0022}

Two studies with 403 participants reported data on reoperation ([@CD012234-bbs2-0010]; [@CD012234-bbs2-0048]). There were low numbers of events. It is uncertain if there is a difference between the treatment groups. The RR was 1.26 (95% CI 0.12 to 13.60) [Analysis 2.7](#CD012234-fig-00207){ref-type="fig"}. This was very low‐certainty evidence downgraded once for inconsistency and twice for imprecision.

#### Other secondary outcomes {#CD012234-sec4-0023}

No study reported on readmission to hospital.

#### Summary of comparison {#CD012234-sec4-0024}

Thirty‐six studies compared irrigation with antibacterial and non‐antibacterial irrigants and 33 reported the outcome of SSI; data from 30 studies with over 5000 participants could be included in the analysis. There may be a lower incidence of SSI in participants treated with antibacterial irrigation solutions compared with non‐antibacterial irrigants. This was low‐certainty evidence downgraded once for risk of bias in varying domains affecting studies that account for over half the weight of the analysis and once because publication bias is suspected. A pre‐planned subgroup analysis showed that the possible benefit was present in each of the surgical contamination subgroups that we were able to assess (clean versus clean‐contaminated versus contaminated or dirty) although the results in the clean group were based on small numbers of participants and very low numbers of events. Exploratory subgroup analysis confirmed that it was reasonable to combine different types of antibacterial solution in a single analysis. It is very uncertain whether there is a difference in the incidence of wound dehiscence between the treatment groups; this was very low‐certainty evidence based on three studies.

### Comparison 3: comparison of two non‐antibacterial irrigation solutions {#CD012234-sec3-0028}

[Table 8](#CD012234-tbl-0008){ref-type="table"}

One study (20 participants) compared irrigating with saline and artifical cerebrospinal fluid (CSF) in 20 participants undergoing clipping of cerebral aneurysms (classed as clean) ([@CD012234-bbs2-0047]).

Two studies compared irrigation with icodextrin and Ringer\'s solution. One enrolled 426 women undergoing primary removal of myomas or endometriotic cysts ([@CD012234-bbs2-0057]); a second study enrolled 449 women undergoing laparoscopic gynaecological surgery for a range of diagnoses ([@CD012234-bbs2-0004]). Both these studies involved surgeries classed as clean‐contaminated.

#### Primary outcome: SSI {#CD012234-sec4-0025}

##### Saline versus artificial CSF {#CD012234-sec5-0001}

[@CD012234-bbs2-0047] did not report SSI.

##### Icodextrin versus Ringer\'s solution {#CD012234-sec5-0002}

The RR for [@CD012234-bbs2-0057] was 2.89 (95% CI 0.30 to 27.56; 426 participants). In [@CD012234-bbs2-0004] it was not clear that the infection data reported referred to SSI; attempts to clarify this with the study authors have not been successful so far. There is no clear evidence of a difference. This was low‐certainty evidence downgraded twice for imprecision based only on the data from the trial where we were confident this was SSI data ([@CD012234-bbs2-0057]).

#### Primary outcome: wound dehiscence {#CD012234-sec4-0026}

This was not reported by either study.

#### Secondary outcome: mortality {#CD012234-sec4-0027}

##### Icodextrin versus Ringer\'s solution {#CD012234-sec5-0003}

Both [@CD012234-bbs2-0004] and [@CD012234-bbs2-0057] reported no deaths in either intervention group (total of 875 participants). Since no estimate of effect was therefore calculable no full GRADE assessment was made; the evidence is affected by imprecision however [Analysis 3.1](#CD012234-fig-00301){ref-type="fig"}.

#### Secondary outcome: adverse events {#CD012234-sec4-0028}

##### Saline versus artificial CSF {#CD012234-sec5-0004}

[@CD012234-bbs2-0047] reported the number of participants with postoperative events; this included neurological events and events visualised on CT or MRI scans. There were two participants with events in each group (total of 20 participants); because of the inclusion of imaging results in these data we have not reported an effect estimate and have not undertaken a GRADE assessment.

##### Icodextrin versus Ringer\'s solution {#CD012234-sec5-0005}

Both [@CD012234-bbs2-0004] and [@CD012234-bbs2-0057] reported total number of participants with adverse events and the number with events that were considered to be related to treatment. There was, on average, no difference in the number of participants with an adverse event (RR 0.99, 95% CI 0.96, 1.02; I^2^ = 0%; 875 participants) [Analysis 3.2](#CD012234-fig-00302){ref-type="fig"}. The effect estimate for events considered to be related to treatment may be a more meaningful measure; this also showed no clear difference, on average, with confidence intervals that included the possibility of a small benefit from icodextrin as well as harm: RR 1.35 (95% CI 0.98 to 1.86; I^2^ = 0%; 875 participants) [Analysis 3.3](#CD012234-fig-00303){ref-type="fig"}. This was moderate‐certainty evidence downgraded once for imprecision. [@CD012234-bbs2-0004] also reported the proportions of participants with serious adverse events (RR 1.20, 95% CI 0.80 to 1.78; 426 participants) and serious events that were considered to be treatment‐related (RR 0.71, 95% CI 0.29 to 1.73; 449 participants). In both cases there may be little or no difference between the treatment groups (low‐certainty evidence).

#### Other secondary outcomes {#CD012234-sec4-0029}

No studies reported data for other secondary outcomes.

#### Summary of comparison {#CD012234-sec4-0030}

There were two comparisons where both arms involved a solution without antibacterial properties. A single study comparing saline with artifical CSF in brain surgery (clean) did not report either SSI or wound dehiscence. Two studies compared icodextrin with Ringer\'s solution in gynaecological surgery (clean‐contaminated) but only one clearly reported SSI and neither reported wound dehiscence. There is no clear difference in SSI incidence between the treatment groups. This was low‐certainty evidence downgraded twice for imprecision.

### Comparison 4: comparison of povidone iodine with alternative antiseptic {#CD012234-sec3-0029}

[Table 8](#CD012234-tbl-0008){ref-type="table"}

One study compared povidone iodine with superoxidised water irrigation (Dermacyn) in 190 participants undergoing coronary artery bypass graft (CABG) (classed as clean) ([@CD012234-bbs2-0030]).

One three‐armed study compared povidone iodine with chlorhexidine in 53 adults undergoing surgery for peritonitis (classed as dirty) ([@CD012234-bbs2-0058]); a third group were randomised to saline irrigation (see comparison 2). The number of participants relevant to this comparison was 33.

#### Primary outcome: SSI {#CD012234-sec4-0031}

##### Povidone iodine versus superoxidised water (Dermacyn) {#CD012234-sec5-0006}

There may be more infections in wounds irrigated with povidone iodine compared with Dermacyn. The RR for [@CD012234-bbs2-0030] was 2.80 (95% CI 1.05 to 7.47; 190 participants). This would represent an absolute difference of 95 more SSIs per 1000 people treated with povidone iodine than with superoxidised water (95% CI 3 more to 341 more). This was low‐certainty evidence downgraded once for risk of bias and once for imprecision.

##### Povidone iodine versus chlorhexidine {#CD012234-sec5-0007}

It is uncertain whether there is a difference between the groups. The RR in [@CD012234-bbs2-0058] was 1.13 (95% CI 0.78 to 1.63; 29 participants). This represents a completed case analysis, as early mortality cases were excluded from the analysis and could not be accurately assigned to groups. This was very low‐certainty evidence downgraded twice for risks of bias across multiple domains and twice for imprecision.

Details for both studies are given in [Table 9](#CD012234-tbl-0009){ref-type="table"}; GRADE judgements are summarised in [Table 8](#CD012234-tbl-0008){ref-type="table"}.

#### Primary outcome: wound dehiscence {#CD012234-sec4-0032}

This was not reported by any of the studies.

#### Secondary outcome: mortality {#CD012234-sec4-0033}

##### Povidone iodine versus superoxidised water (Dermacyn) {#CD012234-sec5-0008}

[@CD012234-bbs2-0030] reported deaths together with the need for reopening of the chest due to bleeding. There were four deaths in total but it was not clear in which group they occurred. A full GRADE assessment was not possible but certainty would be affected by risk of bias as well as imprecision.

##### Povidone iodine versus chlorhexidine {#CD012234-sec5-0009}

It is uncertain whether there is a difference between the groups. The RR in [@CD012234-bbs2-0058] was 0.45 (0.05 to 3.90; 33 participants). These data refer to deaths within four days of surgery; later mortality was recorded but was not reported separately for the treatment groups. This was very low‐certainty evidence downgraded twice for risks of bias across multiple domains and twice for imprecision.

#### Secondary outcome: hospital stay {#CD012234-sec4-0034}

##### Povidone iodine versus chlorhexidine {#CD012234-sec5-0010}

It is uncertain whether there is a difference between the groups.The difference in means in [@CD012234-bbs2-0058] was 3.30 days more in the povidone iodine group (95% CI 0.53 to 6.07; 33 participants). This was very low‐certainty evidence downgraded twice for risks of bias across multiple domains and twice for imprecision.

#### Secondary outcome: reoperation (return to theatre) {#CD012234-sec4-0035}

##### Povidone iodine versus Dermacyn {#CD012234-sec5-0011}

It is uncertain whether there is a difference between the groups. The RR in [@CD012234-bbs2-0030] was 8.80 (95% CI 0.48 to 161.11; 178 participants) based on four events, all in the povidone iodine group. This was very low‐certainty evidence downgraded once for risk of bias and twice for imprecision.

#### Other secondary outcomes {#CD012234-sec4-0036}

No studies reported data for other secondary outcomes.

#### Summary of comparison {#CD012234-sec4-0037}

There were two studies where one arm was povidone iodine and the other was another antiseptic solution. Each study undertook a different comparison. Numbers of participants were low. The comparison with superoxidised water (Dermacyn) was undertaken in clean cardiac operations while the comparison with chlorhexidine was in dirty operations for peritonitis. There may be more infections in wounds treated with povidone iodine compared with superoxidised water; low‐certainty evidence downgraded once for risk of bias and once for imprecision. It is very uncertain whether there is a difference in SSI incidence between povidone iodine and chlorhexidine; very low‐certainty evidence downgraded twice for risk of bias across multiple domains and twice for imprecision. Neither study reported wound dehiscence.

### Comparison 5: comparisons of different antibiotic irrigation solutions {#CD012234-sec3-0030}

[Table 8](#CD012234-tbl-0008){ref-type="table"}

One three‐arm study compared use of cephapirin with cefoxitin in 132 women undergoing caesarean sections (classed as clean‐contaminated) ([@CD012234-bbs2-0024]); a third group were randomised to saline irrigation (see comparison 2). The number of participants relevant to this comparison was 85.

One three‐arm study compared the use of clindamycin with gentamicin in 51 women undergoing planned axillary node dissection ([@CD012234-bbs2-0036]); a third group of women were randomised to saline (see comparison 2). The number of participants relevant to this comparison was 34. All participants received an initial saline irrigation, women in the two antibiotic groups received a second irrigation with either gentamicin or clindamycin solution. This surgery was classed as clean.

One three‐arm study compared the use of epicillin with lincomycine in a group of 162 adults and children undergoing surgery for appendicitis (classed as contaminated) ([@CD012234-bbs2-0028]); a third group of participants were randomised to saline irrigation (see comparison 2).

One five‐arm study assessed irrigation with four different antibiotic solutions (cephapirin, cefamandole, moxalactam or ampicillin) or saline in 360 women undergoing caesarean section ([@CD012234-bbs2-0013]). The comparison of antibiotic irrigation versus saline is included in comparison 2; we were also able to assess six comparisons involving the individual antibiotics.

One study assessed irrigation with either cefazolin of cefamandole in women undergoing caesarean section. [@CD012234-bbs2-0038] enrolled 207 women and randomised 113 to groups relevant to this review.

#### Primary outcome: SSI {#CD012234-sec4-0038}

##### Cephapirin versus cefoxitin {#CD012234-sec5-0012}

The RR for [@CD012234-bbs2-0024] was not estimable because there were no SSI events in either treatment group (85 participants). Therefore no full GRADE assessment was possible but the certainty of the evidence would be affected by risks of bias as well as imprecision.

##### Epicillin versus lincomycine {#CD012234-sec5-0013}

[@CD012234-bbs2-0028] did not specify the number of participants relevant to this comparison (162 total participants) and did not report any outcome data by the intervention group in which the event occurred, instead reporting only the total number of events in all three intervention groups for both SSI and adverse events. We could not analyse these data further and no full GRADE assessment was possible, but the certainty of the evidence would be affected by risks of bias as well as imprecision.

##### Clindamycin versus gentamicin {#CD012234-sec5-0014}

The RR for [@CD012234-bbs2-0036] was not estimable because there were no SSI events in either treatment group (34 participants relevant to this comparison). Therefore no full GRADE assessment was possible; the certainty of this evidence would be affected by imprecision.

##### Cephapirin versus cefamandole {#CD012234-sec5-0015}

The RR for [@CD012234-bbs2-0013] was 1.37 (95% CI 0.24 to 7.95; 134 participants) based on 3 out of70 participants with SSI in the cephapirin group and 2 out of 64 in the cefamandole group.

##### Cephapirin versus moxalactam {#CD012234-sec5-0016}

The RR for [@CD012234-bbs2-0013] was 1.69 (95% CI 0.29 to 9.84; 149 participants) based on 3 out of 70 participants with SSI in the cephapirin group and 2 out of 79 in the moxalactam group.

##### Cephapirin versus ampicillin {#CD012234-sec5-0017}

The RR for [@CD012234-bbs2-0013] was 7.00 (95% CI 0.37 to 133.06; 140 participants) based on 3 out of 70 participants with SSI in the cephapirin group and 0 out of 70 in the ampicillin group.

##### Cefamandole versus moxalactam {#CD012234-sec5-0018}

The RR for [@CD012234-bbs2-0013] was 1.23 (95% CI 0.18 to 8.52; 143 participants) based on 2 out of 64 participants with SSI in the cefamandole group and 2 out of 79 in the moxalactam group.

##### Cefamandole versus ampicillin {#CD012234-sec5-0019}

The RR for [@CD012234-bbs2-0013] was 5.46 (95% CI 0.27 to 111.65; 134 participants) based on 2 out of 64 participants with SSI in the cefamandole group and 0 out of 70 in the ampicillin group.

##### moxalactam versus ampicillin {#CD012234-sec5-0020}

The RR for [@CD012234-bbs2-0013] was 4.44 (95% CI 0.22 to 90.88; 149 participants) based on 2 out of 79 participants with SSI in the moxalactam group and 0 out of 70 in the ampicillin group.

##### Cefazolin versus cefamandole {#CD012234-sec5-0021}

The RR for ([@CD012234-bbs2-0038]) was 4.58 (95% CI 0.22 to 93.38; 113 participants) based on 2 out of 59 participants with SSI in the cefazolin group and 0 out of 54 in the cefamandole group.

Where a full GRADE assessment was possible, in each case we judged these estimates to represent low‐certainty evidence, which was downgraded twice for serious imprecision. Details for all studies are given in [Table 9](#CD012234-tbl-0009){ref-type="table"}; GRADE judgements are summarised in [Table 8](#CD012234-tbl-0008){ref-type="table"}.

#### Primary outcome: wound dehiscence {#CD012234-sec4-0039}

This was not reported by any of the studies.

#### Secondary outcome: adverse events {#CD012234-sec4-0040}

##### Cephapirin versus cefoxitin {#CD012234-sec5-0022}

[@CD012234-bbs2-0024] reported only a single type of adverse event (endometritis); these data were not further analysed.

##### Epicillin versus lincomycine {#CD012234-sec5-0023}

[@CD012234-bbs2-0028] reported that one abscess occurred in the groups treated with antibiotics but did not report in which group the event occurred therefore no full GRADE assessment was possible although the certainty of the evidence would be affected by risks of bias as well as imprecision.

[@CD012234-bbs2-0013] reported that there were no occurrences of abscess in any group; because there were zero events in every group (total 360 participants), no estimates of effect could be calculated for any comparison. The study also reported the proportion of participants with infection‐related morbidity; these data did not clearly represent all participants with adverse events and were not further analysed for any of the six comparisons of antibiotics.

No full GRADE assessment was possible for any of the comparisons but any assessment of the certainty of the evidence would be affected by imprecision.

#### Secondary outcome: mortality {#CD012234-sec4-0041}

##### Clindamycin versus gentamicin {#CD012234-sec5-0024}

The RR for [@CD012234-bbs2-0036] was not estimable because there were no events in either treatment group (34 participants relevant to this comparison). Therefore no GRADE assessment was possible.

No other studies reported this outcome.

#### Secondary outcome: length of stay: {#CD012234-sec4-0042}

##### Cephapirin versus cefoxitin {#CD012234-sec5-0025}

There may be little or no difference between the groups; the difference in means in [@CD012234-bbs2-0024]was 0.10 days (lower for the cephapirin group) (95% CI ‐0.78 to 0.58; 85 participants). This was low‐certainty evidence downgraded twice for imprecision.

##### Clindamycin versus gentamicin {#CD012234-sec5-0026}

[@CD012234-bbs2-0036] reported a median length of stay of 3 days (range 1 to 3) in each group (total 34 relevant participants) suggesting that there may be little difference between the groups. This was low‐certainty evidence downgraded twice for imprecision.

No other studies reported this outcome.

#### Other secondary outcomes {#CD012234-sec4-0043}

No studies reported data for other secondary outcomes.

#### Summary of comparison {#CD012234-sec4-0044}

There were 10 comparisons of different antibiotic solutions. Each comparison was assessed in a single study; six comparisons were represented by the same trial that randomised participants to saline or one of four different antibiotic solutions. Numbers of participants were low. All of the comparisons reported SSI as an outcome and none reported wound dehiscence. For three comparisons we could not calculate an estimate of effect, either because there were no events (cephapirin versus cefoxitin and clindamycin versus gentamicin) or because no group data were reported (epicillin versus lincomycine). In each of the other comparisons (cephapirin versus cefamandole; cephapirin versus moxalactam; cephapirin versus ampicillin; cefamandole versus moxalactam; cefamandole versus ampicillin; moxalactam versus ampicillin; cefazolin versus cefamandole) there was low‐certainty evidence of no clear difference between the groups, downgraded twice for imprecision because of wide confidence intervals, which included the possibility of no effect and both benefit and harm for each treatment. All except the last of these comparisons were represented by the single, multi‐arm trial. Although all classes of surgery were represented, effect estimates were only calculable for those comparisons assessed in clean‐contaminated surgery.

### Comparison 6: comparison of two different methods of irrigation delivery {#CD012234-sec3-0031}

[Table 3](#CD012234-tbl-0003){ref-type="table"}

Comparison of standard (non‐pulsed) saline irrigation using a jug or a syringe with pulsatile saline irrigation was assessed by two studies ([@CD012234-bbs2-0019]; [@CD012234-bbs2-0033]) with a total of 484 participants. [@CD012234-bbs2-0019] enrolled 356 people (ages not reported clearly) having surgery for displaced neck of femur (classed as clean). [@CD012234-bbs2-0033] enrolled 137 adults undergoing open elective abdominal surgery scheduled to last at least two hours (classed as clean‐contaminated).

#### Primary outcome: SSI {#CD012234-sec4-0045}

Both [@CD012234-bbs2-0019] and [@CD012234-bbs2-0033] assessed SSI. There may, on average, be a lower incidence of SSI in participants treated with pulsatile irrigation compared with standard irrigation. There were 13 cases of SSI in the 230 participants in the pulsatile groups compared with 42 out of 254 in the standard groups. The pooled RR was 0.34 (95% CI 0.19, 0.62; I^2^ = 0%; 484 participants) [Analysis 4.1](#CD012234-fig-00401){ref-type="fig"}. This was low‐certainty evidence, which was downgraded twice for multiple additional risks of bias in [@CD012234-bbs2-0019], which contributed 69% of the weight in the analysis; both studies were necessarily at high risk of performance bias due to the nature of the comparison. The RR equates to an absolute risk difference of 109 (95% CI 62 to 134) fewer SSIs per 1000 participants with pulsatile irrigation than with standard irrigation.

Because there was only a single study in each surgical class and populations were mixed or adult we were unable to conduct pre‐planned subgroup analyses on the basis of either surgical category or adult/paediatric populations.

#### Primary outcome: wound dehiscence {#CD012234-sec4-0046}

[@CD012234-bbs2-0033] reported that there was one incidence of wound dehiscence in the standard irrigation group. The RR for this was 0.31 (95% CI 0.01 to 7.55; 128 participants). This was low‐certainty evidence downgraded twice for imprecision.

#### Secondary outcome: mortality {#CD012234-sec4-0047}

[@CD012234-bbs2-0019] reported that there were 25 deaths among the 356 participants but did not state in which treatment group they occurred; [@CD012234-bbs2-0033] did not report mortality. No GRADE assessment was possible.

#### Secondary outcome: adverse events {#CD012234-sec4-0048}

[@CD012234-bbs2-0033] reported the number of participants with complications that were not wound infections. The RR was 1.31 (95% CI 0.87 to 1.97; 128 participants). This was low‐certainty evidence downgraded twice for imprecision.

#### Secondary outcome: use of systemic antibiotics {#CD012234-sec4-0049}

[@CD012234-bbs2-0033] reported that 14 of the 16 participants with wound infection were treated with systemic antibiotics but did not report data by treatment group; no GRADE assessment was possible.

#### Secondary outcome: antibiotic resistance {#CD012234-sec4-0050}

[@CD012234-bbs2-0019] reported that \"half\" of the wound infections tested positive for MRSA but did not report data by treatment group. [@CD012234-bbs2-0033] reported some qualitative data on the organisms isolated. No GRADE assessment was possible.

#### Secondary outcome: length of stay {#CD012234-sec4-0051}

[@CD012234-bbs2-0033] reported the median length of stay as 9 days in both groups, the range in the pulsatile group was 5 to 45 days compared with 4 to 71 days in the standard group. This suggested that there may be little difference between the groups. This was moderate‐certainty evidence downgraded once for imprecision.

#### Secondary outcome: reoperation {#CD012234-sec4-0052}

[@CD012234-bbs2-0033] reported the need for reoperation for two specific reasons: major debridement and relaparotomy. The effect estimate for all reintervention showed no clear difference between the groups (RR 0.56, 95% CI 0.14 to 2.26; 128 participants). This was low‐certainty evidence downgraded twice for imprecision.

#### Secondary outcome: hospital readmission {#CD012234-sec4-0053}

[@CD012234-bbs2-0033] reported readmissions to hospital; there is no clear difference between the groups. The RR was 1.41 (95% CI 0.53 to 3.73; 128 participants). This was low‐certainty evidence downgraded twice for imprecision.

#### Summary of comparison {#CD012234-sec4-0054}

Two studies assessed pulsatile versus standard techniques of irrigation using saline. One was conducted in clean and one in clean‐contaminated surgeries. There may be fewer incidences of SSI in participants treated with pulsatile irrigation compared with normal irrigation. This was low‐certainty evidence downgraded twice for multiple additional risks of bias in the study with the majority of the weight in the analysis; both studies were also at high risk of performance bias. There is no clear difference between the groups in the incidence of wound dehiscence; low‐certainty evidence downgraded twice for imprecision.

Discussion {#CD012234-sec1-0006}
==========

Summary of main results {#CD012234-sec2-0011}
-----------------------

We identified a total of 59 studies involving 14,738 participants. Most included studies had a parallel‐group design (there was one split‐body design and two factorial designs that assessed, respectively, skin preparation and intravenous antibiotics as well as wound irrigation). Most studies reported the primary review outcome (SSI), with other outcomes of interest sparsely reported. Key results for each comparison and outcome are summarised below.

### Surgical site infection {#CD012234-sec3-0032}

#### Comparison with no intervention {#CD012234-sec4-0055}

Twenty studies with 7192 participants compared some form of irrigation with no irrigation, The irrigation fluid was either non‐antibacterial (typically saline) or an antiseptic or antibiotic solution. The majority of these studies reported analysable SSI data, which contributed to a pooled analysis, and we were able to carry out one of the prespecified subgroup analyses based on surgical classification. We also undertook an exploratory analysis on the basis of type of irrigation solution, which supported our informed decision to conduct a single analysis that included studies that used different types of irrigation solution. Based on available data there was, on average, no clear difference between the groups in incidence of SSI, and this was also the case in the two subgroups (clean‐contaminated versus contaminated or dirty). This was low‐certainty evidence downgraded for risk of bias and imprecision; although fewer infections were reported in the groups treated with irrigation, confidence intervals included both benefit and harm despite large numbers of participants.

#### Comparison of antibacterial irrigation with non‐antibacterial irrigation {#CD012234-sec4-0056}

Thirty‐six studies (6163 participants) compared a non‐antibacterial (typically saline) irrigation with either an antiseptic (14 studies) or an antibiotic solution (22 studies). The majority of these studies reported analysable SSI data, which contributed to a pooled analysis, and we were able to carry out one of the prespecified subgroup analyses based on surgical classification. We also undertook an exploratory analysis, which confirmed that it was reasonable to conduct a single analysis that included studies that used different types of antibacterial irrigation solution. There may, on average, be a lower incidence of SSI in participants treated with antibacterial irrigation compared with non‐antibacterial irrigation. This was low‐certainty evidence, which was downgraded once due to risk of bias across multiple domains in studies accounting for much of the analysis weight, and once due to the probability of publication bias.

#### Comparisons between interventions of the same class {#CD012234-sec4-0057}

Several single studies compared two different irrigants without antibacterial properties or compared two different antiseptic agents or two different antibiotics. No studies compared antibiotics with antiseptics. The great majority of these studies were underpowered and had limited reporting of methodology. Only one comparison was represented by more than one study (icodextrin versus lactated Ringer\'s solution) and this was also the only comparison of this nature with adequately powered and well‐reported studies; however SSI was not the primary outcome of either study and in one study we were not clear that ambiguous data actually represented this outcome.

As a consequence of the poor reporting and small numbers of participants, events or both, all of the comparisons between agents of the same class represented low‐certainty evidence. Only one comparison found that there may be a difference between the groups: there may be more SSI in participants treated with povidone iodine compared with superoxidised water (downgraded for risk of bias as well as imprecision); in all other cases, based on available evidence, there is no clear difference between the treatment groups. Individual studies represented particular classes of surgical contamination and the applicability of the evidence from the comparisons to participants in other surgical classes may be reduced by indirectness.

#### Comparison of pulsatile irrigation with standard irrigation {#CD012234-sec4-0058}

There was low‐certainty evidence from two studies that, on average, there may be fewer SSIs in participants treated with pulsatile compared with standard (non‐pulsed ‐ pouring method) irrigation. This was based on participants undergoing clean or clean‐contaminated surgery and may therefore be only indirectly relevant to participants undergoing more contaminated surgeries. We downgraded this evidence twice for risk of bias across multiple domains in the study with the greatest weight in the analysis.

### Wound dehiscence {#CD012234-sec3-0033}

Only a minority of studies reported wound dehiscence across all comparisons. For no comparison where this was reported is there a clear difference between the groups. This was low‐ or very low‐certainty evidence in each case. Imprecision was a factor in all comparisons, inconsistency or high risk of bias were also present in some cases.

### Secondary outcomes {#CD012234-sec3-0034}

Many studies did not report any of the secondary outcomes we specified for this review. Those that did often only reported one or two and these were most often length of hospital stay or adverse event data. We pooled data that reported mean lengths of stay and provided narrative summaries where medians were reported. With adverse event data we pooled studies that reported the number of participants in each group with an event. We documented reports of specific types of adverse events but did not analyse these with the exception of abscess formation, which we had prespecified as being of particular interest to the review; we analysed this separately. Mortality was reported in only a minority of studies; in many instances this is likely to be a consequence of there being zero events in low‐risk participants undergoing clean or clean‐contaminated procedures. Outcomes related to antibiotic resistance -- proportion of participants on systemic antibiotics in the 30‐day postoperative period and incidence of antibiotic‐resistant infection were especially poorly reported. There were few data and the data that were reported were often incomplete. The evidence for the impact of interventions on length of hospital stay was low or moderate certainty; where differences were seen they were too small to be clinically important.

Overall completeness and applicability of evidence {#CD012234-sec2-0012}
--------------------------------------------------

A wide range of types of surgery is included in this review and all four categories of surgery (clean, clean‐contaminated, contaminated and dirty) were represented. However, as might be anticipated, only small numbers of participants undergoing clean operations were identified. Therefore, although we did not identify a material difference between subgroups in our planned analyses based on surgical category, it should be emphasised that most of the data relate to clean‐contaminated, contaminated or dirty surgeries. Only one very small study assessed the comparison of no intervention with intervention in participants undergoing clean surgery and numbers were low for the comparison between antibacterial and other solutions too.

A substantial number of studies included only women because of the nature of the surgery undertaken (e.g. caesarean sections), although we do not believe this would impact on the relevance of the results to all surgical patients. Few studies included only children although many included both adults and children.

Publication dates of included studies ranged from 1968 to 2016. This is likely to be a source of considerable differences between participants and surgical techniques, while the development of antibiotic resistance over time may also make results from early studies less directly relevant to current practice. Twenty of the 59 studies ‐ approximately one third ‐ were published before 1990. There were variations in the use of prophylactic antibiotics, as would be anticipated given the different types and contamination levels of surgery involved and the time span across which studies were conducted and published. This may affect the applicability of some of the evidence.

We did not include studies that compared irrigation with another intervention, so can present no evidence for the value of irrigation compared with, for example, antibiotics delivered by another method. This represents a gap in the comprehensive evidence synthesis but other reviews have included these studies (see [Agreements and disagreements with other studies or reviews](#CD012234-sec2-0015){ref-type="sec"}). We would have included any studies that compared the use of an antibiotic solution with an antiseptic solution but none were identified. This is a clear gap in the evidence and possible methods for dealing with this are discussed in [Implications for research](#CD012234-sec1-0009){ref-type="sec"}. We also did not identify any studies that compared the use of different volumes of the same solution.

Although the great majority of included studies reported the primary outcome of SSI, few reported wound dehiscence and participant numbers were such that there was insufficient power for a difference between groups to be detected. Key secondary outcomes such as adverse events and antibiotic resistance were poorly and inconsistently assessed and reported in most trials and for most comparisons. Mortality was reported in only a minority of studies, although we believe that this is at least partially explained by a zero incidence in many studies not being formally reported. Although we planned to look at the time points of outcome assessment, in practice the overwhelming majority of data related to short‐term post‐surgical assessment at between two and eight weeks. Long‐term follow‐up was rare and limited to a small number of orthopaedic or spinal operations, which followed participants for several months, but even in these cases they reported limited data beyond the initial postoperative period. This is unlikely to be a serious threat to the applicability of the results for SSI but it may have implications for other outcomes such as mortality.

Despite searching multiple databases and extensive citation checking we are not confident that we have identified all extant studies although we believe we are likely to have identified the great majority of published studies. Analysis of funnel plots for comparisons of intervention versus no intervention and for antibacterial versus non‐antibacterial interventions suggested that publication bias was possible or likely. The implications of this are explored in [Potential biases in the review process](#CD012234-sec2-0014){ref-type="sec"}.

Quality of the evidence {#CD012234-sec2-0013}
-----------------------

In studies that compare irrigation with no irrigation or compare different irrigation techniques it is difficult or impossible for personnel to be blinded to treatment allocation. Since none of these studies explicitly reported doing so, we classified them all as being at high risk of performance bias. However we did not downgrade for this risk of performance bias if no other domain was classed as posing a high risk of bias. Blinding of outcome assessment is a more important risk of bias and this was reported to be low for only a minority of studies; in many more it was unclear whether this was undertaken for the key outcomes of SSI and wound dehiscence. Just under half of studies were at risk of bias other than inherent performance bias, and the great majority were poorly reported in multiple domains, placing them at unclear risk of bias on many factors.

Where possible we conducted preplanned sensitivity analyses, which looked at the impact of removing studies at a high risk of bias in one or more domains; we were able to do this for the outcome of SSI for the comparisons between irrigation and no irrigation and between antibacterial and non‐antibacterial irrigation. When we performed the sensitivity analysis for the comparison of no irrigation with irrigation we did not remove studies which were only at high risk in the domain of performance bias, because all studies necessarily had a high risk in this domain. The results of these sensitivity analyses suggested that data from studies with a high risk of bias were not acting to increase an estimate of effect, although such studies included large numbers of participants.

Poor reporting means that we are not confident that most of the studies that did not show a clear high risk of bias in any domain are free from such a risk; it is likely that many are but that this is not evident from the limited reporting of the study.

Finally as noted in [Overall completeness and applicability of evidence](#CD012234-sec2-0012){ref-type="sec"} and [Potential biases in the review process](#CD012234-sec2-0014){ref-type="sec"}, we are concerned that the certainty of the evidence may be compromised by selective incompleteness ‐ a pattern of missingness which may serve to increase the estimates of effect.

Potential biases in the review process {#CD012234-sec2-0014}
--------------------------------------

We believe that this review is unlikely to be affected by language bias; it includes studies in Slovak, Korean, Persian, French and Danish. Studies in other languages, including Chinese and German were also identified and considered for inclusion at full text (see [Excluded studies](#CD012234-bbs1-0002){ref-type="ref-list"}).

We identified a substantial number of trials through citation searching in addition to those found through database and trial registry searches. However, while we have some confidence that we are likely to have identified the great majority of relevant published studies, we cannot rule out the possibility that there are unpublished studies which are not included in the review and which may have affected the results. We were able to construct funnel plots for the primary outcome of SSI for both the comparison of irrigation with no treatment and the comparison of antibacterial with non‐antibacterial solutions. In the latter case there was a strong suggestion that there may be small studies with negative results that were absent from the evidence identified and we downgraded the certainty of the evidence once because of this. The appearance of the funnel plot for the comparison with no treatment was ambiguous, while we could not rule this out there was no clear suggestion of a publication bias effect. There were too few trials in the other analyses to permit funnel plot analyses so we are unable to assess the likelihood of publication bias in these sections of the review; it is nevertheless possible that it may be present. The impact of publication bias of the type we may have identified is to increase the estimate of effect relative to the true effect of the intervention.

The exploratory subgroup analysis, which we used to confirm our strategy of comparing any type of irrigation with no irrigation, suggested that none of the heterogeneity in that analysis was explained by whether the solution used was antibiotic, antiseptic or antibacterial. However, we have identified that there may be fewer SSIs in participants treated with antibacterial (antiseptic or antibiotic) irrigation compared with no irrigation. The fact that we found no evidence of a differential effect of solution type in the comparison with no irrigation may represent an additional reason for caution in the interpretation of this data, alongside the noted risks of bias and publication bias. Equally, however, it is important not to over interpret subgroup analyses, particularly when these are not prespecified. We should also note that the two analyses (irrigation versus no irrigation; antibacterial versus non‐antibacterial) contained different proportions of participants in the different surgical categories, meaning that baseline incidence of SSI will differ.

In the majority of the included studies the source of funding was not reported and where it was reported it was mostly non‐commercial. Whilst it is possible that funding may play a role in the potential differential absence of small negative trials, it may be more likely due to the other factors including the reluctance of both journals and authors to pursue publication in such cases. We identified only one completed study that was without extant publication in our search or trial registers, this had only recently passed its completion date; we also identified one study that had passed the planned completion date but that did not have an identified publication.

Agreements and disagreements with other studies or reviews {#CD012234-sec2-0015}
----------------------------------------------------------

We identified a number of reviews as being relevant to this synthesis; these proved extremely helpful to our citation searching although none had the same scope as our review in all respects. Existing reviews fell into the following classes: reviews focusing on a particular type of surgery (e.g. [@CD012234-bbs2-0171]); and reviews focusing on a particular agent or class of agents (e.g. [@CD012234-bbs2-0157] and [@CD012234-bbs2-0173], which look at the use of intraoperative povidone iodine); in some cases they focused even more narrowly on a specific intervention for a specific operation (e.g. [@CD012234-bbs2-0156]; [@CD012234-bbs2-0184]).

Some reviews differed from our work in that they included studies other than RCTs ‐ either quasi‐RCTs (some of which were classed as RCTs) or even less rigorous research methodologies. Some also used a very wide definition of irrigation or had a broader objective and included any method of topical application of their agent of interest to the wound, including, for example, assessments of aerosols, dry powder or very low volumes of liquid. There were also broader definitions of the area irrigated; we did not include studies where only internal (e.g.) uterine, bladder or bowel irrigation was reported. We have employed a narrower definition of irrigation but adopted a much broader approach to the types of agents and classes of surgery which were of interest. Several reviews also considered comparisons that were outside the scope of our review because the use of irrigation of a particular type was not the only systematic difference between the treatment groups. Finally our review has a much more recent search than many of these and, while many studies in the review were old, over a third of the included studies ‐ including many of those with large numbers of participants and stronger methodologies ‐ were published from 2010 onwards, with a significant number having 2015 and 2016 publication dates.

The most recent review, and the one with the closest scope to ours is [@CD012234-bbs2-0152], which focuses on prophylactic irrigation; this review supported the recent recommendations of the World Health Organization on prevention of SSI ([@CD012234-bbs2-0188]). For a number of reasons [@CD012234-bbs2-0152] included fewer studies than our review as it excluded studies where wounds could already be considered to be infected (and where treatment was therefore not considered prophylactic) and was restricted to irrigation at the level of the wound rather than deeper (e.g. peritoneal) irrigation. The authors also required that there be a description of appropriate antibiotic prophylaxis, which we did not; many of the studies included here had very limited reporting of co‐interventions and reporting of antibiotic use varied. There were other variations in the inclusion criteria ‐ including a restriction by De Jonge to four, widely spoken European languages whereas we applied no language restrictions. A combination of these factors accounts for many of the differences between their review and ours. One principal result of the differing inclusion criteria is that our review includes many studies in obstetric surgery, which are not included in theirs. A small number of trials, which were included in their review, were excluded from ours based on differing interpretation of adequate randomisation or volume of liquid required for irrigation.

Authors\' conclusions {#CD012234-sec1-0007}
=====================

The evidence base identified by this review was generally of low certainty, which means that the true effects may be substantially different to the estimates of effect. Therefore where we have identified a difference in surgical site infection (SSI) incidence ‐ as with the comparisons of antibacterial and non‐antibacterial interventions and pulsatile versus standard methods ‐ these should be considered in the context of uncertainty. This is particularly the case as we suspect that the evidence base may have been affected by the tendency for small studies with negative results to remain unpublished and absent from meta‐analyses. Clinicians should also consider whether the evidence is relevant to the surgical populations under consideration, for instance where the surgery is considered to be a clean procedure. They should also take into consideration the limited data available on wound dehiscence. They may also wish to consider the varying reporting of prophylactic antibiotic use delivered by other means (e.g. oral, intramuscular etc); in some of the studies in the review no such prophylaxis was reported whereas their practice may be to routinely use this for the procedure under consideration ‐ or vice‐versa. They may wish to consider this in conjunction with the evidence of this review on the efficacy of different types of irrigation solutions. The limited reporting of many relevant outcomes should also be considered.Finally, while many studies in the review are recent, others are old and predate current levels of, and concern over, the development of antibiotic resistance.We did not identify any trials that compared antibiotic irrigation with antiseptic irrigation; this represents a gap in the direct evidence base, which may merit further investigation. If the possible benefit of antibacterial irrigation treatment represents a true effect this is particularly worth investigating, given growing concerns over antibiotic resistance.The evidence base we have identified means that this gap in the evidence could be investigated using a network meta‐analysis; an analysis of the indirect evidence for the comparison could then inform a decision as to whether new primary research was warranted.There was a considerable amount of heterogeneity between the studies we identified and this was not explicable by surgery class in prespecified analyses. Exploratory analyses also confirmed that this was not explained by our decision to combine studies using different types of irrigation fluids. We did not pre‐specify the operative point of irrigation as being a factor of interest (i.e. at what level of wound closure it was undertaken); this did vary between studies and is a factor that may benefit from investigation. Future trials should also carefully consider how prophylactic antibiotics would be used and documented.Any future network analysis could also consider indirect evidence for comparisons of different volumes of particular solutions. Any further research, whether primary or secondary should also take account of the level of contamination of procedures under consideration although we have not identified this as an effect modifier.Finally pulsatile irrigation should be explored further in primary research. The authors of one of the included studies [@CD012234-bbs2-0033] suggest that pulsatile irrigation may reduce bacterial counts and help to remove tissue that could otherwise act as a focus for infection but the mechanism for its possible benefit is not clear and would require further research.Any new primary research should use this systematic review and meta‐analysis as a guide for calculating sample sizes, in order to have sufficient power to detect a difference in SSIs, particularly if undertaken in participants undergoing clean or clean‐contaminated surgery where event rates are low.Any such trial should use appropriate and robust research methodology to reduce the risks of bias, should use internationally recognised criteria for the diagnosis of SSI and should have adequate follow‐up procedures and duration to ensure that SSIs occurring after hospital are recorded. Other outcomes such as wound dehiscence ‐ a primary review outcome for which there was little evidence ‐ and health‐related quality of life should also be considered. In view of the limited reporting of relevant outcomes that this review has identified, consideration should be given to the development and use of core outcome sets defined using transparent and rigorous methodology.We identified a number of ongoing trials and the completion dates of these should be taken into consideration in the planning of a network meta‐analysis.

The authors are grateful to the following peer reviewers of the protocol: Liz McInnes, Emma Maund, Brian Hong, Jesús Lopez‐Alcalde, and Jamie Fenton. We also thank copy editors Denise Mitchell and Clare Dooley. We are also grateful to the following additional peer reviewers of the review: Kurinchi Gurusamy (Editor) and Gemma Villanueva.

The authors would like to thank Diebrecht Appelen, Pia Brandt Danborg, Debra Fayter, Alireza Firooz, Ursula Gonthier, Jae Hung Jung, Jörn Klein, Zhenmi Liu, Jesús Lopez‐Alcalde, Zuzana Mitrova, Teslin Seale Ahlenius and Gemma Villanueva for providing translation services. They are also grateful to Maggie Westby for assistance with statistical analysis.

**The Cochrane Wounds Specialised Register**

1 (surg\* near5 infect\*) AND INREGISTER 2 ((surg\* near5 wound\*)) AND INREGISTER 3 ((surg\* near5 site\*)) AND INREGISTER 4 ((surg\* near5 incision\*)) AND INREGISTER 5 ((surg\* near5 dehisc\*)) AND INREGISTER 6 ((wound\* near5 dehisc\*)) AND INREGISTER 7 ((wound\* near5 infect\*)) AND INREGISTER 8 ((wound near5 disruption\*)) AND INREGISTER 9 (\"wound complication\*\") AND INREGISTER 10 (SSI) AND INREGISTER 11 \#1 OR \#2 OR \#3 OR \#4 OR \#5 OR \#6 OR \#7 OR \#8 OR \#9 OR \#10 AND INREGISTER 12 ((intraoperative near3 wash\*)) AND INREGISTER 13 ((intra‐operative near3 wash\*)) AND INREGISTER 14 (irrigat\*) AND INREGISTER 15 (lavage) AND INREGISTER 16 \#12 OR \#13 OR \#14 OR \#15 AND INREGISTER 17 \#11 AND \#16 AND INREGISTER

**The Cochrane Central Register of Controlled Clinical Trials (CENTRAL)**

\#1 MeSH descriptor: \[Surgical Wound Infection\] explode all trees \#2 MeSH descriptor: \[Surgical Wound Dehiscence\] explode all trees \#3 (surg\* near/5 infect\*):ti,ab,kw \#4 (surg\* near/5 wound\*):ti,ab,kw \#5 (surg\* near/5 site\*):ti,ab,kw \#6 (surg\* near/5 incision\*):ti,ab,kw \#7 (surg\* near/5 dehisc\*):ti,ab,kw \#8 (wound\* near/5 dehisc\*):ti,ab,kw \#9 (wound\* near/5 infect\*):ti,ab,kw \#10 (wound near/5 disruption\*):ti,ab,kw \#11 (wound next complication\*):ti,ab,kw \#12 SSI:ti,ab,kw \#13 {or \#1‐\#12} \#14 MeSH descriptor: \[Therapeutic Irrigation\] explode all trees \#15 (intraoperative near/3 wash\*):ti,ab,kw \#16 (intra‐operative near/3 wash\*):ti,ab,kw \#17 irrigat\*:ti,ab,kw \#18 lavage:ti,ab,kw \#19 {or \#14‐\#18} \#20 {and \#13, \#19} in Trials

**Ovid MEDLINE**

1\. exp Surgical Wound Infection/ 2. exp Surgical Wound Dehiscence/ 3. (surg\* adj5 infect\*).tw. 4. (surg\* adj5 wound\*).tw. 5. (surg\* adj5 site\*).tw. 6. (surg\* adj5 incision\*).tw. 7. (surg\* adj5 dehisc\*).tw. 8. (wound\* adj5 dehisc\*).tw. 9. (wound\* adj5 infect\*).tw. 10. (wound adj5 disrupt\*).tw. 11. wound complication\*.tw. 12. SSI.tw. 13. or/1‐12 14. (intraoperative adj3 wash\*).tw. 15. (intra‐operative adj3 wash\*).tw. 16. exp Therapeutic Irrigation/ 17. irrigat\*.tw. 18. lavage.tw. 19. or/14‐18 20. and/13,19 21. randomized controlled trial.pt. 22. controlled clinical trial.pt. 23. randomi?ed.ab. 24. placebo.ab. 25. clinical trials as topic.sh. 26. randomly.ab. 27. trial.ti. 28. or/21‐27 29. exp animals/ not humans.sh. 30. 28 not 29 31. 20 and 30

**Ovid Embase**

1\. exp surgical infection/ 2. exp wound dehiscence/ 3. (surg\* adj5 infect\*).tw. 4. (surg\* adj5 wound\*).tw. 5. (surg\* adj5 site\*).tw. 6. (surg\* adj5 incision\*).tw. 7. (surg\* adj5 dehisc\*).tw. 8. (wound\* adj5 dehisc\*).tw. 9. (wound\* adj5 infect\*).tw. 10. (wound adj5 disrupt\*).tw. 11. wound complication\*.tw. 12. SSI.tw. 13. or/1‐12 14. (intraoperative adj3 wash\*).tw. 15. (intra‐operative adj3 wash\*).tw. 16. exp lavage/ 17. exp wound irrigation/ 18. irrigat\*.tw. 19. lavage.tw. 20. or/14‐19 21. and/13,20 22. Randomized controlled trials/ 23. Single‐Blind Method/ 24. Double‐Blind Method/ 25. Crossover Procedure/ 26. (random\* or factorial\* or crossover\* or cross over\* or cross‐over\* or placebo\* or assign\* or allocat\* or volunteer\*).ti,ab. 27. (doubl\* adj blind\*).ti,ab. 28. (singl\* adj blind\*).ti,ab. 29. or/22‐28 30. exp animals/ or exp invertebrate/ or animal experiment/ or animal model/ or animal tissue/ or animal cell/ or nonhuman/ 31. human/ or human cell/ 32. and/30‐31 33. 30 not 32 34. 29 not 33 35. 21 and 34

**EBSCO CINAHL Plus**

S33 S19 AND S32 S32 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 OR S12 S31 TI allocat\* random\* or AB allocat\* random\* S30 MH \"Quantitative Studies\" S29 TI placebo\* or AB placebo\* S28 MH \"Placebos\" S27 TI random\* allocat\* or AB random\* allocat\* S26 MH \"Random Assignment\" S25 TI randomi?ed control\* trial\* or AB randomi?ed control\* trial\* S24 AB ( singl\* or doubl\* or trebl\* or tripl\* ) and AB ( blind\* or mask\* ) S23 TI ( singl\* or doubl\* or trebl\* or tripl\* ) and TI ( blind\* or mask\* ) S22 TI clinic\* N1 trial\* or AB clinic\* N1 trial\* S21 PT Clinical trial S20 MH \"Clinical Trials+\" S19 S12 AND S18 S18 S13 OR S14 OR S15 OR S16 OR S17 S17 TI lavage OR AB lavage S16 TI irrigat\* OR AB irrigat\* S15 (MH \"Therapeutic Irrigation\") S14 TI intra‐operative N3 wash\* OR AB intra‐operative N3 wash\* S13 TI intraoperative N3 wash\* OR AB intraoperative N3 wash\* S12 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8 OR S9 OR S10 OR S11 S11 TI SSI OR AB SSI S10 TI wound complication\* OR AB wound complication\* S9 TI wound\* N5 disrupt\* OR AB wound\* N5 disrupt\* S8 TI wound\* N5 dehisc\* or AB wound\* N5 dehisc\* S7 TI surg\* N5 dehisc\* or AB surg\* N5 dehisc\* S6 TI surg\* N5 incision\* or AB surg\* N5 incision\* S5 TI surg\* N5 site\* or AB surg\* N5 site\* S4 TI surg\* N5 wound\* or AB surg\* N5 wound\* S3 TI surg\* N5 infection\* or AB surg\* N5 infection\* S2 (MH \"Surgical Wound Dehiscence\") S1 (MH \"Surgical Wound Infection\")

**Trials Registers**

All trials registers were searched using the terms (lavage OR irrigation) AND surgery on 7 March 2017.

[ClinicalTrials.gov](ClinicalTrials.gov) (280 total results)[World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP)](World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP)) (31 records for 29 trials)[EU Clinical Trials Register](EU Clinical Trials Register) (19 results)

1. Was the allocation sequence randomly generated? {#CD012234-sec3-0035}
==================================================

Low risk of bias {#CD012234-sec4-0059}
----------------

The investigators describe a random component in the sequence generation process such as: referring to a random number table; using a computer random number generator; coin tossing; shuffling cards or envelopes; throwing dice; drawing of lots.

High risk of bias {#CD012234-sec4-0060}
-----------------

The investigators describe a non‐random component in the sequence generation process. Usually, the description would involve some systematic, non‐random approach, for example: sequence generated by odd or even date of birth; sequence generated by some rule based on date (or day) of admission; sequence generated by some rule based on hospital or clinic record number.

Unclear {#CD012234-sec4-0061}
-------

Insufficient information about the sequence generation process to permit judgement of low or high risk of bias.

2. Was the treatment allocation adequately concealed? {#CD012234-sec3-0036}
=====================================================

Low risk of bias {#CD012234-sec4-0062}
----------------

Participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent method, was used to conceal allocation: central allocation (including telephone, web‐based and pharmacy‐controlled randomisation); sequentially numbered drug containers of identical appearance; sequentially numbered, opaque, sealed envelopes.

High risk of bias {#CD012234-sec4-0063}
-----------------

Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation based on: use of an open random allocation schedule (e.g. a list of random numbers); assignment envelopes without appropriate safeguards (e.g. envelopes were unsealed, non‐opaque, or not sequentially numbered); alternation or rotation; date of birth; case record number; any other explicitly unconcealed procedure.

Unclear {#CD012234-sec4-0064}
-------

Insufficient information to permit judgement of low or high risk of bias. This is usually the case if the method of concealment is not described or not described in sufficient detail to allow a definite judgement, for example if the use of assignment envelopes is described, but it remains unclear whether envelopes were sequentially numbered, opaque and sealed.

3. Blinding ‐ was knowledge of the allocated interventions adequately prevented during the study? {#CD012234-sec3-0037}
=================================================================================================

Low risk of bias {#CD012234-sec4-0065}
----------------

Any one of the following.

No blinding, but the review authors judge that the outcome and the outcome measurement are not likely to be influenced by lack of blinding.Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.Either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non‐blinding of others unlikely to introduce bias.

High risk of bias {#CD012234-sec4-0066}
-----------------

Any one of the following.

No blinding or incomplete blinding, and the outcome or outcome measurement is likely to be influenced by lack of blinding.Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.Either participants or some key study personnel were not blinded, and the non‐blinding of others likely to introduce bias.

Unclear {#CD012234-sec4-0067}
-------

Either of the following.

Insufficient information to permit judgement of low or high risk of bias.The study did not address this outcome.

4. Were incomplete outcome data adequately addressed? {#CD012234-sec3-0038}
=====================================================

Low risk of bias {#CD012234-sec4-0068}
----------------

Any one of the following.

No missing outcome data.Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing bias).Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups.For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a clinically relevant impact on the intervention effect estimate.For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes not enough to have a clinically relevant impact on observed effect size.Missing data have been imputed using appropriate methods.

High risk of bias {#CD012234-sec4-0069}
-----------------

Any one of the following.

Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing data across intervention groups.For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce clinically relevant bias in intervention effect estimate.For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing outcomes enough to induce clinically relevant bias in observed effect size.\'As‐treated\' analysis done with substantial departure of the intervention received from that assigned at randomisation.Potentially inappropriate application of simple imputation.

Unclear {#CD012234-sec4-0070}
-------

Either of the following.

Insufficient reporting of attrition/exclusions to permit judgement of low or high risk of bias (e.g. number randomised not stated, no reasons for missing data provided).The study did not address this outcome.

5. Are reports of the study free of suggestion of selective outcome reporting? {#CD012234-sec3-0039}
==============================================================================

Low risk of bias {#CD012234-sec4-0071}
----------------

Either of the following.

The study protocol is available and all of the study's prespecified (primary and secondary) outcomes that are of interest in the review have been reported in the prespecified way.The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were prespecified (convincing text of this nature may be uncommon).

High risk of bias {#CD012234-sec4-0072}
-----------------

Any one of the following.

Not all of the study\'s prespecified primary outcomes have been reported.One or more primary outcomes are reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not prespecified.One or more reported primary outcomes were not prespecified (unless clear justification for their reporting is provided, such as an unexpected adverse effect).One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta‐analysis.The study report fails to include results for a key outcome that would be expected to have been reported for such a study.

Unclear {#CD012234-sec4-0073}
-------

Insufficient information to permit judgement of low or high risk of bias. It is likely that the majority of studies will fall into this category.

6. Other sources of potential bias {#CD012234-sec3-0040}
==================================

Low risk of bias {#CD012234-sec4-0074}
----------------

The study appears to be free of other sources of bias.

High risk of bias {#CD012234-sec4-0075}
-----------------

There is at least one important risk of bias. For example, the study:

had a potential source of bias related to the specific study design used; orhas been claimed to have been fraudulent; orhad some other problem.

Unclear {#CD012234-sec4-0076}
-------

There may be a risk of bias, but there is either:

insufficient information to assess whether an important risk of bias exists; orinsufficient rationale or evidence that an identified problem will introduce bias.

In cluster‐randomised trials, particular biases to consider include: (i) recruitment bias; (ii) baseline imbalance; (iii) loss of clusters; (iv) incorrect analysis; and (v) comparability with individually randomised trials.

\(i\) Recruitment bias can occur when individuals are recruited to the trial after the clusters have been randomised, as the knowledge of whether each cluster is an 'intervention' or 'control' cluster could affect the types of participants recruited.

\(ii\) Cluster‐randomised trials often randomise all clusters at once, so lack of concealment of an allocation sequence should not usually be an issue. However, because small numbers of clusters are randomised, there is a possibility of chance baseline imbalance between the randomised groups, in terms of either the clusters or the individuals. Although not a form of bias as such, the risk of baseline differences can be reduced by using stratified or pair‐matched randomisation of clusters. Reporting of the baseline comparability of clusters, or statistical adjustment for baseline characteristics, can help reduce concern about the effects of baseline imbalance.

\(iii\) Occasionally, complete clusters are lost from a trial, and have to be omitted from the analysis. Just as for missing outcome data in individually randomised trials, this may lead to bias. In addition, missing outcomes for individuals within clusters may also lead to a risk of bias in cluster‐randomised trials.

\(iv\) Many cluster‐randomised trials are analysed by incorrect statistical methods, not taking the clustering into account. Such analyses create a 'unit of analysis error' and produce over‐precise results (the standard error of the estimated intervention effect is too small) and P values that are too small. They do not lead to biased estimates of effect. However, if they remain uncorrected, they will receive too much weight in a meta‐analysis.

\(v\) In a meta‐analysis including both cluster and individually randomised trials, or including cluster‐randomised trials with different types of clusters, possible differences between the intervention effects being estimated need to be considered. For example, in a vaccine trial of infectious diseases, a vaccine applied to all individuals in a community would be expected to be more effective than if the vaccine was applied to only half of the people. Another example is provided by a Cochrane Review of hip protectors. The cluster trials showed large positive effect, whereas individually randomised trials did not show any clear benefit. One possibility is that there was a 'herd effect' in the cluster‐randomised trials (which were often performed in nursing homes, where compliance with using the protectors may have been enhanced). In general, such 'contamination' would lead to underestimates of effect. Thus, if an intervention effect is still demonstrated despite contamination in those trials that were not cluster‐randomised, a confident conclusion about the presence of an effect can be drawn. However, the size of the effect is likely to be underestimated. Contamination and 'herd effects' may be different for different types of cluster.

Comparison 1All irrigation versus no irrigationOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 SSI](#CD012234-fig-00101){ref-type="fig"}Analysis 1.1Comparison 1 All irrigation versus no irrigation, Outcome 1 SSI.146106Risk Ratio (M‐H, Random, 95% CI)0.87 \[0.68, 1.11\]1.1 clean or clean‐contaminated74801Risk Ratio (M‐H, Random, 95% CI)1.00 \[0.82, 1.21\]1.2 contaminated or dirty71305Risk Ratio (M‐H, Random, 95% CI)0.74 \[0.47, 1.16\][2 Adverse events](#CD012234-fig-00102){ref-type="fig"}Analysis 1.2Comparison 1 All irrigation versus no irrigation, Outcome 2 Adverse events.3403Risk Ratio (M‐H, Random, 95% CI)1.05 \[0.76, 1.44\][3 Abscess](#CD012234-fig-00103){ref-type="fig"}Analysis 1.3Comparison 1 All irrigation versus no irrigation, Outcome 3 Abscess.3331Risk Ratio (M‐H, Random, 95% CI)0.91 \[0.54, 1.54\][4 Mortality](#CD012234-fig-00104){ref-type="fig"}Analysis 1.4Comparison 1 All irrigation versus no irrigation, Outcome 4 Mortality.2280Risk Ratio (M‐H, Random, 95% CI)0.86 \[0.36, 2.04\][5 Hospital stay](#CD012234-fig-00105){ref-type="fig"}Analysis 1.5Comparison 1 All irrigation versus no irrigation, Outcome 5 Hospital stay.71597Mean Difference (IV, Random, 95% CI)‐0.13 \[‐0.38, 0.12\][6 Return to theatre (reoperation)](#CD012234-fig-00106){ref-type="fig"}Analysis 1.6Comparison 1 All irrigation versus no irrigation, Outcome 6 Return to theatre (reoperation).23247Risk Ratio (M‐H, Random, 95% CI)0.72 \[0.28, 1.84\][7 Readmission to hospital](#CD012234-fig-00107){ref-type="fig"}Analysis 1.7Comparison 1 All irrigation versus no irrigation, Outcome 7 Readmission to hospital.23247Risk Ratio (M‐H, Random, 95% CI)0.70 \[0.10, 4.90\]

Comparison 2Antibacterial irrigation versus non‐antibacterial irrigationOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 SSI](#CD012234-fig-00201){ref-type="fig"}Analysis 2.1Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 1 SSI.305141Risk Ratio (M‐H, Random, 95% CI)0.57 \[0.44, 0.75\]1.1 clean4680Risk Ratio (M‐H, Random, 95% CI)0.16 \[0.03, 0.89\]1.2 clean‐contaminated132210Risk Ratio (M‐H, Random, 95% CI)0.57 \[0.40, 0.79\]1.3 contaminated or dirty132251Risk Ratio (M‐H, Random, 95% CI)0.61 \[0.40, 0.92\][2 Wound dehiscence](#CD012234-fig-00202){ref-type="fig"}Analysis 2.2Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 2 Wound dehiscence.3660Risk Ratio (M‐H, Random, 95% CI)1.26 \[0.65, 2.45\][3 Adverse events](#CD012234-fig-00203){ref-type="fig"}Analysis 2.3Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 3 Adverse events.3178Risk Ratio (M‐H, Random, 95% CI)0.55 \[0.22, 1.34\][4 Abscess](#CD012234-fig-00204){ref-type="fig"}Analysis 2.4Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 4 Abscess.91309Risk Ratio (M‐H, Random, 95% CI)0.82 \[0.42, 1.62\][5 Mortality](#CD012234-fig-00205){ref-type="fig"}Analysis 2.5Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 5 Mortality.111121Risk Ratio (M‐H, Random, 95% CI)0.81 \[0.48, 1.36\][6 Hospital stay](#CD012234-fig-00206){ref-type="fig"}Analysis 2.6Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 6 Hospital stay.7635Mean Difference (IV, Random, 95% CI)‐0.85 \[‐1.60, ‐0.09\][7 Return to theatre (reoperation)](#CD012234-fig-00207){ref-type="fig"}Analysis 2.7Comparison 2 Antibacterial irrigation versus non‐antibacterial irrigation, Outcome 7 Return to theatre (reoperation).2403Risk Ratio (M‐H, Random, 95% CI)1.26 \[0.12, 13.60\]

Comparison 3Icodextrin versus lactated Ringer\'s solutionOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 Mortality](#CD012234-fig-00301){ref-type="fig"}Analysis 3.1Comparison 3 Icodextrin versus lactated Ringer\'s solution, Outcome 1 Mortality.2875Risk Ratio (M‐H, Fixed, 95% CI)0.0 \[0.0, 0.0\][2 Adverse events](#CD012234-fig-00302){ref-type="fig"}Analysis 3.2Comparison 3 Icodextrin versus lactated Ringer\'s solution, Outcome 2 Adverse events.2875Risk Ratio (M‐H, Random, 95% CI)0.99 \[0.96, 1.02\][3 Treatment‐related adverse events](#CD012234-fig-00303){ref-type="fig"}Analysis 3.3Comparison 3 Icodextrin versus lactated Ringer\'s solution, Outcome 3 Treatment‐related adverse events.2875Risk Ratio (M‐H, Random, 95% CI)1.35 \[0.98, 1.86\]

Comparison 4Standard irrigation versus pulsatile irrigationOutcome or subgroup titleNo. of studiesNo. of participantsStatistical methodEffect size[1 SSI](#CD012234-fig-00401){ref-type="fig"}Analysis 4.1Comparison 4 Standard irrigation versus pulsatile irrigation, Outcome 1 SSI.2484Risk Ratio (M‐H, Random, 95% CI)0.34 \[0.19, 0.62\]

We have clarified that this review does not include studies where the irrigation was confined to the interior of (e.g.) the uterus, bowel or bladder, but did include studies in which (e.g.) the peritoneum was irrigated in addition to such procedures. We also did not include studies of surgery in the oral or aural cavities or in the eyes.

The protocol did not specify methods for dealing with studies with a \'split‐body\' design, in which two operative sites are present on each participant and these are randomised to different treatment groups. We decided to include these studies in the review but not to include them in meta‐analyses with participant‐level randomisation; we included only one such study in the review and this decision did not materially affect the meta‐analyses involved due to limited data.

We prespecified two subgroup analyses on the basis of the surgical category and on the basis of whether participants were adults or children. We conducted the surgical category analysis for the primary outcome of SSI for the two comparisons with the largest number of participants and studies. However, small numbers of studies enrolling only children meant that we judged that the second prespecified analysis would be uninformative. We did not carry out any subgroup analyses for the secondary outcomes because there were many fewer studies and they were not well distributed between the surgical categories. We did carry out an exploratory subgroup analysis on the basis of the type of irrigation solution used in order to check that our analysis approach was reasonable. This is clearly reported as an additional post‐hoc analysis.

In addition to planned sensitivity analyses we conducted additional analyses to assess the impact of (1) including a study that we suspected contained participants also included in another study and (2) excluding a study where we had conducted a completed‐case analysis because of a substantial amount of attrition and the explanation provided for this attrition.

We had planned to analyse outcomes by the time point at which they were reported based on short, medium or long term. In practice we found that the overwhelming majority of the data reported were for time points of between two and eight weeks postoperatively, with the majority being at either four or six weeks, sometimes with interim but unreported follow‐up points. We therefore decided that we would group all the data together for the outcomes reported; dividing data reported at points that narrowly spanned the 30‐day cut‐off for short‐term data was not considered informative (medium term spanned from 30 days to 12 months).

In response to suggestions from the peer reviewers we have added adverse events to the \'Summary of findings tables\'; we are grateful to them for this suggestion.

Characteristics of included studies \[ordered by study ID\] {#CD012234-sec2-0022}
===========================================================

[@CD012234-bbs2-0001]Methods2‐arm RCT\
Setting: NR; appears to be single hospital in Saudi Arabia\
Participants reportedly followed up for 1 month, no additional detailsParticipants254 adults and children (aged 5‐80 years, mean age 21 (Group I) and 24 years (Group II)) undergoing appendectomy for acute appendicitis were randomised; 249 analysed\
Inclusion criteria: people undergoing appendectomy through gridiron incision for clinically suspected acute appendicitis\
Exclusion criteria: allergy to ampicillin; systemic diseases requiring systemic antibiotic administrationInterventionsGroup I: (saline): wound irrigation with 100 mL normal sterile saline at closure (134 participants randomised; 132 analysed; 2 participants withdrawn post‐randomisation)\
Group II: (Ampicillin): wound irrigation with 1 g Ampicillin powder dissolved in 100 mL normal sterile saline (120 participants randomised; 117 analysed; 3 participants withdrawn post‐randomisation)\
Co‐interventions: IV metronidazole (500 mg for adults; 15 mg/kg for children) and gentamicin (75 mg for adults and 1.5 mg/kg for children) 1 h before surgery. If appendix was found to be gangrenous or perforated antibiotics were continued for 5 ds postoperatively.Outcomes**Primary outcome: SSI** (defined as presence of purulent discharge in wound, regardless of culture results, or as occurrence of serous discharge with a positive culture) within 1 month\
Group I (Saline): 7/132 (134 randomised)\
Group II (Ampicillin): 1/117 (120 randomised)\
**Secondary outcome: adverse events including abscess:**\
Abscess\
Group I (saline): 0/132\
Group II (Ampicillin): 0/117\
Other specific post‐operative complications were reported but total number of participants with adverse events was not clear.\
**Secondary outcome: hospital stay:** reported to be reduced by 2.5 d by avoidance of wound infection. Median reported for participants with (5.5, range 3‐11 d) and without infection (3.0, range 2‐11 d) but not for each treatment group.NotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"254 patients fulfilled the criteria and were randomized into two groups using sealed envelopes\"\
Comment: no information on how the randomisation sequence was generated.Allocation concealment (selection bias)Unclear riskQuote: \"254 patients fulfilled the criteria and were randomized into two groups using sealed envelopes that were opened intraoperatively\"\
Comment: although sealed envelopes were used it is not clear that they were opaque or that the allocation sequence was fully concealed at all times.Blinding of participants and personnel (performance bias) All outcomesHigh riskComment: no direct quote but it is clear that personnel were made aware of allocation once the envelopes were opened. Unclear if participants were awareBlinding of outcome assessment (detection bias) All outcomesUnclear riskComment: no direct quote but it is unclear whether the outcome assessment was performed by individuals aware of group allocation.Incomplete outcome data (attrition bias) All outcomesHigh riskComment: there were a small number of post‐randomisation exclusions for protocol violations described. However there were low numbers of events relative to these exclusions, increasing the risk of attrition bias impacting the results.Selective reporting (reporting bias)Unclear riskComment: rhe data for one of the secondary outcomes (bed‐stay) were not reported on a per‐group base making this outcome difficult to evaluate.Other biasUnclear riskComment: there was no evidence of other sources of bias but reporting was not clear enough to be certain.[@CD012234-bbs2-0002]Methods2‐arm RCT\
Setting: single centre; 1 surgical unit in UK\
Follow‐up: close monitoring during hospital stay; full inquiry into possible infection signs at 6‐week outpatient clinic follow‐upParticipants330 participants undergoing elective colorectal surgery (mean ages 61 (Group I) and 63 years (Group II)); 300 analysed\
Inclusion criteria: participants undergoing elective colorectal surgery\
Exclusion criteria: NRInterventionsGroup I (taurolidine PVP): peritoneal lavage in 2 stages with 250 mL 2% taurolidine in 5% PVP (150 participants)\
Group II (saline): peritoneal lavage in 2 stages with 250 mL normal saline (150 participants)\
In each group 250 mL lavage solution diluted in a further 250 mL normal saline was placed in the abdomen as a washout and then removed with suction. This was followed by instillation of a second 250 mL undiluted lavage solution, which was left in the abdomen. If abdominal drains were present these were clamped for at least 20 min.\
Cointerventions: all participants (except 11 who had severe constricting colonic lesions and were in imminent danger of bowel obstruction) received up to 8 doses of magnesium sulphate (4 g by mouth) for 48 h starting 72 h before surgery followed by 2 sachets of sodium picosulphate (Picolax; Fering Pharmaceutical, Feltham, UK) given in the 24 h immediately before surgery. Participants with severe constricting colonic lesions were prepared according to the wishes of the surgeon; 8 received Klean‐Prep (Norgine, Oxford, UK) in place of Picolax and 3 no preparation. All participants received cefotaxime 1 g and metronidazole 500 mg IV at induction of anaesthesia, and 8 h and 16 h later. 5 participants with penicillin allergy received gentamicin 160 mg on induction, and 120 mg at 8 h and 16 h after induction; doses were individually adjusted according to body mass, renal function and age.Outcomes**Primary outcome: SSI** (defined as spontaneous or incisional discharge from the wound, either of pus or serous fluid, with an infective organism positively identified on culture)\
Group I (taurolidine PVP): 17/150 (10 superficial, 7 deep)\
Group II (saline): 17/150 (12 superficial, 5 deep)\
**Secondary outcome: 30‐day mortality**\
Group I (taurolidine PVP): 4/150\
Group II (saline): 4/150\
**Secondary outcome: adverse events including abscess**:\
Pelvic abscess\
Group I (taurolidine PVP): 2/150\
Group II (saline): 1/150\
Other specific post‐operative complications were reported but total number of participants with adverse events was not clear.\
**Secondary outcome: length of hospital stay**\
Group I (taurolidine PVP): median 11 d for 133 participants without infection; 18 d for 17 with infection (paper reports N = 134, error suspected)\
Group II (saline): median 11 d for 133 participants without infection; 18 d for 17 with infection (mean NR, range NR)NotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"This paper reports a randomized controlled trial\.....Bottles of lavage fluid were dispensed in identical containers according to a computer‐generated randomized code held by the hospital pharmacy with no stratification for severity of contamination or procedure. \"\
Comment: appears there was a computer‐generated randomisation sequenceAllocation concealment (selection bias)Unclear riskQuote: \"Bottles of lavage fluid were dispensed in identical containers according to a computer‐generated randomized code held by the hospital pharmacy with no stratification for severity of contamination or procedure.\"\
Comment: although the allocation sequence was held by the hospital pharmacy it is not clear whether it was adequately concealed.Blinding of participants and personnel (performance bias) All outcomesLow riskQuote: \"Bottles of lavage fluid were dispensed in identical containers according to a computer‐generated randomized code held by the hospital pharmacy\... The trial and control solutions were indistinguishable to users.\"\
Comment: personnel appear to have been blinded; although there is no direct information on participants it is likely that they were also blinded.Blinding of outcome assessment (detection bias) All outcomesLow riskQuote: \"All patients were monitored closely after operation until hospital discharge for clinical signs of abdominal sepsis and wound infection by an independent (non‐operating) trained assessor (J.AJ.).\"\
Comment:Incomplete outcome data (attrition bias) All outcomesHigh riskQuote: \"Sixteen patients were withdrawn from the trial after consent because the operative procedure performed did not constitute elective colorectal surgery \...\.... A further eight patients were withdrawn as lavage was not undertaken for logistical reasons, such as breakage of solution bottles. A further six patients were withdrawn at the time of surgery because of overt sepsis or severe faecal spillage, which rendered the intraoperative lavage a therapeutic rather than a prophylactic measure. Thus 300 patient reports were available for analysis.\"\
Comment: almost 10% of randomised participants were not included in the analysis. Although full reasons are given for this the number of withdrawals is almost equivalent to the number of events.Selective reporting (reporting bias)Low riskComment: the data for one of the secondary outcomes (bed‐stay) were not fully reported (measure of variance lacking) but no other evidence of selective reportingOther biasUnclear riskComment: there was no evidence of other sources of bias but reporting was not clear enough to be certain.[@CD012234-bbs2-0003]MethodsParallel‐group RCT\
Setting: single hospital in USA\
Follow‐up: 6 weeks (review of records after discharge)Participants223 women undergoing cesarean section\
Inclusion criteria: women delivered by caesarean section\
Exclusion criteria: allergy to penicillin or cephalosporins, taken an antibiotic within 7 d of surgery or required antibiotics around time of surgery for other reasons. Participants with temperature elevated to 38^o^C or with foul amniotic fluid prior to or immediately after surgery were considered to have infection and excluded.\
High risk and low risk participants were separated according to duration of labor prior to cesarean section, with 6 h arbitrarily chosen as the division point. Each group contained both high risk (more than 6 h labour) and low risk (less than 6 h labour) participantsInterventionsGroup I: irrigation with 2 g cefamandole in 1000 mL normal saline (73 participants)\
Group II: irrigation with 1000 mL normal saline (75 participants)\
Group III: no irrigation (75 participants)Outcomes**Secondary outcome: length of stay**\
Group I: low risk: 5.2 (0.3) d (N = 46); high risk: 5.3 (0.2) (N = 27)\
Group II: low risk: 5.9 (0.4) d (N = 40); high risk 6.8 (0.6) (N = 35)\
Group III: low risk 5.8 (0.3) d (N = 44); high risk: 6.9 (0.4) (N = 31)\
**Secondary outcome: adverse events**\
Only a specific event (metritis) was reported\
Group I: low risk: 2 (4.3% of 46); high risk: NR\
Group II: low risk: 4 (10% of 40); high risk: NR\
Group III: low risk: 9 (20.5% of 44); high risk: NR\
Infection data were also reported but were not clearly SSI and were not reported for all participants\
Group I: low risk: NR; high risk: 3 (11.1% of 27)\
Group II: low risk: NR; high risk: 17 (48.6% of 35)\
Group III: low risk: NR; high risk: 17 (54.8% of 31)NotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"members of each group were then assigned to a cohort according to a computer‐generated table of random numbers under the direction of the hospital pharmacy\"\
Comment: appropriate method used to generate randomisation sequence; randomisation stratified by duration of labour: \> 6 h vs \< 6 hAllocation concealment (selection bias)Unclear riskQuote: \"under the direction of the hospital pharmacy\"\
Comment: unclear whether adequate methods were used to conceal allocationBlinding of participants and personnel (performance bias) All outcomesHigh riskQuote: \"Physicians who performed the operation and provided postoperative care were unaware of the type of irrigation provided\"\
Comment: physicians were unaware of the type of irrigation used but are likely to have been aware of whether irrigation was used or not. It is unclear whether participants were aware of treatment allocation.Blinding of outcome assessment (detection bias) All outcomesUnclear riskQuote: \"Patients were followed postoperatively by the resident and attending physicians on service\"\
Comment: not clear whether outcomes were determined by personnel blinded to treatment allocation.Incomplete outcome data (attrition bias) All outcomesUnclear riskQuote: \"of all 451 patients who had cesarean sections during the study period, 223 were included\"\
Comment: it appears that the 223 participants described as included were all included in the analyses but it\'s not completely clear that this is the total number who were randomised.Selective reporting (reporting bias)High riskComment: not all data relating to outcomes of infection, adverse events and postoperative hospitalisations were reported.Other biasUnclear riskComment: no obvious source of additional bias but reporting insufficient to be certain[@CD012234-bbs2-0004]MethodsParallel‐group RCT\
Setting: 16 referral centres in the USA\
Follow‐up: 28‐56 dParticipants449 women (age 32.6 years in Adept group vs 32.3 in lactated Ringer\'s solution group) undergoing laparoscopic gynaecological surgery. Primary diagnoses included pelvic pain, infertility endometriosis and known adhesions.\
Inclusion criteria: aged \> 18 years and in good health. Laparoscopic surgery was planned for a gynaecologic procedure that included adhesiolysis followed by a second follow‐up laparoscopy 4--8 weeks later.\
Exclusion criteria: preoperative: the use of concomitant systemic corticosteroids, antineoplastic agents, and/or radiation; pregnancy; diagnosis of an active pelvic or abdominal infection, or cancer; and a known allergy to starch‐based polymers. Intraoperative exclusion criteria included women requiring an additional non obstetric/gynaecologic surgical procedure to be performed during the laparoscopic procedure; unplanned surgery necessitating opening the bowel (excluding appendectomy); any laparotomy procedure; and use of another adhesion reduction agent. Adhesion site exclusion criteria included women having \< 3 of the available anatomical study sites with adhesions or, if fewer than three were lysed, removal of any anatomical sites being scored for the purposes of the study; and an inability to visualise clearly all available anatomical score sites.InterventionsGroup I: irrigated with a minimum 100 mL Adept (icodextrin 4% solution) solution every 30 min during surgery; any remaining solution at end of surgery was aspirated and then 1 L instilled from a fresh supply of solution (227 ITT, 205 PP participants)\
Group II: irrigated with a minimum 100 mL lactated Ringer\'s solution every 30 min during surgery; any remaining solution at end of surgery was aspirated and then 1 L instilled from a fresh supply of solution (222 ITT 205 PP participants)Outcomes**Postoperative infections** were reported but unclear whether these referred to SSI\
Group I (icodextrin): 1% of 227 calculated as 2 Group II (Ringer\'s solution): 3% of 222 calculated as 7\
**Secondary outcome: adverse events**\
Group I (icodextrin): 221/227 of which 44 serious; 55 considered related, reported as serious 8 participants (25 events)\
Group II (Ringer\'s solution): 218/222 of which 36 serious; 38 considered related, reported as serious 11 participants (19 events)\
**Secondary outcome: mortality**\
Group I (icodextrin): 0/227\
Group II (Ringer\'s solution): 0/222NotesFunding: Innovata Limited, Vectura Group***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"Treatment was randomized by computer‐generated randomization on a 1:1 basis\"\
Comment: an appropriate method of generating the randomisation sequence was reported.Allocation concealment (selection bias)Low riskQuote: \"Patient numbers were allocated to treatment group before labelling of the blinded study treatment bags. The study solutions were presented in identical 1 L infusion bags, and each bag had an outer wrap that contained the study code and patient number on an identification label\"\
Comment: adequate method for concealment of treatment allocation reportedBlinding of participants and personnel (performance bias) All outcomesLow riskQuote: \"Double‐blinding was possible because Adept and LRS are both clear and odourless solutions with similar viscosities to water.\"\
Comment: blinding appears to have been undertaken for personnel and participants.Blinding of outcome assessment (detection bias) All outcomesLow riskQuote: \"Safety was assessed by serious adverse events (SAEs), adverse events, and changes in laboratory values. Patients completed diary cards between initial surgery and follow‐up surgery. At postoperative checkup (visits 3 and 4), cards were assessed to monitor progress. They allowed the patient to record their well‐being and all concomitant medications. All adverse events whether they were considered related to study solutions or not, were investigated, and the details of nature, severity, duration, outcome, and relationship to study device were recorded\"\
Comment: safety outcomes were assessed by participants who were blinded to treatment allocation.Incomplete outcome data (attrition bias) All outcomesLow riskQuote: \"Safety was assessed in the intent‐to‐treat (ITT) population, which included all patients who had the study solution instilled. Efficacy results are presented for the per protocol (PP) population. These patients were those who had completed both first‐ and second‐look laparoscopies without major protocol violations.\"\
Comment: the outcomes relevant to this review were assessed using the ITT population so almost all randomised participants were included in the analyses.Selective reporting (reporting bias)Low riskComment: outcomes were prespecified; all planned outcomes appeared fully reported.Other biasLow riskComment: no evidence of other sources of bias and reporting is sufficient to be reasonably confident that this is the case[@CD012234-bbs2-0005]MethodsParallel‐group RCT\
Setting: single hospital in UK\
Follow‐up: NRParticipants35 participants with gross peritonitis or frank fecal soiling and a positive culture swab at operation\
Inclusion criteria: gross peritonitis or frank fecal soiling and a positive culture swab at operation\
Exclusion criteria: NRInterventionsGroup I: 2% taurolin in 5% PVP solution (normal saline) up to 200 mL instilled prior to closure of abdomen or afterwards through a tube drain. Additional 200 mL could be instilled daily if required for 7 d (17 participants)\
Group II: 5% PVP solution (normal saline) to 200 mL instilled prior to closure of abdomen or afterwards through a tube drain. Additional 200 mL could be instilled daily if required for 7 d (18 participants)\
Additional antibiotic use was documented as including gentamycin, lincomycin, cephalosporin \[cephalosporine\], ampicillinOutcomes**Secondary outcome: mortality**\
Group I (taurolin): 3/17\
Group II (PVP): 0/18NotesOutcome was classed as \"good\" or \"bad\" where a normal recovery with normal wound healing and no sepsis was a good result and all other outcomes were bad Funding NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"Envelopes containing cards, previously randomly arranged were available in theatre for selection of solution A or solution B\"\
Comment: no information on how the random sequence arrangement was generatedAllocation concealment (selection bias)Unclear riskQuote: \"Envelopes containing cards, previously randomly arranged were available in theatre for selection of solution A or solution B\"\
Comment: no information on whether or how the random sequence arrangement was concealed.Blinding of participants and personnel (performance bias) All outcomesLow riskQuote: \"Two solutions were prepared \....in identical bottles labelled A and B\"\
Comment: it appears that measures were taken to blind personnel and participants.Blinding of outcome assessment (detection bias) All outcomesLow riskQuote: \"Thirty‐five patients entered the trial. It was intended to include a much larger number but at this stage there was a marked difference in results which was statistically significant\..... so the code was broken\"\
Comment: it appears that measures were taken to ensure blinded outcome assessmentIncomplete outcome data (attrition bias) All outcomesLow riskComment: it appears that all randomised participants were included in the analysis. However many fewer participants than planned were randomised (see other sources of bias).Selective reporting (reporting bias)High riskOutcomes were not prespecified and \"a good result\" was defined only in the results section.Other biasHigh riskQuote: \"For ethical reasons it was decided the trial should be stopped as soon as a statistically significant difference between the two groups emerged\...\...\...\...Thirty‐five patients entered the trial. It was intended to include a much larger number but at this stage there was a marked difference in results which was statistically significant\..... so the code was broken.\"\
Trial was stopped very early (a long way short of planned recruitment). Although this was preplanned this approach to early stopping is highly likely to produce an artefactual difference between groups[@CD012234-bbs2-0006]MethodsParallel‐group RCT\
Setting: single hospital in Norway\
Follow‐up: 6 weeks postoperativelyParticipants85 participants with perforated appendicitis and generalised peritonitis\
Inclusion criteria: diagnosis of perforated appendicitis and generalised peritonitis verified at laparotomy\
Exclusion criteria: age \< 6 years; known allergy to ampicillin or tinidazole, localised infiltration or abscess around the appendix.InterventionsGroup I: 24 hs postoperative lavage with 0.9% saline 1 L x 20 for adults, 0.5 L for children (39 participants)\
Group II: no postoperative lavage (44 participants)\
Cointerventions: intra‐operative peritoneal lavage with 2 L of saline; 2 g ampicillin every 6 hs and 800 mg tinidazole daily until oral fluids commenced then pivampicillin 500 mg 3/d and 1 g tinidazole daily orally; children received pivampicillin 100 mg/kg/d and tinidazole 400 mg daily (rectal) for 5 dOutcomes**Primary outcome: SSI** (wound infection defined as temperature \> 38.5 C for \> 24 h plus localised, drainage‐confirmed accumulation of fluid in the abdominal incision\
Group I (postoperative lavage): 9/39\
Group II (no postoperative lavage): 2/44\
**Secondary outcome: length of stay**\
Group I (postoperative lavage): median 5 d (range 3‐11) 39 participants\
Group II (no postoperative lavage): median 5 d (range 4 ‐12) 44 participantsNotesTreatment (postoperative lavage) was discontinued early in 10/39 participants***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"As soon as the diagnosis of perforated appendicitis with generalized peritonitis was verified at laparotomy, the patient was randomized\...\"\
Comment: no information on how the randomisation sequence was produced.Allocation concealment (selection bias)Unclear riskQuote: \"As soon as the diagnosis of perforated appendicitis with generalized peritonitis was verified at laparotomy, the patient was randomized\...\"\
Comment: no information as to whether allocation was adequately concealed.Blinding of participants and personnel (performance bias) All outcomesHigh riskComment: allocation to postoperative lavage versus no postoperative lavage would be evident to both personnel and participants.Blinding of outcome assessment (detection bias) All outcomesUnclear riskComment: unclear whether outcome assessment was performed by blinded individualsIncomplete outcome data (attrition bias) All outcomesLow riskComment: 2/85 randomised participants were withdrawn for a documented reason (ampicillin allergy); although both were in the same group the number is low and is unlikely to have been a source of bias.Selective reporting (reporting bias)Unclear riskComment: outcomes were not all prespecified in the methods although a priori definitions for intra‐abdominal and wound infection were given.Other biasUnclear riskComment: no evidence of other source of bias but reporting insufficient to be certain[@CD012234-bbs2-0007]MethodsParallel‐group RCT\
Setting: appears to be single hospital in USA\
Follow‐up: 4‐6 weeks postoperativelyParticipants40 women undergoing caesarean section at high risk of infectionInterventionsGroup I: irrigation with cefazolin; 2 g in 1000 cc normal saline; 700 cc intrauterine 100 cc in each gutter and 100 cc subcutaneously (20 participants)\
Group II: irrigation with 1000 cc normal saline 700 cc; intrauterine 100 cc in each gutter and 100 cc subcutaneously (20 participants)\
Cointerventions: none reportedOutcomes**Primary outcome: SSI** (defined only as \"wound infection\")\
Group I (cefazolin): 1/20\
Group II (saline): 1/20NotesAbstract only. Funding NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"Patients at high risk of infection were randomly placed in two groups\"\
Comment: no information as to how the randomisation sequence was generatedAllocation concealment (selection bias)Unclear riskQuote: \"Patients at high risk of infection were randomly placed in two groups\"\
Comment: no information as to whether there was adequate concealment of allocationBlinding of participants and personnel (performance bias) All outcomesUnclear riskComment: no specific quote, no information as to whether these groups were blinded to treatment allocationBlinding of outcome assessment (detection bias) All outcomesUnclear riskComment: there is no information as to who performed the outcome evaluation or whether they were blinded to treatment allocationIncomplete outcome data (attrition bias) All outcomesLow riskQuote: \"Only 2 of 40 high risk patients who received prophylactic irrigation developed\....\"\
Comment: it appears that all randomised participants were included in the analysis.Selective reporting (reporting bias)Unclear riskQuote: \"The objective of this study is to determine the impact of copious antibiotic irrigation versus normal saline (ns) on the incidence of post‐cesarean wound infections\"\
Comment: the primary outcome was specified and reported but it is not clear from the abstract which other outcomes the study may have planned to assess.Other biasUnclear riskComment: there were no additional sources of bias noted but the abstract reporting was insufficient to be certain.[@CD012234-bbs2-0008]Methods2‐arm RCT\
Setting: single centre; 1 surgical unit in the UKm\
Follow‐up: included outpatient assessment 6 weeks post‐surgeryParticipants54 women undergoing planned Patey mastectomy for carcinoma of the breast (mean age 56; range 32‐75 years) randomised (52 women and 53 breasts analysed)\
Inclusion criteria: Patey mastectomy\
Exclusion criteria: participants with allergy to tetracyclineInterventionsGroup I (tetracycline): lavage of 1 g tetracycline in 100 mL saline (23 women)\
Group II (saline): lavage of 100 mL saline (30 women)\
Lavage was given at wound closure and was contained within the axilla and skin flaps as much as possible during closure.\
Cointerventions: drainage was standardised to Vygon suction drains to axilla and skin flaps; drains removed at request of surgical staff when drainage for previous 24 hs appeared minimalOutcomes**Primary outcome: SSI** (not defined)\
Group I (tetracycline): 0/23\
Group II (saline): 1/30\
**Primary outcome: wound dehiscence** Group I (tetracycline): 0/23\
Group II (saline): 1/30 (described as \"minor\")NotesOne woman underwent bilateral mastectomy and was randomised for each breast.\
Funding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"\....were randomized to receive at wound closure\"\
Comment: no information on how the randomisation sequence was generatedAllocation concealment (selection bias)Unclear riskQuote: \"\....were randomized to receive at wound closure\"\
Comment: no information on whether allocation was adequately concealedBlinding of participants and personnel (performance bias) All outcomesUnclear riskComment: no direct quote but no information on whether participants and personnel were blindedBlinding of outcome assessment (detection bias) All outcomesUnclear riskQuote: \"Records were kept on a standard form by the nursing staff, who were unaware of the patient\'s randomization.\"\
Comment: no information on whether the blinded nursing staff performed outcome assessment at follow‐up.Incomplete outcome data (attrition bias) All outcomesLow riskQuote: \"Two women were excluded after randomization because they subsequently did not undergo Patey mastectomy\"\
Comment: the number of exclusions was very small and both were accounted for by a substantive operative protocol deviationSelective reporting (reporting bias)Unclear riskComment: there is no evidence of selective reporting but because most outcomes were not specified in the methods section it is not clear whether it may have occurredOther biasUnclear riskThere may be a minor unit of analysis issue due to the randomisation of one woman twice for each breast. Otherwise there is no evidence of other bias but the reporting is not full enough to be sure.[@CD012234-bbs2-0009]Methods2‐arm RCT\
Setting: single centre, Emergency Department in Mexico\
Follow‐up: 2 and 4 weeks after operationParticipants350 participants entered into study; 283 considered evaluable (mean age of 27.99 years (SD 12.81 years), range from 9‐82 years); (67 rejected from final analysis due to finding of another pathology different from appendix)\
Inclusion criteria: adults and children of both sexes admitted with a clinical diagnosis of acute abdomen suggestive of acute appendicitis with aid of laboratory and X‐ray, confirmed during operation and by histopathologic study\
Exclusion criteria: age \< 5 years, allergy to metronidazole or aminoglycosides, antibiotic therapy within 72 h preceding operation, pregnancy, those with other intraperitoneal bacterial infection not originating from the appendix, and those with any immune deficiency (diabetes mellitus, chronic renal insufficiency, malnourishment, chemotherapy, radiotherapy, corticosteroid therapy, asplenism)InterventionsGroup I: no irrigation (156 participants)\
Group II: syringe pressure irrigation with saline: after closure of the fascial planes, subcutaneous fat tissue irrigated with 300 mL of normal saline solution, delivered with a 20‐mL syringe with a 19‐gauge IV catheter, applying to the embolus the force of one hand, at a distance of 2 cm from the wound tissues, aspirating the fluid collected in the wound with a bulb syringe (127 participants)\
Cointerventions: each participant was administered metronidazole (30 mg/kg/day) 3/d, plus amikacin (15 mg/kg/d) once daily IV 30--45 min before skin incision. In cases of uncomplicated appendicitis they were stopped within the first 24 h, whereas in cases of complicated appendicitis they were maintained for a minimum of 7 dOutcomes**Primary outcome: SSI** (Definition: \"A wound was considered to be infected\...when there was a collection of pus or a positive bacteriologic culture from a wound discharge\")\
Group I: (no irrigation): 39/156\
Group II: (syringe pressure irrigation): 11/127\
**Secondary outcome: adverse events**. The authors stated that \"Antibiotics used for prophylaxis were well tolerated without any case of allergy or intolerance.\" The proportion of participants with any adverse event was not reported.NotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"All patients included were randomly assigned by a computerized assignment system into 2 groups of the trial.\"\
Comment: randomisation sequence generated by computerAllocation concealment (selection bias)Low riskQuote: \"The randomization chart was kept by our statistician, who was blind to the follow‐up, until June 1995.\"\
Comment: appears that allocation sequence was concealed from trial personnelBlinding of participants and personnel (performance bias) All outcomesHigh riskQuote: \"Statistical analysis of the results\...was conducted by our statistician who was blind to the surgical procedures and follow‐up.\"\
Comment: control arm did not include comparator intervention and so unable to conceal allocation to staff present at operation. Study design indicated as \"double blind,\" so assumption that participants were not told of their treatment allocation\
High risk of physicians not being blinded; unclear or low risk for participantsBlinding of outcome assessment (detection bias) All outcomesLow riskQuote: \"\...sought by daily examination of all patients by one of the members of the research team who was blind to the random allocation and the surgical procedures, until discharge.\"\
Quote: \"\...reevaluated at the outpatient consultation 2 and 4 weeks after operation by the responsible author who was blind to the random assignment and the surgical procedures.\"\
Comment: appears that outcome assessment for SSI was conducted by blinded assessorIncomplete outcome data (attrition bias) All outcomesHigh riskQuote: \"A total of 350 patients were entered into the study, and 283 (80.9%) were considered evaluable. The reason for rejection of the 67 (19.1%) patients from the final analysis was the finding of another pathology different from the appendix.\"\
Comment: the number of exclusions was high and the study did not achieve its aim of including 133 participants in each arm. Therefore confirmation of appendicitis during surgery appears to be an inclusion criterion and so exclusions based on pathology do not violate inclusion criteria. There was a high rate of exclusion relative to event rate for the primary outcome.Selective reporting (reporting bias)Unclear riskComment: main end point (defined surgical wound infection) was reported overall and for complicated and uncomplicated types of appendicitis. It is unclear whether there were any other end points specified in the study protocol.Other biasUnclear riskComment: there was no evidence of other sources of bias but reporting was insufficient to be certain.[@CD012234-bbs2-0010]Methods2‐arm RCT\
Setting: single centre at hospital in Taiwan\
Follow‐up: at 2 weeks, 1 month and 3 months after operation, and then every 3 months until end of study (approximately 19 months)Participants244 participants (age range 20‐89 years; Group I: average 67.1 years, (range 20‐82 years); Group II: average 65.4 years (range 22‐89 years)).\
Inclusion criteria: primary instrumented lumbosacral posterolateral fusion for degenerative spinal disorder with lumbar or lumbosacral segmental instability defined by chronic back, buttock and/or leg pain and degenerative spondylolisthesis, degenerative scoliosis or isthmic spondylolisthesis\
Exclusion criteria: prior spinal surgery, spinal trauma, malignant tumour, infectious spondylitis, rheumatoid arthritis, ankylosing spondylitis, metabolic bone disease, skeletal immaturity or immunosuppressive treatmentInterventionsGroup I (povidone‐iodine): wounds irrigated with 0.35% povidone‐iodine solution to soak for 3 min, followed by irrigation with 2000 cc normal saline to remove povidone‐iodine solution (120 participants)\
Group II (saline): wounds irrigated with only 2000 cc normal saline (124 participants)\
Cointerventions: wound closure by layer after suction drainage applied; drain removed 48 h or 72 h post‐operatively. Routine analgesic pain control applied for 3 d. Pre‐operative IV bolus injection of cefazolin (1000 mg) and gentamicin (60 mg); additional cefazolin (1000 mg/6 h) and gentamicin (60 mg/12 h) also given for 48 hs after surgery, and then oral cefazolin (500 mg/6 h) for 3 dOutcomes**Primary outcome: SSI** (Definition: \"Infections were classified as superficial (above lumbosacral fascia) or deep (below lumbosacral fascia), and as early onset (within 2 weeks postoperatively) or late onset (otherwise). All deep infections were confirmed by laboratory parameters including erythrocyte sedimentation rate (ESR) and level of C‐reactive protein (CRP) and a positive culture of biopsy.\"\
Group I (povidone‐iodine): 0/120\
Group II (saline): 6/124 (2 early onset; 4 late onset)\
**Primary outcome: wound dehiscence within 30 d** (time NR but it says all others healed with sutures removed on day 14 so can presume \< 30 d. No infection found in wounds)\
Group I: 1/120\
Group II: 2/124\
**Secondary outcome: proportion of participants with postoperative SSI using systemic antibiotics within 30 d of surgery**\
Group II: (saline): \"After radical debridement and parenteral antibiotics (according to sensitivities) for 6 weeks and oral antibiotics for 2 months, a satisfactory outcome has been reached except in two cases.\"\
**Secondary outcome: occurrence of infections showing antibiotic resistance**\
Group II: (saline): MRSA cultured from 5/6 cases\
**Secondary outcome: surgical re‐intervention rates**\
Group I: (povidone‐iodine): 3 participants underwent exploration of the non‐union site and re‐arthrodesis with autogenous bone graft\
Group II: (saline): 4 participants underwent exploration of the non‐union site and re‐arthrodesis with autogenous bone graft\
Group II: (saline): \"After radical debridement and parenteral antibiotics (according to sensitivities) for 6 weeks and oral antibiotics for 2 months, a satisfactory outcome has been reached except in two cases.\" These 2 cases had implants removed 4 months post‐operatively as infection could not be eradicatedNotesInterventions: no information given on duration of irrigation of wounds with normal saline for either group.\
Funding: Quote: \"No funds were received in support of this work. No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this manuscript.\"***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"Patients\...were randomly assigned to either treatment group. An independent person unaware of the subject characteristics and the study design delivered pre‐coded sealed enveloped randomly (containing serial numbers from 1 to 300) to the assignment of the subjects into the two groups.\"\
Comment: clearly states how sequence was generatedAllocation concealment (selection bias)Unclear riskQuote: \"An independent person unaware of the subject characteristics an the study design delivered pre‐coded sealed enveloped randomly (containing serial numbers from 1 to 300) to the assignment of the subjects into the two groups. The sealed envelope was not opened until the middle of the surgery before wound irrigation.\"\
Comment: although sealed envelopes were used it is not clear that they were opaque or that the allocation sequence was fully concealed at all times.Blinding of participants and personnel (performance bias) All outcomesUnclear riskComment: no direct quote, but no information on how personnel might have been blinded to the treatment performed. Unclear whether participants were blinded, but report states it was \"single blind\"Blinding of outcome assessment (detection bias) All outcomesUnclear riskQuote: \"All clinical and radiographic assessments were made by independent observers other than the treating surgeons.\"\
Comment: unclear whether observers were aware of treatment groupIncomplete outcome data (attrition bias) All outcomesLow riskComment: no direct quote, but no evidence of attritionSelective reporting (reporting bias)Unclear riskComment: no evidence of selective reporting but not enough information to be certainOther biasUnclear riskComment: there was no evidence of other sources of bias but reporting was insufficient to be certain[@CD012234-bbs2-0011]Methods2‐arm RCT\
Setting: single centre at hospital in Taiwan\
Follow‐up: at 2 weeks, 4 weeks and 2 months after operation, and then every 3 months until end of study (mean follow‐up 15.5 months for both groups)Participants417 consecutive eligible participants enrolled. 3 who died during the follow‐up period were excluded (1 case in Group I and 2 cases in Group II); 414 were included (average age 64 years (Group I) and 61 years (Group II))\
Inclusion criteria: pre‐operative diagnosis of degenerative scoliosis or stenosis; degenerative disc disease; disc prolapse; traumatic spinal fracture; spinal metastasis lesion. Undergoing procedure such as decompression for degenerative stenosis; decompression, fusion and fixation for degenerative scoliosis or stenosis; fixation of traumatic spinal fracture; discectomy for disc prolapse; excision with fixation for spinal metastatic lesions.\
Exclusion criteria: those with overt or suspected pyogenic vertebral osteomyelitis, discitis, or any form of pre‐operative spinal infection were excluded. Those with fever or other suspected sources of infection also excludedInterventionsGroup I (povidone‐iodine): surgical wound soaked with dilute povidone‐iodine solution for 3 min after operation. Commercially available Betadine solution used had a concentration of 10% povidone‐iodine (100 mg povidone‐iodine per 1 mL solution). Approximately 5 mL povidone‐iodine was diluted with normal saline to achieve a 0.35% povidone‐iodine (3.5% Betadine) solution for use during the operation. The wound was irrigated with copious amounts of normal saline (2000 mL) after Betadine solution irrigation (208 participants)\
Group II (saline): irrigation with copious normal saline (2000 mL) performed alone (206 participants)\
Cointerventions: each participant received 1 dose of parenteral cefazolin (1000 mg) and gentamicin (60 mg) 1 h before surgery. Cefazolin (1000 mg) every 6 hs and gentamicin (60 mg) every 12 hs were then given for 48 hs after surgery. Additional doses of antibiotics were given to maintain antibiotics levels during prolonged surgery. Following IV antibiotics, cefazolin (500 mg every 6 hs) was continued orally for 3 d. Drains were retained until \< 100 mL of output was observed.Outcomes**Primary outcome: SSI** (Definition: \"Infection was suspected when unusual pain, tenderness, erythema, induration, fever, or wound drainage was noted. Such findings were investigated with measurement of erythrocyte sedimentation rate, C‐reactive protein, and bacteriological cultures from the operative site or blood. Cultures were obtained from blood and wound discharge by aseptic methods.\")\
Group I (povidone‐iodine): 0/208\
Group II (saline): 7/206 (one superficial and 6 deep)\
**Secondary outcome: occurrence of infections which show antibiotic resistance**\
Group II (saline): MRSA cultured from 5/7 cases\
**Secondary outcome: surgical re‐intervention rates**\
Group II (saline): 7/206 (all those with highly suspected wound infection underwent surgical debridement)NotesFunding: Quote: \"No funds were received in support of this work. No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this manuscript.\"***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"Patients were randomly assigned to two groups, using pre‐coded sealed envelopes containing serial numbers from 1 to 500. Patients with odd serial numbers were group 1 (study group) and those with even serial number were group 2 (controls).\"\
Comment: clearly states how sequence was generatedAllocation concealment (selection bias)Unclear riskQuote: \"Patients were randomly assigned to two groups, using pre‐coded sealed envelopes containing serial numbers from 1 to 500. Envelopes were not opened until the end of surgery, before wound irrigation. Patients with odd serial numbers were group 1 (study group) and those with even serial number were group 2 (controls)\
Comment: although sealed envelopes were used it is not clear that they were opaque or that the allocation sequence was fully concealed at all times.Blinding of participants and personnel (performance bias) All outcomesUnclear riskComment: no direct quote, but no information on how personnel might have been blinded to the treatment performed. Unclear whether participants were blinded, but report states it was \"single blind\"Blinding of outcome assessment (detection bias) All outcomesUnclear riskComment: no direct quote; no information given regarding who collected outcome assessment dataIncomplete outcome data (attrition bias) All outcomesHigh riskQuote: \"Three patients who died during the follow‐up period were excluded (one case in group 1 and two cases in group 2).\"\
Comment: number of exclusions is low but similar to number of eventsSelective reporting (reporting bias)Unclear riskComment: no evidence of selective reporting but not enough information to be certainOther biasUnclear riskComment: there was no evidence of other sources of bias but reporting was not clear enough to be certain[@CD012234-bbs2-0012]MethodsParallel RCT\
Setting: single centre in Republic of Korea\
Follow‐up: 2 weeksParticipants34 patients undergoing gastrectomy\
Inclusion criteria: naive stomach cancer patients\
Exclusion criteria: history of diabetes, pneumonia, urinary tract infection, chemotherapyInterventionsGroup I: saline exchange after gastrectomy (17 participants)\
Group II: no saline exchange during surgery (17 participants)\
Co‐interventions: preoperative cefametazol 1 gOutcomes**Primary outcome: SSI**\
Superficial, deep SSI defined by [@CD012234-bbs2-0163]\
Group I (saline exchange): 1/17\
Group II (no saline exchange): 3/17NotesFunding: NR\
Reported in Korean. Data extraction and risk of bias assessment performed by translator***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskComment: random number table was usedAllocation concealment (selection bias)Unclear riskComment: method of allocation concealment was not describedBlinding of participants and personnel (performance bias) All outcomesHigh riskComment: personnel were blinded because they were under anaesthesia but personnel would have been aware of the allocation due to the nature of the comparisonBlinding of outcome assessment (detection bias) All outcomesLow riskComment: outcome assessors were blindedIncomplete outcome data (attrition bias) All outcomesLow riskComment: all participants were includedSelective reporting (reporting bias)Low riskComment: pre‐specified outcomes were reportedOther biasLow riskComment: not detected[@CD012234-bbs2-0013]MethodsParallel‐group, 5‐arm RCT\
Setting: single hospital in USA\
Follow‐up: unclearParticipants360 women undergoing caesarean section. Both caesareans in labour and without labour were included. Mean ages between 24.59 and 27.52 years. Gestational ages between 37.85 and 39.31 weeks\
Inclusion criteria: women undergoing caesarean section\
Exclusion criteria: history of penicillin or cephalosporin allergy, taking antibiotics, known infectious process (e.g. chorioamnionitis or urinary tract infection)InterventionsGroup 1: saline lavage (800 mL)\
Group 2: 2 g cephapirin sodium lavage\
Group 3: 2 g cefamandole nafate lavage\
Group 4: 2 g moxalactam disodium lavage\
Group 5: 2 g ampicillin sodium lavage\
Inferred that each antibiotic lavage used 800 mL\
Cointerventions: none reportedOutcomes**Primary outcome: SSI** (wound breakdown with positive culture or presence of cellulitis)\
Group 1 (saline): 3/77\
Group 2 (cephapirin): 3/70\
Group 3 (cefamandole): 2/64\
Group 4 (moxalactam): 2/79\
Group 5 (ampicillin): 0/70\
**Secondary outcome: adverse events including abscess**\
There were 0 abscess events; other adverse events reported were infection‐related morbidity as follows\
Group 1 (saline): 22/77\
Group 2 (cephapirin): 17/70\
Group 3 (cefamandole): 8/64\
Group 4 (moxalactam): 19/79\
Group 5 (ampicillin): 10/70NotesFunding NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"A computer‐generated table of pseudo‐random numbers\.... was used by the pharmacy to assign each patient to one of five groups\"\
Comment: an acceptable method of sequence generation was reported.Allocation concealment (selection bias)Unclear riskQuote: \"A computer‐generated table of pseudo‐random numbers\.... was used by the pharmacy to assign each patient to one of five groups\"\
Comment: there was no information on how allocation concealment was undertaken.Blinding of participants and personnel (performance bias) All outcomesLow riskQuote: \"A vitamin \.... was added to each solution for disguise\"\
\"The patients and physicians were unaware of the group assignment until after completion of the study and chart review by the authors\"\
Comment: blinding of both participants and physicians was undertaken.Blinding of outcome assessment (detection bias) All outcomesUnclear riskComment: no specific quote but it was unclear who performed the outcome assessments and hence whether they were blinded to group allocation.Incomplete outcome data (attrition bias) All outcomesLow riskComment: all randomised participants were included in the analyses.Selective reporting (reporting bias)Unclear riskComment: the outcomes were not defined in the methods section so it is unclear whether all planned outcomes were fully reported.Other biasUnclear riskComment: no apparent sources of additional bias but reporting insufficient to be certain[@CD012234-bbs2-0014]Methods2‐arm RCT with 2 phases\
Setting: NR, but appears to be a general surgery department at a hospital in the Netherlands\
Follow‐up: at 4, 8 and 14 d, and 4 weeks after surgeryParticipants592 participants, of which 34 excluded (18 in the control group and 16 in the povidone‐iodine group) because they died before the end of the control period or had to be operated upon again through the same wound during this period. 2 wounds were present in 21 participants (9 in the control group and 12 in the povidone‐iodine group). A total of 582 wounds were evaluated in 558 participants.\
Inclusion criteria: all elective and acute patients who underwent intra‐abdominal operations or operations for inguinal hernia\
Exclusion criteria: children \< five years of age and those undergoing vascular reconstruction.InterventionsGroup I (control): quote \"No special measures were taken\"\
Group II (povidone‐iodine): carried out in 2 phases. Subcutaneous tissues irrigated with a povidone‐iodine solution at the end of the operation. Lavage with an ample amount of 1% aqueous povidone‐iodine solution (Phase 1) or 10% aqueous povidone‐iodine solution (Phase 2). Lavage was performed after closure of the fascia with interrupted polyglactin 910 sutures. After lavage for 1 min, excess fluid was aspirated and skin closed with interrupted with nylon sutures. If present, drains were brought out through a second wound.Outcomes**Primary outcome: SSI** (Definition: \"Diagnosis of wound infection made if a purulent discharge form the wound was seen within a period of four weeks after the operation or if culturing of fluid from the wound was positive.\")\
Group I (control): Phase 1: 21/142 wounds Phase 2: 15/137 wounds (270 participants? ‐ participant numbers unclear)\
Group II (povidone‐iodine): Phase 1: 17/154 wounds Phase 2: 22/149 wounds (291 participants? ‐ participant numbers unclear)NotesParticipants: age NR\
Outcomes: these appear to refer to number of wounds, not participants\
Funding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"The patients were divided at random into two groups.\"\
Comment: it is unclear how randomisation was performed.Allocation concealment (selection bias)Unclear riskQuote: \"The patients were divided at random into two groups.\"\
Comment: no information on whether the randomisation sequence was concealedBlinding of participants and personnel (performance bias) All outcomesHigh riskQuote: \"In the first group, no special measures were taken.\"\
Comment: the control arm did not involve an intervention as a comparator, and so unable to conceal allocation to staff present at the operation. Unclear whether all staff were aware of the different phases of the study (and concentrations of solution used as the intervention).\
Unclear whether participants were aware of treatment allocationBlinding of outcome assessment (detection bias) All outcomesUnclear riskQuote: \"Postoperatively, all wounds were assessed by the same investigator\...\"\
Comment: unclear as to whether the investigator was blinded to the treatment allocationIncomplete outcome data (attrition bias) All outcomesHigh riskQuote: \"34, 18 in the control group and 16 in the povidone‐iodine group, were excluded because they either died before the end of the control period or had to be operated upon again through the same wound during this period.\"\
Comment: number of exclusions is high. No reasons given for cause of death or re‐operationsSelective reporting (reporting bias)Unclear riskNo evidence of reporting bias, but report is not complete enough to be sureOther biasUnclear riskComment: there was no evidence of other sources of bias but reporting was not clear enough to be certain[@CD012234-bbs2-0015]Methods4‐arm RCT\
Setting: 2 hospitals in USA\
Follow‐up: 6 weeksParticipants\'High risk\' patients (for developing post operative febrile morbidity) undergoing cesarean section for a variety of reasons\
158 women included in study\
Inclusion criteria: women in active labour or with ruptured membranes, at least one digital vaginal examination (i.e. high risk from developing postoperative febrile morbidity)\
Exclusion criteria: allergy to cephalosporins or penicillin, presence of fever ≥ 37.8 C during labour with suspicion of chorioamnionitis, maternal use of antibiotics in 2‐week period before deliveryInterventionsGroup I: 8 doses of IV cefoxitin 2 g (1st dose after umbilical cord clamp, then every 6 hs) (39 participants)\
Group II: irrigation of uterus and peritoneum with 2 g cefoxitin (in 1000 mL of normal saline). After delivery of the placenta, the fundus of the uterus was irrigated with 300 mL, the uterine incision with 150 mL, after closure of the first layer 150 mL, bladder flap 150 mL, remainder used to irrigate peritoneal cavity and excess suctioned away before closure of the abdomen (42 participants)\
Group III: combination of IV antibiotic (8 doses of 2 g cefoxitin) and irrigation with cefoxitin (in 1000 mL of normal saline) i.e. treatments of groups I and II combined (38 participants)\
Group IV: control group who received no prophylactic antibiotics (39 participants)Outcomes**Primary outcome: SSI (wound infection)**\
Group I (IV antibiotics only): 0/39\
Group II (irrigation with antibiotics only): 0/42\
Group III (IV antibiotics plus irrigation with antibiotics): 0/38\
Group IV (no IV and no irrigation):1/39\
**Secondary outcome: hospital stay (mean (SD) d)**\
Group I: 4.8 (1.1)\
Group II: 4.9 (1.0)\
Group III 4.9 (1.2)\
Group IV: 5.4 (1.4)\
**Secondary outcome: adverse events**\
Infectious (endomyometritis, urinary tract infection, wound infection (1 case, see above), pulmonary infection, septicaemia)\
Group I: 2/39\
Group II: 3/42\
Group III: 2/38\
Group IV: 14/39\
Non‐infectious (seroma, transfusion reaction, atelectasis)\
Group I: 1/39\
Group II: 1/42\
Group III: 1/38\
Group IV: 0/39NotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"Randomization into one of four treatment groups was performed by using a table of random numbers\"\
Comment: an appropriate method appears to have been usedAllocation concealment (selection bias)Unclear riskComment: there is no information about allocation concealmentBlinding of participants and personnel (performance bias) All outcomesHigh riskComment: there is no information about blinding. It is possible that participants were blinded, but personnel would be aware of treatment as the protocols are quite different.Blinding of outcome assessment (detection bias) All outcomesUnclear riskComment: there is no information about blinding or who performed outcome assessmentIncomplete outcome data (attrition bias) All outcomesLow riskComment: all participants are accounted for in the resultsSelective reporting (reporting bias)Unclear riskComment: the outcomes do not appear to have been pre‐specified, although febrile morbidity was extensively definedOther biasUnclear riskComment: there is no evidence of additional sources of bias but the reporting is insufficient to be confident that there were none.[@CD012234-bbs2-0016]Methods2‐arm RCT\
Setting: single hospital in UK\
Follow‐up: 1 monthParticipants129 patients undergoing elective and emergency colorectal surgery\
Age: unknown;\
Type of operations: unknown\
Inclusion criteria: NR\
Exclusion criteria: NRInterventionsGroup I: 1000 mL saline lavage at the end of the operation (65 participants)\
Group II: 1000 mL saline lavage with 1 g cefotetan at the end of the operation (64 participants)\
Co‐interventions: Groups I and II both received 500 mg metronidazole and 120 mg gentamicin IV at anaesthesia inductionOutcomesPrimary outcome:\
**SSI** (defined as discharge of pus from the wound \"wound sepsis\")\
Group I (saline): 18/65\
Group II (cefotetan): 15/64NotesFunding: NR\
Limited information from paper***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"Patients were randomly allocated to receive either 1 liter of saline lavage or 1 liter of saline containing 1g of cefotetan\...\"\
Comment: the method of randomisation is not describedAllocation concealment (selection bias)Unclear riskComment: there is no mention of allocation concealmentBlinding of participants and personnel (performance bias) All outcomesUnclear riskComment: there is no mention of blinding of participants or personnelBlinding of outcome assessment (detection bias) All outcomesUnclear riskQuote: \"Post‐operatively, patients were assessed regularly by a single observer for the development of wound sepsis\...\"\
Comment: there is no mention of blinding of the observerIncomplete outcome data (attrition bias) All outcomesLow riskComment: participants are all accounted for in the outcome data of interestSelective reporting (reporting bias)Unclear riskComment: the outcome of interest (SSI) is reported but it is not clear that related results are fully reportedOther biasUnclear riskComment: there is not enough methodological information to judge whether there were any additional sources of bias[@CD012234-bbs2-0017]Methods2‐arm RCT\
Setting: single hospital in Turkey\
Follow‐up: participants were examined at 2 and 6 weeks after surgery. Wounds examined twice daily during hospitalisation. After discharge, women were instructed to contact investigators immediately if any of the listed symptoms appeared. Women who contacted the investigators were examined within 12 hParticipants520 women with indications for elective or emergency caesarean section (incidence of emergency surgery (45.5 vs 51.5%; P  = 0.53))\
Inclusion criteria: past 37 weeks\' gestation and required a caesarean section (elective or emergency).\
Exclusion criteria: anaemia (haemoglobin: \< 7 g/dL), chorioamnionitis and fever on admissionInterventionsGroup I: underwent wound irrigation before wound closure with 100 mL of sterile saline with a 30--60 mL syringe (260 participants)\
Group II: no wound irrigation before wound closure (260 participants)Outcomes**Primary outcomes: SSI** (wound drained purulent material or serosanguineous fluid in association with induration, warmth and tenderness)\
Group I (saline): 17/260\
Group II (no irrigation): 19/260\
**Secondary outcomes: mean length of hospital stay**\
Group I (saline): 2.05 (0.21) d\
Group II (no irrigation): 2.04 ( 0.20)NotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"Consenting patients were preoperatively randomised using numerically ordered cards in sealed envelopes\"\
Comment: method of sequence generation is not reportedAllocation concealment (selection bias)Unclear riskQuotes: \"Consenting patients were preoperatively randomised using numerically ordered cards in sealed envelopes\" \"The investigator was not blinded to the procedure allocation\" \"The allocated envelope was opened by the clinician just before surgery\"\
Comment: the use of sealed envelopes suggests an attempt to conceal some aspect of allocation but the authors state that the investigator was not blinded to allocation; envelopes are not stated to be opaqueBlinding of participants and personnel (performance bias) All outcomesHigh riskQuote: \"The allocated envelope was opened by the clinician just before surgery. The procedure allocation was recorded in the women\'s charts\"\
Comment: personnel and participants were both aware of treatmentBlinding of outcome assessment (detection bias) All outcomesHigh riskQuote: \"The procedure allocation was recorded in the women\'s charts\" \"The investigator was not blinded to the procedure allocation\"\
Comment: it is not explicitly stated but the report suggests the outcome assessors were not blindedIncomplete outcome data (attrition bias) All outcomesLow riskComment: data are reported for all participantsSelective reporting (reporting bias)Unclear riskComment: apart from SSI, it is unclear which outcomes were prespecifiedOther biasLow riskComment: there is no evidence of other bias[@CD012234-bbs2-0018]MethodsParallel‐group RCT\
Setting: single hospital in UK\
Follow‐up: 4 weeks postoperativelyParticipants192 participants undergoing appendectomy via grid iron incision\
Inclusion criteria: appendectomy via a right iliac fossa incision\
Exclusion criteria: female participants of child bearing age not adequately protected by contraceptive practiceInterventionsGroup I: 50 mL 2% taurolin in 5% PVP in \"saline sufficient to produce solutions of equal tonicity\"; wound irrigated for 2 min; then 10 mL instilled through a quill after closure of the skin\
Group II 50 mL of 5% PVP in \"saline sufficient to produce solutions of equal tonicity\" wound irrigated for 2 min; then 10 mL instilled through a quill after closure of the skin\
Cointerventions: antibiotics and drains as requiredOutcomes**Primary outcome: SSI** (wound sepsis) defined as a wound discharging pus\
Group I (taurolin): 18/99\
Group II (placebo): 29/93\
**Secondary outcome: length of stay**\
Group I (taurolin): 6.4 d (mean, no SD)\
Group II (placebo): 6.6 d (mean, no SD)NotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"the taurolin and placebo being randomly allocated to sequential numbers 1 to 200\"\
Comment: no information on how the randomisation sequence was generatedAllocation concealment (selection bias)Unclear riskQuote: \"the taurolin and placebo being randomly allocated to sequential numbers 1 to 200\"\
Comment: no information on whether allocation was adequately concealedBlinding of participants and personnel (performance bias) All outcomesLow riskQuote: \"neither solution was distinguishable to users\"\
Comment: it appeared that personnel (and participants) were blindedBlinding of outcome assessment (detection bias) All outcomesUnclear riskQuote:\"During the hospital stay the wound was observed be a member of the medical staff participating in trial\"\
Comment: it was unclear whether the individual who assessed the outcomes was blinded to treatment groupIncomplete outcome data (attrition bias) All outcomesLow riskComment: the 8 participants who were not included in the analyses were clearly documented. Although 7 of these were placebo group‐allocated participants it appears unlikely that these exclusions would have affected the results.Selective reporting (reporting bias)Unclear riskComment: the primary outcome was specified but it was unclear which other outcomes were planned to be recordedOther biasUnclear riskComment: there is no evidence of other sources of bias but reporting was insufficient to be certain.[@CD012234-bbs2-0019]Methods2‐arm RCT\
Setting: multicentre trial: 4 UK hospitals in the \"South of England\"\
Study period: 18‐months\
Follow‐up: 30 d post surgery or discharge from unit (1 assessor in each hospital reviewed participants\' wounds twice a week until discharge)Participants356 participants with a displaced intracapsular fractured neck of femur, due to be treated with a hemiarthroplasty, were randomised into 2 groups\
Inclusion criteria: displaced intracapsular fractured neck of femur, due to be treated with a hemiarthroplasty\
Exclusion criteria: NRInterventionsGroup I: the 'pulse lavage' group had a 2‐L normal saline wash delivered via pulsatile lavage in stages throughout the procedure (164 participants)\
Group II: the control group had a 2‐L normal saline wash delivered by a jug or a syringe according to the surgeon\'s preference with 1 L being given before prosthesis insertion and 1 L after insertion (192 participants)\
Co‐interventions: NROutcomes**Primary outcome: SSI**\
Wound infections were diagnosed using criteria from the Nosocomial Infection National Surveillance Survey and graded as superficial or deep.\
Group I (pulse lavage): 9/164 (3/164 \'deep\')\
Group II (control): 30/192 (10/192 \'deep\')\
**Secondary outcome: occurrence of infections with antibiotic resistance**\
No group data but quote: \"Half of the deep space infections were due to methicillin‐resistant Staphylococcus aureus\"\
**Secondary outcome: mortality**\
NR by group. There were 25 deaths within the study period (7%); 18 of these were associated with American Society of Anaesthesiologists (ASA) scores of 3 or belowNotesFunding: no records***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"\...all patients\... were randomized into two groups\"\
Comment: no details about methodAllocation concealment (selection bias)Unclear riskComment: no mention of allocation concealmentBlinding of participants and personnel (performance bias) All outcomesHigh riskComment: no mention of blinding, but nature of intervention and control means personnel would not be blind to treatmentBlinding of outcome assessment (detection bias) All outcomesUnclear riskQuote: \"One assessor in each hospital reviewed patients\' wounds twice a week until discharge\"\
Comment: no mention of blinding and it is unclear if the assessor would have been aware of treatmentIncomplete outcome data (attrition bias) All outcomesHigh riskQuote: \"the difference in size between the two groups was due to \'start up\' problems within the hospitals where pulse lavage had not been previously associated with hemiarthroplasty operations\" \"In cases where hemiarthroplasties were due to have pulse lavage but this was forgotten, the cases were struck from the study\"\
Comment: the authors describe issues with implementing the pulse lavage intervention and although they describe participants being excluded at some point for this reason (presumably post‐randomisation) there are no details about them. It is probable that this introduced bias to the study.Selective reporting (reporting bias)High riskComment: data are fully reported for some outcomes but others are not reported by groupOther biasUnclear riskComment: there is insufficient information to judge[@CD012234-bbs2-0020]Methods2‐arm, parallel‐group RCT\
Setting: single centre in USA\
Follow‐up: NRParticipants196 women undergoing caesarean delivery. 94 were elective repeat procedures, age 27.5 vs 28.2 years\
Inclusion criteria: women presenting with term (\> 37 weeks) singleton pregnancies undergoing routine caesarean delivery for arrest of dilation, arrest of descent, foetal malpresentation or as an elective repeat procedure\
Exclusion criteria: women diagnosed with chorioamnionitis, type I diabetes, placenta previa, placenta accreta, maternal coagulopathy, multiple gestation, HIV--positive status, prior severe gastrointestinal disease, or non‐reassuring fetal monitoring requiring immediate deliveryInterventionsGroup I: irrigation with 500‐1000 mL warm saline after closure of the uterine incision but before closure of the abdominal wall (97 participants)\
Group II: no irrigation (99 participants)Outcomes**Primary outcome: SSI** (undue tenderness, erythema, discharge, or separation of the incision accompanying maternal fever)\
Group I (saline irrigation): 1/97\
Group II (no irrigation): 2/99\
**Secondary outcome: length of stay (d)**\
Group I (saline irrigation): 2.9 (1.0)\
Group II (no irrigation): 2.8 (0.9)\
**Secondary outcome: adverse events** (postpartum complications including SSI)\
Group I (saline irrigation): 14/97\
Group II (no irrigation): 13/99NotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"Assignment was performed by pulling sequentially numbered opaque envelopes containing computer‐randomized individual allocations.\"\
Comment: an appropriate method of random sequence generation was reportedAllocation concealment (selection bias)Low riskQuote: \"Assignment was performed by pulling sequentially numbered opaque envelopes containing computer‐randomized individual allocations.\"\
Comment: an appropriate method of allocation concealment was reportedBlinding of participants and personnel (performance bias) All outcomesHigh riskQuote: \"This randomization was carried out by research staff before initiation of the study, and the patients were blinded to treatment once assigned.\"\
Comment: although participants were blinded to treatment allocation it is unclear whether personnel were also blinded, the nature of the intervention groups suggests that they were not.Blinding of outcome assessment (detection bias) All outcomesLow riskQuote: \"Postoperative care providers were blinded to group assignment to minimize potential bias. \.... The randomizing physician collected the initial data. Data entry was performed by data technicians who did not participate in the design or execution of the study; these technicians also reviewed the charts of each randomized patient to assess the accuracy of information provided by the treating physician. The senior investigator performed periodic reviews of data entry to ensure completeness and accuracy of information in the computer database. The data analysis was performed by an investigator blinded to group assignment.\"\
Comment: blinded outcome assessment was conductedIncomplete outcome data (attrition bias) All outcomesLow riskComment: all randomised participants were included in the analysesSelective reporting (reporting bias)Low riskQuote: \"The primary outcome measure was the incidence of maternal morbidity, defined as the presence of at least one of the following:\...\"\
Comment: primary and secondary outcomes were clearly specified and fully reported.Other biasLow riskComment: there were no other sources of bias evident and reporting was sufficient to be reasonably confident that this was the case.[@CD012234-bbs2-0021]Methods2‐arm RCT\
Setting: single hospital in Slovakia\
Follow‐up: 7.8 months (mean) 2‐14 months (range): follow‐up at 2 weeks, 6 weeks and then 3‐monthlyParticipants162 children (undergoing 182 surgical procedures on soft and bone tissues in the proximal femur, hip and pelvic regions. mean age was 7.9 vs 7.5 years Types of procedures: adductor tenotomy, femoral or pelvic osteotomy, extraction of metal materials, open reductions, epiphysiodesis, resection or biopsy. Children had the following long‐term conditions: developmental dysplasia of the hip, cerebral palsy, tumours, Perthes disease\
Inclusion criteria: children undergoing surgery of the femur, hip or pelvis\
Exclusion criteria: NRInterventionsGroup I: lavage with 3.5% Betadine solution (0.35% povidone iodine) diluted in 30 mL sterile saline\
Group II: lavage with 30 mL sterile saline\
Cointerventions: antibiotic prophylaxis begun preoperatively in participants with femoral or pelvic osteotomy or massive surgery of soft tissues and continued for 48‐72 hs postoperatively (dose determined by weight). Drains left in until second postoperative day where necessaryOutcomes**Primary outcome: SSI** (positive bacteriological examination)\
Group I (Betadine lavage): 0/89\
Group II (saline lavage): 2/73NotesFunding: NR\
Slovak; data entry and risk of bias based on information provided by translator***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskComment: no information about the sequence generation process but stated that the participants were allocated to 2 groups randomlyAllocation concealment (selection bias)Unclear riskComment: no information on whether the allocation was adequately concealedBlinding of participants and personnel (performance bias) All outcomesUnclear riskComment: no information on whether personnel or participants were blinded to the interventionsBlinding of outcome assessment (detection bias) All outcomesUnclear riskComment: no information on who assessed the presence of SSI or whether they were blinded to treatment allocationIncomplete outcome data (attrition bias) All outcomesLow riskQuote \"In the first group (89 patients) \[we\] found no peri‐ or post‐operative infection. In the second group of patients (73) \[we\] brought to light two surface infection\[s\] (2.7%)\"\
Comment: it appears that all participants were included in the analysisSelective reporting (reporting bias)Unclear riskComment: outcomes were not specified in the methods section so difficult to be certain whether all planned outcomes were assessedOther biasUnclear riskNo evidence of additional bias but reporting insufficient to be certain[@CD012234-bbs2-0022]Methods2‐arm RCT\
Setting: NR, appears to be single centre in Japan\
Follow‐up: NRParticipants16 children (aged 2‐12 years) undergoing appendectomy for perforated appendicitis\
Inclusion criteria: generalised peritonitis or nonlocalised abscess\
Exclusion criteria: NRInterventionsAfter appendectomy, the peritoneal cavity was lavaged with 100 mL/kg (1500‐4000 mL) of the following warmed lavage solutions:\
Group I : normal saline (8 participants)\
Group II: acidic oxidative water (AOPW), a strong acidic water produced by the electrolysis of tap water containing 10% W/V sodium chloride (8 participants)\
Co‐interventions: antibiotics moxalactam \[reported as LMOX\] (100 mg/kg/d) or cefazolin \[reported as CEZ\] (50 mg/kg/d) were given in both groups for 5 d or until serum C‐reactive protein was at a normal levelOutcomes**Primary outcome: SSI**\
No definition given for wound infection\
Group I (saline): 4/8\
Group II (APOW): 1/8\
**Secondary outcome: adverse events: abscess formation**\
Group I (saline): 1/8\
Group II (APOW): 0/8\
**Secondary outcome: length of hospital stay (mean (SD) d)**\
Group IS (saline): 22.7 (11.1)\
Group II (APOW): 12.1 (5.1)NotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"They were randomly divided into two groups\"\
Comment: no details of randomisation methodAllocation concealment (selection bias)Unclear riskComment: no mention of allocation concealmentBlinding of participants and personnel (performance bias) All outcomesUnclear riskComment: no mention of blindingBlinding of outcome assessment (detection bias) All outcomesUnclear riskComment: no mention of who performed the assessment of outcomes or whether blinding occurredIncomplete outcome data (attrition bias) All outcomesLow riskComment: all participants are included in the resultsSelective reporting (reporting bias)High riskComment: outcomes were not prespecified beyond \"effectiveness and safety\"Other biasUnclear riskComment: there is not enough methodological detail to judge[@CD012234-bbs2-0023]Methods2‐arm RCT\
Setting: appears to be multiple centres, Japan (\"our affiliated hospitals\")\
Follow‐up: 30 d\
Duration of study: 2008‐2012Participants44 children aged 3‐14\
Group I: 16 boys and 4 girls, ranging in age from 4‐11 years\
Group II: 12 boys and 12 girls, ranging in age from 3‐14 years\
Inclusion criteria: children (age not defined) appendectomy for perforated appendicitis with extensive or panperitonitis\
Exclusion criteria: pre‐operative antibiotics or requirement of antibiotics due to massive abscess formationInterventionsAfter appendectomy, the peritoneal cavity was lavaged with 100 mL/kg saline or SAEW (strong acid electrolysed water, generated by electrolysis of tap water containing 0.2% NaCl), in Groups I and II, respectively. After closure of the fascial layer, the wound was washed out with 200 mL same solution before skin suture\
Group I: 100 mL/kg saline (20 participants)\
Group II: 100 mL/kg SAEW (24 participants)\
Co‐intervention: cefmetazole, 100 mg/kg/d, was given initially to both groups, which was replaced by the most sensitive antibiotics after identification of causative pathogens for 5 or 7 d depending on response. The abdominal wall was disinfected with povidone iodine, and laparotomy was performed via a pararectal incision, saving the muscle layers, followed by appendectomy, carried out in the same manner in both groups.Outcomes**Primary outcome: SSI**\
Defined as infection at the operation site, occurring up to 30 d after surgery, with confirmed causative pathogen(s) identical to those of the appendicitis.\
Group I (saline): 4/20\
Group II (SAEW): 0/24\
**Secondary outcome: adverse events (intraperitoneal abscess)**\
Group I (saline): 1/20\
Group II (SAEW): 1/24\
**Secondary outcome: length of hospital stay (mean (SD) d)**\
Group I (saline): 9.4 (4.7)\
Group II (SAEW): 8.7 (4.0)Notes34 participants were excluded from the study because some had received antibiotics before the operation and some had required antibiotics for massive abscess formation to be resected primarily with appendectomy\
Funding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"Patients were allocated randomly to one of two treatment groups\"\
Comment: no details about method of randomisationAllocation concealment (selection bias)Unclear riskComment: no mention of allocation concealmentBlinding of participants and personnel (performance bias) All outcomesUnclear riskComment: no mention of blindingBlinding of outcome assessment (detection bias) All outcomesUnclear riskComment: no mention of who performed the outcome assessment or whether blinding occurredIncomplete outcome data (attrition bias) All outcomesHigh riskQuote: \"34 patients were excluded from the study\...\"\
Comment: it is unclear if the exclusions were before or after randomisationSelective reporting (reporting bias)Low riskComment: all outcomes of interest appear to be reportedOther biasUnclear riskComment: there is not enough methodological information to judge[@CD012234-bbs2-0024]Methods3‐arm RCT\
Setting: Kaiser‐Permanente Medical Center ‐ Santa Clara, USA\
Follow‐up: at least 8 weeksParticipants128 women undergoing cesarean section for various indications including repeat, breech and cephalopelvic disproportion. (132 entered study but 4 were excluded for irrigation protocol deviation and data are only presented for 128)\
Inclusion criteria: undergoing cesarean section\
Exclusion criteria: fever or other evidence of infection in labour, history of sensitivity to cephapirin or cefoxitinInterventionsGroup I: following delivery of the placenta, the uterine cavity and incision, bladder flap, pelvic gutters, and subcutaneous tissue were irrigated with 2 mg cephapirin in 1000 mL normal saline (44 participants)\
Group II: irrigation with 2 mg cefoxitin in 1000 mL normal saline (41 participants)\
Group III: irrigation with 1000 mL normal saline only (43 participants)Outcomes**Primary outcome: SSI (**defined as purulent wound discharge with or without wound separation)\
Group I (cephapirin): 0/44\
Group II (cefoxin): 0/41\
Group III (saline): 3/43\
**Secondary outcome: endometritis** (defined as persistent fever, uterine tenderness, foul‐smelling lochia, with no other obvious source of infection)\
Group I (cephapirin):4/44\
Group II (cefoxin): 1/41\
Group III (saline): 5/43 (one of these also had wound infection)\
**Secondary outcome: length of hospital stay (mean (SD) d)**\
Group I (cephapirin): 4.8 (1.2)\
Group II (cefoxin): 4.9 (1.9)\
Group III (saline): 5.2 (2.1)Notes4 excluded from the analysis for protocol deviation\
Funding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"\... bags were sequenced randomly by a lottery method and used in numerical order\"\
Comment: the method is not explained in enough detail to know whether it was appropriateAllocation concealment (selection bias)Unclear riskQuote: \"\... bags were sequenced randomly by a lottery method and used in numerical order\"\
Comment: there is not enough detail about the method of randomisation and allocation concealment to judgeBlinding of participants and personnel (performance bias) All outcomesLow riskQuote: \"\...bags of irrigant were prepared by pharmacy personnel\" \"One millilitre of multivitamin infusion was added to create an identical appearance of all solutions\" \"Patients, physicians, operating room personnel, and data collectors were thus blinded to the group assignment.\"\
Comment: steps were have been taken to ensure blinding of participants and personnelBlinding of outcome assessment (detection bias) All outcomesLow riskQuote: \"Patients, physicians, operating room personnel, and data collectors were thus blinded to the group assignment.\"\
Comment: steps appear to have been taken to ensure blinding of outcome assessorsIncomplete outcome data (attrition bias) All outcomesUnclear riskQuote: \"One hundred thirty‐two patients were entered in the study. Four patients were eliminated from the statistical analysis because of deviations from the protocol of irrigation technique\"\
Comment: there are only a few participants lost during the study but no details of these participants are reported and since numbers of events are small this could potentially have an impact.Selective reporting (reporting bias)Low riskComment: the outcomes of interest appear to be fully reportedOther biasLow riskComment: there is no evidence of other bias[@CD012234-bbs2-0025]Methods2‐arm RCT\
Setting: NR; appears to be single hospital in USA\
Follow‐up: NRParticipants200 participants undergoing elective and emergency gastrointestinal surgery (procedures on biliary tract 63/100 vs 57/100; gastroduodenal 14 vs 19 and colon 23 vs 24). Mean age was 61.7/61.6 years (range 17‐93). Malignancy present in 29/100 versus 25/100; diabetes 6/100 vs 8/100; obesity 30/100 vs 18/100\
Inclusion criteria: elective or emergency procedures on the gastrointestinal tract\
Exclusion criteria: parenteral antibiotics had been administered preoperatively or intraoperatively; a colostomy was required; if frank pus was encountered at operationInterventionsGroup I (kanamycin sulphate and cephalothin sodium): operative site was irrigated intermittently from the beginning to completion of the operation with a solution containing 1 g of kanamycin sulphate and 1 g of cephalothin sodium in 1000 mL of normal saline solution (100 participants)\
Group II (saline): operative site was irrigated intermittently from the beginning to completion of the operation with a solution of normal saline (100 participants)\
Cointerventions: the average volume of irrigant used for each operation was 750 mL. No cointerventions were reportedOutcomes**Primary outcome: SSI (postoperative wound infection)**\
Group I (kanamycin sulphate and cephalothin sodium): 3/100\
Group II (saline): 9/100\
**Secondary outcome: mortality (postoperative deaths‐ last recorded 43 d post‐op)**\
Group I (kanamycin sulphate and cephalothin sodium): 5/100\
Group II (saline): 3/100\
Note: 2 participants who died had wound infections but sepsis was not the cause of the deaths\
**Secondary outcome: antibiotic resistance**\
Details of individual species recovered from wounds of participants with SSI were reported together with their sensitivity or resistance where this was tested for. Multiple species reported for each participant\
**Secondary outcome: adverse events**\
Postoperative peritonitis:\
Group I (kanamycin sulphate and cephalothin sodium): 0/100\
Group II (saline): 1/100\
**Secondary outcome: antibiotic resistance**\
Resistance of specific organisms to kanamycin sulphate and cephalothin sodium reported for each type of surgery. Large numbers of samples reported as not testedNotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"Designation was made by computer‐generated listing using a standard table of random numbers.\"\
Comment: sequence generation used an appropriate methodAllocation concealment (selection bias)Unclear riskQuote: \"Designation was made by computer‐generated listing using a standard table of random numbers.\"\
Comment: no indication as to whether allocation was adequately concealedBlinding of participants and personnel (performance bias) All outcomesUnclear riskQuote: \"a prospective, randomized, double‐blind study\"\
Comment: it was unclear who was blinded; while participants would probably be blinded it is unclear if personnel wereBlinding of outcome assessment (detection bias) All outcomesUnclear riskQuote: \"a prospective, randomized, double‐blind study\"\
Comment: it was unclear whether the double‐blinding referred to outcome assessorsIncomplete outcome data (attrition bias) All outcomesLow riskComment: all randomised participants were included in the analysesSelective reporting (reporting bias)Unclear riskComment: outcomes were not defined in the methods section so it is difficult to be sure whether all planned outcomes were fully reported.Other biasUnclear riskComment: no evidence of other sources of bias but reporting insufficient to be certain[@CD012234-bbs2-0026]MethodsParallel‐group RCT (factorial)\
Setting: single hospital in the USA\
Follow‐up: NRParticipants100 women undergoing caesarean section\
Inclusion criteria: women undergoing caesarean section; indications for surgery included elective repeat caesarean, failed trial of labour after prior caesarean, abnormal presentation, failure to progress, cephalopelvic disproportion, and severe pre‐eclampsia without thrombocytopenia or coagulopathy Exclusion criteria: chorioamnionitis at caesarean, emergency caesarean for foetal distress with inadequate time for skin preparationInterventionsGroup I: saline irrigation (500 mL) of pelvis and subcutaneous tissue at uterine and fascial closure (50 participants)\
Group II: cefazolin irrigation (1 g in 500 mL saline) of pelvis and subcutaneous tissue at uterine and fascial closure (50 participants)\
Cointerventions: factorial randomisation to 2 alternative skin preparations: povidone iodine 7.5% scrub followed by povidone iodine 10% solution (standard skin preparation) versus 5‐min scrub with parachlorometaxylenol followed by povidone iodine scrub and solution (special skin preparation). No additional interventions were reported.Outcomes**Primary outcome: SSI** (hyperemic skin incision and fluctuant mass which when opened contained purulent material)\
Group I (saline): 4/50 (3/25 with standard skin preparation; 1/25 with special skin preparation)\
Group II (cefazolin): 2/50 (2/25 with standard skin preparation)\
**Secondary outcome: adverse events** (endometritis)\
Group I (saline): 30/50 (16/25 with standard skin preparation; 14/25 with special skin preparation)\
Group II (cefazolin): 11/50 (8 with standard skin preparation; 3/25 with special skin preparation)NotesFunding: supported in part by the Vicksburg Hospital Medical Foundation***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"Random assignment was achieved by card selection from sealed opaque envelopes with group appointment derived from a random number table\"\
Comment: it appeared that an appropriate method was used to generate the randomisation sequenceAllocation concealment (selection bias)Unclear riskQuote: \"Random assignment was achieved by card selection from sealed opaque envelopes with group appointment derived from a random number table\"\
Comment: it was not clear that enough measures were taken to ensure adequate concealment of allocationBlinding of participants and personnel (performance bias) All outcomesUnclear riskComment: there was no information on whether personnel and participants were blinded to treatment allocationBlinding of outcome assessment (detection bias) All outcomesUnclear riskComment: there was no information on who performed the outcome assessment or whether they were blinded to treatment allocationIncomplete outcome data (attrition bias) All outcomesLow riskComment: all randomised participants were included in the analysesSelective reporting (reporting bias)Unclear riskComment: outcomes were not clearly prespecified so difficult to determine if all planned outcomes were fully assessedOther biasUnclear riskComment: no obvious additional sources of bias but reporting insufficient to be certain[@CD012234-bbs2-0027]Methods2‐arm RCT\
Setting: single hospital in Australia\
Follow‐up: letter or text message 4 weeks after surgery (following discharge from hospital)Participants3270 women undergoing caesarean section. Of those followed up 1508 had elective surgery and 1519 had surgery during labour. Mean age was 28.5 years in the Betadine group vs 28.6 years in the no Betadine group. 13.8% versus 12.9% had diabetes\
Inclusion criteria: women undergoing caesarean section either elective or during labour (stratified randomisation)\
Exclusion criteria: suspected or known allergy to iodineInterventionsGroup I: wound irrigation with 50 mL of 10% aqueous povidone iodine (Betadine) solution just before skin closure (1634 participants randomised; 1634 received allocated intervention; 1520 analysed)\
Group II: no irrigation (1636 participants randomised; 1636 received allocated intervention; 1507 analysed)\
Cointerventions: alcoholic povidone iodine for skin preparation unless an allergy to iodine present, in which case chlorhexidine was used. Prophylactic cephalothin administered to all women soon after spinal anaesthesiaOutcomes**Primary outcome: SSI** (wound abscess or wound draining pus or sero‐sanguinous fluid, or redness, induration, warmth and tenderness or if woman's general practitioner had seen her and prescribed antibiotics for presumed infection)\
Group I (povidone iodine irrigation): 144/1520\
Group II (no irrigation): 147/1507\
**Secondary outcome: return to theatre**\
Group I (povidone iodine irrigation): 7/1520\
Group II (no irrigation): 9/1507\
**Secondary outcome: hospital readmission**\
Group I (povidone iodine irrigation): 39/1520\
Group II (no irrigation): 30/1507\
Completed case analyses reported here: ITT population 1634 vs 1636 ‐ used in analyses for SSINotesFunding: states \"we had no funding for this study\...\"***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"The allocation was prepared using computer generated list of random numbers using a variable block of 10 and performed by a staff member not part of the clinical team\"\
Comment: acceptable method of sequence generation; randomisation also stratified by elective versus non‐elective procedureAllocation concealment (selection bias)Low riskQuote: \"Women were randomised to 'Betadine' or 'no Betadine' group using sequentially numbered sealed opaque envelopes that contained the allocation\..... After all layers were sutured and just prior to starting skin closure, the envelope with the allocation was opened by one of the theatre nurse\[sic\]\"\
Comment: appropriate measures appear to have been taken to ensure allocation concealment.Blinding of participants and personnel (performance bias) All outcomesHigh riskQuote \"In the control group (no Betadine group), layers would be sutured in exactly the same manner right up to the point of skin closure as it was only at this point that the allocation was revealed to the surgical team.\"\
Comment: surgical personnel were aware of group allocation; unclear whether participants were blindedBlinding of outcome assessment (detection bias) All outcomesLow riskQuote: \"Information on outcome measures was obtained by the research team blinded to the allocation and also not involved in clinical care of the women\"\
Comment: blinded outcome assessment for all outcomesIncomplete outcome data (attrition bias) All outcomesUnclear riskQuote: \"Of the total number randomised, 243 women were inadequately followed up either due to change of address, wrong telephone number or just not receiving the text messages\"\
Comment: 7% of women were lost to follow‐up; this was balanced between the arms (114 versus 129) and between the types of surgery (elective versus non‐elective) undertaken. Although this is close to the wound infection rate it does not appear likely to have impacted on the risk ratio of infection.Selective reporting (reporting bias)Low riskQuote \"Primary outcome was the incidence of SSI as a whole but also specifically readmission for intravenous antibiotics and/ or return to theatre for wound infection\"\
Comment: The outcomes were specified in the methods section and then fully reportedOther biasLow riskComment: no specific quote but no evidence of other bias and reporting sufficient to be reasonably confident.[@CD012234-bbs2-0028]MethodsThree‐arm RCT\
Setting NR; appears to be single hospital in Switzerland\
Follow‐up: not clear beyond 4 d/discharge from hospitalParticipants162 participants with appendicitis\
Inclusion criteria: people undergoing appendectomy carried out through an incision at McBurney\'s point, without the use of drains and without the use of pre‐, peri‐ or post‐operative systemic antibiotics\
Exclusion criteria: people with perforated or gangrenous appendices or with peritonitisInterventionsGroup I (saline): irrigation with 500 mL saline (0.9%) after the closure of the peritoneum. The liquid was re‐aspirated and the wound was not swabbed. The skin was then closed.\
Group II: (epicillin): irrigation with 500 mL saline with 1 g epicillin (Spectacilline) in solution as for Group I\
Group III: (lincomycine): irrigation with 500 mL saline with 600 mL lincomycine (Lincocin) in solution as for Group I\
Cointerventions: NROutcomes**Primary outcome: SSI** (septic complications with spontaneous or induced purulent discharge): results only reported for all groups together (1/162) compared with a non‐randomised group without irrigation (7/158)\
**Secondary outcome: adverse events including abscess**: results only reported for all groups together: 1/162 abscess from one of the antibiotic groupsNotesFunding: NR\
Paper in French; data extracted by one review author, checked by a fluent speaker***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"162 appendicectomies were randomised to treatment by blindly drawn lots\"\
Comment: acceptable method of sequence generationAllocation concealment (selection bias)Unclear riskQuote: \"162 appendicectomies were randomised to treatment by blindly drawn lots\"\
Comment: unclear whether there was adequate concealment of allocationBlinding of participants and personnel (performance bias) All outcomesUnclear riskNo direct quote; no information on whether any personnel were blinded after the treatment allocationBlinding of outcome assessment (detection bias) All outcomesHigh riskQuote \"In the irrigated groups a questionnaire was sent to the treating physician to establish whether postoperative wound infections developed\"\
Comment: no information as to whether the physicians were aware of treatment allocationIncomplete outcome data (attrition bias) All outcomesLow riskComment: all randomised participants appeared in the analysisSelective reporting (reporting bias)High riskComment: the results for the three randomised groups were reported together and contrasted only with a non‐randomised comparison groupOther biasUnclear riskNo other sources of bias were apparent but reporting insufficient to be certain[@CD012234-bbs2-0029]Methods2‐arm RCT\
Setting: a single hospital in Iran\
Follow‐up: 1, 2, 4 and 6 weeks post surgeryParticipants102 participants (mean age: Group I: 50.63 years, Group II: 50.28 years) undergoing open cholecystectomy surgery\
Inclusion criteria: cholecystitis diagnosed by surgeon\
Exclusion criteria: age \> 80 years, diabetes, immunosuppression (acquired or hereditary), history of immunosuppressive therapy, use of antibiotics during referral time for other reasons, history of recurrent cholecystitis, laparoscopic cholecystectomy, limitation for follow up \[sic\]InterventionsGroup I: open cholecystectomy, then before wound closure irrigation with 1 g cefazolin IV \[sic\] antibiotics (51 participants)\
Group II: open cholecystectomy with no antibiotic irrigation before wound closure (51 participants)\
Co‐interventions: same surgery and general anaesthesiaOutcomes**Primary outcome: SSI**\
Signs of infection included erythema, induration, tenderness, warmth, suppurative discharge\
Group I: 6/51\
Group II: 6/51NotesFunding: none reported\
Reported in Persian. Data extraction and \'Risk of bias\' assessment performed by translator***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskComment: they used a random number tableAllocation concealment (selection bias)Unclear riskTranslator did not identify any informationBlinding of participants and personnel (performance bias) All outcomesUnclear riskTranslator did not identify any informationBlinding of outcome assessment (detection bias) All outcomesUnclear riskTranslator did not identify any informationIncomplete outcome data (attrition bias) All outcomesLow riskTranslator judged all randomised participants included in analysisSelective reporting (reporting bias)Unclear riskTranslator did not identify any informationOther biasHigh riskComment: had a potential source of bias related to the specific study design used, they did not have well‐defined outcome, the evaluation of some participants by telephone![@CD012234-bbs2-0030]Methods2‐arm RCT\
Setting: NR; appears to be single hospital in Malaysia\
Follow up at 2, 4 and 6 weeks post‐operatively for wound infection and adverse eventsParticipants190 participants (178 analysed) undergoing CABG surgery. Mean age was 61.6 (7.6) years. Comorbidiities documented were diabetes (44.4%), chronic obstructive pulmonary disease (37.1%), end stage renal failure (18%) and obesity (11.2%)\
Inclusion criteria: scheduled for elective CABG\
Exclusion criteria: emergency cases, those who underwent other surgical procedures in addition to CABG, those allergic to Dermacyn, and those who had infective or other skin lesions over anterior chest wall areaInterventionsGroup I (Dermacyn): Dermacyn wound irrigation (15‐min soak) upon chest closure and after insertion of sternal wires before subcutaneous tissue and skin closure (88 participants analysed)\
Group II (povidone‐iodine): povidone‐iodine would irrigation (15‐min soak) upon chest closure and after insertion of sternal wires before subcutaneous tissue and skin closure (90 participants analysed)\
Cointerventions: IV prophylaxis with 1.2 g Augmentin (amoxicillin and clavulanate) at induction. 2 drains were normally left in the mediastinal cavity.Outcomes**Primary outcome: SSI** (sternotomy wound infection, which was defined according to the Centers for Disease Control and Prevention system. Wound infections were graded as superficial (involving the skin and subcutaneous tissue of the incision), deep (involving fascia, muscle layers, and sternum), or deep organ space.\
Group I (Dermacyn): 5/88 (5 superficial; 0 deep)\
Group II (povidone‐iodine): 14/90 (10 superficial; 4 deep)\
**Secondary outcome: need for reoperation**\
Group I (Dermacyn): 0/88\
Group II (povidone‐iodine): 4/90 (sternal dehiscence requiring surgical debridement and repair)\
**Secondary outcome: mortality**\
12 participants were described as having \"dropped out\"; 4 owing to postoperative mortality and 8 dropped for re‐opening of chest due to bleeding\
Group I (Dermacyn): 7/95\
Group II (povidone iodine): 5/95NotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"patients were consecutively randomized into 2 groups\"\
Comment: no information on how the randomisation sequence was generatedAllocation concealment (selection bias)Unclear riskQuote: \"patients were consecutively randomized into 2 groups\"\
Comment: no information on whether allocation concealment was adequateBlinding of participants and personnel (performance bias) All outcomesUnclear riskComment: no information on whether the participants or personnel were blindedBlinding of outcome assessment (detection bias) All outcomesUnclear riskQuote: \"The sternotomy wounds were inspected on postoperative day 2 and daily until discharge. Patients were then followed up at 2, 4, and 6 weeks postoperatively to assess for the presence of wound infection and Dermacyn side effects.\"\
Comment: no information on whether the inspections and follow‐up were carried out by blinded assessorsIncomplete outcome data (attrition bias) All outcomesHigh riskQuote: \"We recruited 190 patients for this trial, 95 patients in each group. Twelve patients, however, dropped out owing to postoperative mortality (4 cases, 2 deaths due to poor left ventricular function of \< 20% and 2 deaths due to cerebrovascular accident) and chest re‐opened for bleeding (8 cases)\"\
Comment: the number of dropouts (exclusions) was close to the number of primary outcome events. The outcome of mortality can be assessed using the ITT population so is at low risk but the SSI outcome is at high risk.Selective reporting (reporting bias)Unclear riskQuote: \"The primary outcome was the presence of sternotomy wound infection,\"\
Comment: only the primary outcome was prespecified and it is difficult to be certain whether other planned outcomes were fully reported.Other biasUnclear riskComment: no evidence of other bias but reporting insufficient to be certain[@CD012234-bbs2-0031]Methods2‐arm RCT\
Setting: single hospital in USA\
Follow‐up: carried out daily until dischargeParticipants260 randomised participants undergoing enterotomy during abdominal surgery. No further information on participant characteristics.\
Inclusion criteria: enterotomy during abdominal surgery\
Exclusion criteria: NRInterventionsGroup I (kanamycin): lavage prior to closure of the abdominal incision with 100 mL of 1% kanamycin; excess allowed to enter the peritoneal cavity (124 analysed participants; number randomised unclear)\
Group II (saline): lavage prior to closure of the abdominal incision with 100 mL of saline; excess allowed to enter the peritoneal cavity (116 analysed participants; number randomised unclear)\
Cointerventions: concomitant systemic antibiotics in approximately one fifth of woundsOutcomes**Primary outcome: SSI** (not defined)\
Group I (kanamycin): 12/124\
Group II (saline): 23/116\
**Secondary outcomes: mortality, reoperation**\
20 participants were excluded for early postoperative death, reoperation or delayed primary closure. Group allocations and numbers excluded for each reason were not reported\
**Secondary outcome: antibiotic resistance to kanamycin in wound culture**\
Group I (kanamycin): 12/12\
Group II (saline): \"over half\" of 23\
**Secondary outcome: adverse events**\
Respiratory depression was only event reported on:\
Group I (kanamycin): 2/124\
Group II (saline):4/116NotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"The solution, either 1% kanamycin or saline, was administered according to an established randomized schedule\"\
Comment: no information on how the randomisation schedule was generatedAllocation concealment (selection bias)Unclear riskQuote: \"The solution, either 1% kanamycin or saline, was administered according to an established randomized schedule\"\
Comment: no information on whether the allocation was adequately concealedBlinding of participants and personnel (performance bias) All outcomesUnclear riskQuote: \"an established randomized schedule under a double‐blind protocol\"\
Comment: unclear who was blinded to the allocationsBlinding of outcome assessment (detection bias) All outcomesUnclear riskQuote: \"The appearance of the wound was graded daily until discharge by a single observer and any deviation from optimal healing was documented serially with photographs\"\
Comment: unclear whether the single observer was blinded to treatment allocationIncomplete outcome data (attrition bias) All outcomesHigh riskQuote: \"of the 260 patients admitted to the study, 20 were excluded for reasons of early postoperative death, reoperation or delayed primary wound closure\"\
Comment: the number of exclusions was comparable to the numbers of infections in each group; the group allocation of excluded participants was not reported.Selective reporting (reporting bias)High riskComment: outcomes were not defined in the methods section so it is difficult to be sure whether all planned outcomes were fully reported. Some outcomes were not fully reported with data for each treatment group.Other biasUnclear riskComment: no evidence of other sources of bias but reporting insufficient to be certain[@CD012234-bbs2-0032]Methods2‐arm RCT\
Setting: unclear but appears to be a single centre in Germany\
Follow up: NRParticipants197 participants undergoing elective colorectal resection\
Inclusion criteria: NR\
Exclusion criteria: NRInterventionsGroup I: irrigation with polyhexanide 0.04% solution before final wound closure (101 participants)\
Group II: irrigation with Ringer\'s solution before final wound closure (concentration not given) (96 participants)\
Cointerventions: NROutcomes**Primary outcome:** SSI (not defined)\
Group I (polyhexanide): 19/101\
Group II (Ringer\'s solution): 22/96NotesFunding: NR\
Abstract only\
States \"interim analysis was done after 250 patients were screened and is presented here.\"***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote \"This study was conducted as a double blind, randomized, single center study\"\
Comment: no information on how the randomisation sequence was generatedAllocation concealment (selection bias)Unclear riskQuote: \"This study was conducted as a double blind, randomized, single center study\"\
Comment: no information on whether the allocation sequence was adequately concealedBlinding of participants and personnel (performance bias) All outcomesUnclear riskQuote \"This study was conducted as a double blind, randomized, single center study\"\
Comment: although described as double‐blind it is unclear who was blinded and whether the blinding was adequateBlinding of outcome assessment (detection bias) All outcomesUnclear riskQuote \"This study was conducted as a double blind, randomized, single center study\"\
Comment: although described as double‐blind it is unclear who was blinded and whether the blinding was adequateIncomplete outcome data (attrition bias) All outcomesLow riskQuote: \"A total number of 197 elective colorectal resections were randomized. 101 patients received verum. Univariate analysis was followed by multivariate analysis where appropriate. Results: There were 41 wound infections in 197 patients (20.8%). 19 in the verum group, 22 in the control group (p=0.478).\"\
Comment: it appeared that all randomised participants were included in the analysis.Selective reporting (reporting bias)Unclear riskQuote: \"Primary endpoint was the rate of SSI in each group\"\
Comment: there is too little information to be sure if all planned outcomes were assessed and reported.Other biasHigh riskComment: an interim analysis. This is an abstract and there is too little information to determine if there were other additional sources of potential bias.[@CD012234-bbs2-0033]MethodsSetting: 2 tertiary hepatobiliary and pancreatic surgery units in Australia\
Follow‐up: at 1 and 2 weeks following surgery, and thereafter as indicated. Minimum follow‐up 1 month after surgeryParticipants137 consecutive participants enrolled, undergoing major elective open abdominal operative procedures; 128 assigned to treatment (median age 63 years, range 18‐86 years)\
Inclusion criteria: adults undergoing an elective open abdominal operation anticipated to extend beyond 2 h\
Exclusion criteria: those undergoing laparoscopic proceduresInterventionsIn all cases, prior to abdominal closure, the peritoneal cavity was irrigated with least 3 L of warm saline without any added antibiotics. participants then received the following treatment after randomisation:\
Group I (pulse irrigation): surgical irrigation device (Stryker Instruments, Portage, MI) used after fascia closure to irrigate the surgical wound with 2 L of normal saline at room temperature; pressure close to (but not exceeding) 15 psi delivered through cone‐shaped applicator\
Group II (saline): following closure of the fascia in the standard group, 2 L of normal saline at room temperature was poured into the subcutaneous tissue without any agitation\
Excess fluid was removed from the subcutaneous tissue with application of a dry pack. Subcutaneous drainage or closure was not undertaken. The skin was reapproximated with continuous subcuticular 3/0 Monocryl sutures. Skin staples were not used in any case. A Duoderm dressing was applied to the wound.\
Cointerventions: all participants received dexamethasone phosphate 8 mg IV as part of routine antiemetic prophylaxis.\
At induction of anaesthesia all participants received ampicillin 1 g IV, gentamicin IV (2 mg/kg), and metronidazole 500 mg IV. Antibiotics were continued for 24 h postoperatively. In cases of penicillin allergy, vancomycin 1 g IV or cefazolin \[cephazolin\] 1 g IV was administered according to the particular sensitivity reaction.Outcomes**Primary outcome: SSI**\
Wound infection defined as: (1) purulent drainage, with or without laboratory confirmation, from the superficial incision; (2) organisms isolated from an aseptically obtained culture of fluid or tissue from the superficial incision; (3) at least one of the following signs or symptoms of infection: pain or tenderness, localised swelling, redness, or heat and superficial incision is deliberately opened by surgeon, unless the incision was culture‐negative; (4) diagnosis of superficial incisional SSI by the surgeon or the attending physician\
Group I (pulse irrigation): 4/66 (all superficial)\
Group II (saline): 12/62 (2 required major debridement with prolonged course of dressings; one had partial abdominal wall dehiscence)\
**Primary outcome: wound dehiscence within 30 d of operation**\
Group I (pulse irrigation): 0/4\
Group II (saline): 1/12\
**Secondary outcome: participants with postoperative SSI using systemic antibiotics within 30 d of surgery**\
14/16 participants; no data regarding which treatment group these were associated with\
**Secondary outcome: antibiotic‐resistant infections**\
Details of organisms isolated but not of resistance were reported, this was not group data\
**Secondary outcome: adverse events**\
Cellulitis (without wound cultures): 1/16; no data regarding which treatment group this was associated with\
Any non‐wound‐related complication\
Group I (pulse irrigation): 32/66\
Group II (saline): 23/62\
**Secondary outcome: surgical reintervention**\
Relaparotomy\
Group I (pulse irrigation): 3/66\
Group II (saline): 3/62\
Debridement of wounds with SSI\
Group I (pulse irrigation): 0/4\
Group II (saline): 2/12\
**Secondary outcome: length of stay**\
Group I (pulse irrigation): median 9 (range 4‐71) d\
Group II (saline): median 9 (range 5‐45) d\
**Secondary outcome: hospital readmissions**\
Group I (pulse irrigation): 9/66\
Group II (saline): 6/62NotesFunding: supported by a University of Melbourne, Early Career Development Grant, awarded to lead author. No supplementary support was provided by Stryker***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"Grouping allocation was determined by a sealed envelope selection. Blocks of 20 patients were randomized at one time. Diabetic patients were randomized separately to achieve close to even distribution in each group.\"\
Comment: no information on how randomisation schedule was generated.Allocation concealment (selection bias)Unclear riskQuote: \"Grouping allocation was determined by a sealed envelope selection.\"\
Comment: unclear whether opaque envelopes were usedBlinding of participants and personnel (performance bias) All outcomesHigh riskNo direct quote; no information on blinding\
Comment: it is unclear whether participants and personnel were blinded; personnel unlikely to be blinded after randomisation due to difference in intervention procedures between armsBlinding of outcome assessment (detection bias) All outcomesUnclear riskQuote: \"Patients were monitored by a dedicated acute pain service and reviewed daily for any complications arising from their analgesic regime.\"\
Comment: unclear whether personnel were blind to treatment allocationIncomplete outcome data (attrition bias) All outcomesLow riskQuote: \"A total of 137 patients were enrolled, as 8 cases did not reach the 2 h duration required for randomization.\"\
Comment: study flow diagram indicates that 9 were excluded because they did not conform to inclusion criterion of needing to be \> 2 h in duration; there is a discrepancy in the report text stating 8 were excluded for this reason. Attrition bias judged to be low risk given that all others conforming to inclusion criteria were analysedSelective reporting (reporting bias)Unclear riskComment: unclear whether all prescribed outcomes were reportedOther biasUnclear riskComment: no evidence of other sources of bias but reporting insufficient to be certain[@CD012234-bbs2-0034]Methods2‐arm RCT\
Setting: single hospital in Switzerland\
Follow‐up: NRParticipants540 randomised participants undergoing surgery\
Inclusion criteria: participants undergoing surgery\
Exclusion criteria: oto‐rhino‐laryngeal surgical cases; thyroid surgeries; day‐case surgeriesInterventionsGroup I (saline): irrigation with saline. 2 rinses were performed; the first of the operative site, and the second performed before skin closure (273 participants ‐ information derived from graph)\
Group II (povidone‐iodine): irrigation with Betadine‐R solution (10% PVP‐iodine with 1% available iodine, diluted in a 1/10 solution). 2 rinses were performed; the first of the operative site, and the second performed before skin closure. (267 participants ‐ information derived from graph)\
Cointerventions: after 1 min the excess liquid was re‐aspirated. In all participants skin disinfection was carried out using a standard Betadine‐R solution.Outcomes**Primary outcome: SSI** (not defined)\
Group I (saline): 15/273\
Group II (Betadine): 16/267NotesPaper in French; data extracted by one review author, checked by a fluent speaker\
SSI data presented graphically across 2 figures; these data extracted using graph‐reader software\
Funding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote \"A prospective randomized study was undertaken\...\...a draw of two groups on the basis of a pre‐established list, was carried out at entrance to theatre\"\
Comment: not clear how the randomisation sequence was establishedAllocation concealment (selection bias)Unclear riskQuote \"A prospective randomized study was undertaken\...\...a draw of two groups on the basis of a pre‐established list, was carried out at entrance to theatre\"\
Comment: not clear whether allocation sequence was adequately concealedBlinding of participants and personnel (performance bias) All outcomesUnclear riskQuote \" all information about the participant, the type of interventions, the personnel, the bacteriological findings and the antibiotic therapies was stored on a computer\"\
Comment: no information as to whether personnel were blinded to interventionsBlinding of outcome assessment (detection bias) All outcomesUnclear riskNo direct quote but no information as to who determined the presence of SSI or whether they were blinded to treatment allocationIncomplete outcome data (attrition bias) All outcomesUnclear riskNo direct quote: no attrition is reported but results are presented only graphically and it is difficult to determine whether all randomised participants were represented in the results.Selective reporting (reporting bias)High riskNo direct quote: results are not adequately reported for each group and it is very unclear if all outcome data are fully reported.Other biasUnclear riskNo other source of bias was apparent but the reporting was insufficient to be certain.[@CD012234-bbs2-0035]MethodsParallel‐group RCT\
Setting: single hospital in Denmark\
Follow‐up: mean 8 d (5‐16 d)Participants33 participants undergoing surgery for perforated appendix\
Inclusion criteria: all patients admitted for surgery for perforated appendix with diffuse peritonitis. Visible perforation of appendix with free pus in peritoneum, verified by microbiological culture of extracted peritoneal material. Normal function of kidneys in serum‐creatinin concentration demanded.\
Exclusion criteria: pregnant women, \< 15 and \> 75 years, with malignant disorders and known allergy to penicillinInterventionsGroup I: no irrigation\
Group II: postoperative peritoneal flushing with 1 g ampicillin per L flushing fluid\
Group III: postoperative peritoneal flushing without ampicillin in the flushing fluid\
Cointerventions: all participants had systemic antibiotics: ampicillin 2 g 4/d IV, gentamycin 1.5 mg/kg weight as the first dose -- then 1 mg/kg weight 3/d IM, and clindamycin 600 mg 3/d IMOutcomes**Primary outcome: SSI**\
Group I (no irrigation): 4/10\
Group II (ampicillin irrigation): 3/10 Group III (saline irrigation): 2/10\
**Secondary outcome: adverse events (intra‐abdominal abscess)**\
Group I (no irrigation): 1/10\
Group II (ampicillin irrigation): 010 Group III (saline irrigation): 0/10\
**Secondary outcome: length of stay**\
Group I (no irrigation): 14 d (8‐22)\
Group II (ampicillin irrigation): 13 d (9‐20) Group III (saline irrigation): 13 d (10‐22)NotesFunding: NR\
Data extraction and \'Risk of bias\' assessment performed by translator from the Danish; some aspects discussed with a review author***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskComment: described by one Danish word; the envelope systemAllocation concealment (selection bias)Unclear riskComment: described by one Danish word; the envelope systemBlinding of participants and personnel (performance bias) All outcomesHigh riskComment: Groups II and III had additional catheter added for flushing fluids. Group II also had ampicillin added to the flushing fluid. Personnel would therefore be aware of allocation, unclear if participants were also awareBlinding of outcome assessment (detection bias) All outcomesUnclear riskComment: no description of whether assessors were the same as the personnelIncomplete outcome data (attrition bias) All outcomesLow riskComment: all 30 participants were included in analysisSelective reporting (reporting bias)Low riskComment: all outcomes mentioned in the methods section were reported. In the discussion they reported that no kidney or liver dysfunction was observedOther biasUnclear riskComment: none identified[@CD012234-bbs2-0036]MethodsThree‐arm RCT\
Setting: single hospital in Spain\
Follow‐up: unclearParticipants51 women undergoing axillary lymph node dissection for breast neoplasm. Mean age 55.6 years\
Inclusion criteria: diagnosis of breast neoplasm and plans to undergo an elective axillary lymph node dissection of Berg's levels I and II because of axillary metastases determined pre‐operatively by core biopsy or evidence of metastasis in the sentinel lymph node biopsy (SLNB) in the intra‐operative or differential analysis\
Exclusion criteria: allergy to any of the antibiotic drugs to be used, chronic renal failure secondary to possible toxicity of gentamicin, and planned modified radical mastectomyInterventionsGroup I: 2 lavages with 500 mL of physiologic saline (17 participants)\
Group II: lavage with 500 mL of saline followed by lavage with 500 mL of a 240‐mg gentamicin solution (17 participants)\
Group III: lavage with 500 mL of saline followed by lavage with 500 mL of a 600‐mg clindamycin solution (17 participants)\
Cointerventions: pre‐operative systemic antibiotics (amoxicillin‐clavulanic acid 2 g IV; a single dose within 30 min of incision) were employed in all groups. Once the dissection was finished, a Redon drain was placed and connected to a low‐pressure vacuum device (primary closure was undertaken)Outcomes**Primary outcome: SSI** (incisional, not further defined)\
Group I (2 x saline lavages) 0/17\
Group II (saline then 240 mg gentamicin lavages) 0/17\
Group III (saline then 600 mg clindamycin lavages) 0/17\
**Secondary outcome: mortality**\
Group I (2 x saline lavages) 0/17\
Group II (saline then 240 mg gentamicin lavages) 0/17\
Group III (saline then 600 mg clindamycin lavages) 0/17\
**Secondary outcome: length of hospital stay**\
Group I (2 x saline lavages) median 3 d (range 1‐3)\
Group II (saline then 240 mg gentamicin lavages) median 3 d (range 1‐3)\
Group III (saline then 600 mg clindamycin lavages) median 3 d (range 1‐3)NotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote \"The patients were randomized by means of an Internet module into three groups\"\
Comment: mechanism of the internet module used for randomisation unclearAllocation concealment (selection bias)Unclear riskQuote \"The patients were randomized by means of an Internet module into three groups\"\
Comment: no information as to whether the allocation was adequately concealedBlinding of participants and personnel (performance bias) All outcomesUnclear riskQuote: \"The patients were blinded as to whether they received saline, gentamicin, or clindamycin.\"\
Comment: participants were blinded but unclear whether personnel were also blindedBlinding of outcome assessment (detection bias) All outcomesUnclear riskComment: there is insufficient information to determine who performed the assessment of outcomes and whether they were blinded to treatment allocation.Incomplete outcome data (attrition bias) All outcomesLow riskComment: it appears that all the randomised participants were included in the analyses.Selective reporting (reporting bias)Unclear riskComment: the outcomes reported were not prespecified in the methods so it is difficult to determine whether all planned outcomes were fully reported.Other biasUnclear riskComment: there is no evidence of other sources of bias but reporting is insufficiently detailed to be sure.[@CD012234-bbs2-0037]Methods2‐arm RCT\
Setting: NR but appears to be a hospital in Turkey\
Follow‐up: NRParticipants14 participants with perforated appendix (among 279 undergoing appendectomy for acute appendicitis)\
Inclusion criteria: perforated appendix, undergoing appendectomy for acute appendicitis\
Exclusion criteria: appendix not perforatedInterventionsGroup I: peritoneal lavage with irrigation and aspiration (7 participants)\
Group II: aspiration alone (7 participants)\
Co‐interventions: NROutcomes**Primary outcome: SSI**\
Wound infection\
Group I (lavage): 2/7\
Group II (aspiration only): 0/7\
**Secondary outcome: adverse events**\
(1 intra‐abdominal abscess, 1 postoperative ileus)\
Group I (lavage): 1/7\
Group II (aspiration only): 1/7NotesAbstract only but further information received via study author correspondence\
Funding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote (via correspondence): \"The randomisation method is envelope method\"\
Comment: unclear how the randomisation sequence was generatedAllocation concealment (selection bias)Unclear riskComment: insufficient information on use of envelopes to be sure whether allocation was adequately concealedBlinding of participants and personnel (performance bias) All outcomesHigh riskComment: no information on whether participants or personnel were blinded but personnel must have been aware due to differences in interventionBlinding of outcome assessment (detection bias) All outcomesUnclear riskComment: no information on who performed the assessment or whether they were blinded to treatment allocationIncomplete outcome data (attrition bias) All outcomesLow riskIt appears that all randomised participants were included in the analysis.Selective reporting (reporting bias)Unclear riskIt is unclear whether all planned outcomes were fully reported; we contacted the study author in order to fully report SSI outcome on a per‐group basis.Other biasUnclear riskAbstract only and reporting insufficient to be certain there were no other sources of bias.[@CD012234-bbs2-0038]MethodsParallel‐group RCT\
Setting: single medical centre in USA\
Follow‐up: at least 2 weeks postoperativelyParticipants207 women undergoing caesarean section\
Inclusion criteria: non elective caesarean section\
Exclusion criteria: allergic to penicillin or cephalosporins, already on antibiotics, ongoing infection, requiring bacterial endocarditis prophylaxisInterventionsGroup I: cefazolin lavage; 2 g in 1000 mL saline administered to the uterine incision (300 mL), bladder flap (200 mL), abdominal gutters (200 mL) and abdominal incision (remaining fluid)\
Group II: cefamandole lavage; 2 g in 1000 mL saline administered to the uterine incision (300 mL), bladder flap (200 mL), abdominal gutters (200 mL) and abdominal incision (remaining fluid)\
2 additional groups were included in the trial using the same antibiotics delivered IV with saline lavage. These groups are not relevant to this review and we did not extract any data relating to them.\
Cointerventions: normal saline bolus IV after cord clampedOutcomes**Primary outcome: SSI (presence of cellulitis and/or purulent exudate)**\
Group I (cefazolin): 2/59\
Group II (cefamandole) 0/54NotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"Patients were randomly assigned to one of four treatments\"\
Comment: no information on how the randomisation sequence was generated or whether an appropriate method was used.Allocation concealment (selection bias)Unclear riskQuote: \"Patients were randomly assigned to one of four treatments\"\
Comment: no information on whether there was adequate allocation concealment.Blinding of participants and personnel (performance bias) All outcomesLow riskQuote: \"The operating‐room nurses prepared the 1000 mL lavage solutions, to which all surgeons and patients were blinded\"\
Comment: participants and personnel were blinded to treatment allocation.Blinding of outcome assessment (detection bias) All outcomesUnclear riskComment: no specific quote but it was not clear who performed the outcome assessment and whether they were blinded to treatment allocation.Incomplete outcome data (attrition bias) All outcomesLow riskComment: all 207 randomised participants were included in the analyses.Selective reporting (reporting bias)Unclear riskComment: outcomes were not clearly specified in the methods so it is unclear whether all planned outcomes were fully reported.Other biasUnclear riskComment: no obvious sources of additional bias but reporting insufficient to be certain[@CD012234-bbs2-0039]MethodsWithin‐subject design ‐ all participants received both treatment and control\
Setting: single hospital in UK\
Follow‐up: 1, 4 and 8 weeksParticipants30 women undergoing bilateral breast reduction. Participants had breasts randomised to the 2 treatment groups. Mean age 33 years (range 18‐65), mean BMI 26.3\
Inclusion criteria: BMI ≤ 30, undergoing bilateral breast reduction\
Exclusion criteria: NRInterventionsGroup I (saline): breast washed out with saline for approximately 2 min just prior to wound closure (30 participants, 30 breasts)\
Group II (control): no wash out with saline (same 30 participants as Group I, 30 breasts)\
Co‐interventions: each breast was preinfiltrated with 300 mL saline containing adrenaline diluted to 1:500,000, lignocaine and hyaluonidase. Infiltration was performed uniformly through the breast using a spinal needle and syringe, sparing the pedicle. All wounds were closed over corrugated drains which were removed 24 hs after surgery.Outcomes**Primary outcome: SSI**\
Wound discharge, invasive infection\
Group I (saline): 0/30\
Group II (control): 0/30\
**Primary outcome: wound dehiscence**\
Minor wound breakdown in 13/60 breasts (7 \< 1 cm wide, 6 \> 1 cm)\
11/60 participants affected, 9 unilaterally, 2 bilaterally\
Group I (saline): 7/30\
Group II (control): 6/30NotesGeneralisability: outcomes were related to BMI and this group were preselected based on BMI\
Some methodological details were provided via study author correspondence\
Funding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote (from text): \"The side to be washed out with normal saline was randomised so that the contralateral breast acted as each patient\'s own control\"\
Quote (from author correspondence): \"I think we used sealed envelopes\"\
Comment: not enough detail about the method to judge whether appropriate method of sequence generation was used.Allocation concealment (selection bias)Unclear riskQuote (from author correspondence): \"I think we used sealed envelopes\"\
Comment: not enough detail about the method to judge whether there was adequate allocation concealment.Blinding of participants and personnel (performance bias) All outcomesHigh riskComment: there is no mention of blinding. The participants may have been blinded but the personnel would be aware of the different treatments.Blinding of outcome assessment (detection bias) All outcomesUnclear riskQuote (from author correspondence): \"Assessors were blind to the side washed out but could include the surgeons.\"\
Comment: although some assessors were blind to treatment, they could also have included the surgeons who were not blinded.Incomplete outcome data (attrition bias) All outcomesLow riskQuote (from author correspondence): \"All people enrolled were included in the study.\"\
Comment: all participants accounted for in the resultsSelective reporting (reporting bias)Unclear riskComment: there is insufficient information to judge whether all planned outcomes were appropriately assessed.Other biasUnclear riskComment: the study design means that the 2 groups are not independent. It\'s not clear whether the analysis was adjusted for paired data.[@CD012234-bbs2-0040]Methods2‐arm RCT\
Setting: single hospital in USA\
Follow‐up: NRParticipants94 patients undergoing surgery for peritonitis. Mean age Group I: 40.1 years, Group II: 40.3 years\
Inclusion criteria: participants deemed by surgeon, at time of operation, that irrigation would be helpful for mechanical cleansing of peritoneal cavity or for direct application of an antibiotic to a grossly contaminated peritoneum.\
Exclusion criteria: NRInterventionsGroup I (cephalothin): irrigation with solution containing 4 g/L cephatholin (43 participants irrigated with 4 L of solution, 1 participant irrigated with 2 L of solution)\
Group II (saline and multivitamin): irrigation with 0.9% saline solution containing 0.25 mL/L of IV multivitamin solution (Betalin, Eli Lilly, Indiana) (48 participants irrigated with 4 L of solution, 2 participants irrigated with 2 L of solution)\
Cointerventions: use of concomitant antibiotics (cephaolthin; cephalothin plus other antibiotic; penicillin and streptomycin; miscellaneous) was at surgeon\'s discretionOutcomes**Primary outcome: SSI** (no definition provided)\
Group I (cephalothin): 11/44\
Group II (saline and multivitamin): 13/50\
**Secondary outcome: mortality**\
Group I (cephalothin): 5/44\
Group II (saline and multivitamin): 8/50\
**Secondary outcome: antibiotic‐resistant infections**\
Group I (cephalothin): 7 organisms reported to be resistant; 28 to be sensitive\
Group II (saline and multivitamin): 12 organisms reported to be resistant; 49 to be sensitive\
It was not clear how this related to participant‐level data; individual organism types were reported\
**Secondary outcome: adverse events**\
Abscess/peritonitis:\
Group I (cephalothin): 8/44\
Group II (saline and multivitamin): 10/50NotesParticipants: \"Two patients had irrigation of the peritoneal cavity on two separate occasions, each of which was counted as a distinct clinical entity unto itself\"\
Funding: NR\
Time points for all assessments unknown***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"Patients were assigned by the pharmacy to the cephalothin or to the control group by use of a table of random numbers.\"\
Comment: sequence generation used an appropriate method.Allocation concealment (selection bias)Unclear riskQuotes: \"Patients were assigned by the pharmacy to the cephalothin or to the control group by use of a table of random numbers;\" \"The study was double blind, and the charts were fully evaluated prior to breaking the code, which was kept by the pharmacy;\"\
Comment: participants allocated to treatment group by pharmacy who held the randomisation schedule, but unknown whether pharmacy staff were blinded to the allocation sequenceBlinding of participants and personnel (performance bias) All outcomesLow riskQuotes: \"The study was double blind, and the charts were fully evaluated prior to breaking the code, which was kept by the pharmacy.\"\
Comment: appears that treating staff and participants were unaware of treatment allocation until after data collectionBlinding of outcome assessment (detection bias) All outcomesLow riskQuote: \"The study was double blind, and the charts were fully evaluated prior to breaking the code, which was kept by the pharmacy.\"\
Comment: appears that staff were unaware of the allocation until after data collectionIncomplete outcome data (attrition bias) All outcomesLow riskComment: no evidence of attrition, as data reported for all randomised patientsSelective reporting (reporting bias)Unclear riskComment: all outcomes specified in study methods are reported in the results, but not enough information to determine whether all outcomes in the study protocol are reportedOther biasHigh riskQuote: \"Patients were admitted to the study if their surgeon, at the time of operation, believed that irrigation would be helpful for mechanical cleansing of the peritoneal cavity or for direct application of an antibiotic to a grossly contaminated peritoneum.\"\
Comment: potential bias relating to participant selection, based on subjective rather than objective criteria.[@CD012234-bbs2-0041]Methods2‐arm RCT\
Setting: single hospital in Spain\
Follow‐up: NRParticipants128 participants\
Inclusion criteria: colorectal surgery for neoplasms\
Exclusion criteria: NRInterventionsGroup I: intraperitoneal irrigation with normal saline (64 participants)\
Group II: intraperitoneal irrigation with solution containing gentamicin (240 mg) and clindamycin \[clindamicin\] (600 mg) (64 participants)Outcomes**Primary outcome: SSI** (not defined)\
Wound infection (unsure of calculation to numbers as whole numbers/64 do not round to these %)\
Group I (saline): 41.9%; 27/64 (extrapolated from percentage and rounded to nearest whole number)\
Group II (antibiotic): 9.5%; 6/64 (extrapolated from percentage and rounded to nearest whole number)\
Intra‐abdominal infection (excluding 5% cases diagnosed with anastomotic leak) (intra‐abdominal abscess?)\
Group I (saline): 16.3%; 10/64 (extrapolated from percentage and rounded to nearest whole number)\
Group II (antibiotic): 0%; 0/64NotesAbstract only\
Funding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote \"A prospective randomized study of all the patients undergoing colorectal surgery for neoplasms at Hospital General Universitario de Elche during 2010 was performed. Patients were divided in 2 groups\...\"\
Comment: not clear how the randomisation sequence was generatedAllocation concealment (selection bias)Unclear riskQuote \"A prospective randomized study of all the patients undergoing colorectal surgery for neoplasms at Hospital General Universitario de Elche during 2010 was performed. Patients were divided in 2 groups\...\"\
Comment: not clear whether allocation was adequately concealedBlinding of participants and personnel (performance bias) All outcomesUnclear riskComment: no direct quote but no information on blinding of either participants or personnelBlinding of outcome assessment (detection bias) All outcomesUnclear riskComment: no direct quote but no information on how the outcomes were assessed or whether the assessors were blinded to treatment allocationIncomplete outcome data (attrition bias) All outcomesUnclear riskQuote: \"128 patients were analyzed, 64 in each group.\"\
Comment: the number of participants randomised is not stated, only the number analysedSelective reporting (reporting bias)Unclear riskQuote: \"Wound infection and intrabdominal abscess were investigated.\"\
Comment: both these outcomes were reported but it is not clear whether they were the only planned outcomesOther biasUnclear riskComment: no evidence of other bias but reporting insufficient to be confident (abstract only)[@CD012234-bbs2-0042]Methods2‐arm RCT\
Setting: single hospital in Spain\
Follow‐up: 30 d after dischargeParticipants108 participants with adenocarcinoma (5 excluded postoperatively due to anastomotic leak). Mean (SD) age 69.9 (11.3) years. Comorbidities: diabetes mellitus (34%), high blood pressure (48%), dyslipedaemia (32%), cardiopathies (21%), chronic obstructive pulmonary diseases (11%), nondecompensated liver cirrhosis (1%).\
Inclusion criteria: diagnosis of colorectal neoplasms and due to undergo elective operation with curative aims\
Exclusion criteria (preoperative): diagnosis of chronic renal failure\
Exclusion criteria (postoperative): anastomotic leak identified by computed tomography (CT) scan with rectal contrast enemaInterventionsGroup I (saline): irrigation of entire abdominal cavity with 500 mL normal saline, followed by aspiration of the liquid and abdominal wall closure (54 participants)\
Group II (antibiotics): irrigation with 500 mL normal saline, aspiration, then lavage with antibiotic solution (gentamicin 240 g and clindamycin 600 mg dissolved in 500 mL normal saline) for 3 min, aspiration and abdominal wall closure (54 participants)\
Co‐interventions: perioperative antibiotics given to all (ciprofloxacin 400 mg and metronidazol 1500 mg, single dose within 30 min of incision with redose after 4 h if surgery prolonged)Outcomes**Primary outcome: SSI**\
Wound infection defined as presence of purulent discharge from the surgical wound, confirmed with microbiologic culture\
Group I (saline): 14% (calculated as**7/51** analysed participants)\
Group II (antibiotic): 4% (calculated as **2/52** analysed participants)\
**Secondary outcome: mortality**\
Group I (saline): 2 (unclear whether this is out of 51 analysed or 54 randomised participants) \[we will assume completed case here\]\
Group II (antibiotic): 1 (unclear whether this is out of 52 analysed or 54 randomised participants)\
**Secondary outcome: intra‐abdominal abscess**\
Defined as the presence of a fluid collection at CT scan in symptomatic participant (fever, abdominal pain, prolonged postoperative ileus or septic status)\
Group I (saline): 6% (calculated as **3/51** analysed participants)\
Group II (antibiotic): 0 (presumably **0/52** analysed participants)\
**Secondary outcome: length of hospital stay (median (range) d)**\
Group I (saline): 6 (5‐32)\
Group II (antibiotic): 6.5 (5‐14)NotesFunding: financial support provided by Fundacion Navarro Tripodi***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"The patients were randomized by means of an Internet randomization module\"\
Comment: **a**ppropriate method of sequence generation appears to have been usedAllocation concealment (selection bias)Unclear riskComment: no mention of allocation concealmentBlinding of participants and personnel (performance bias) All outcomesHigh riskComment: there is no mention of blinding participants or personnel but differences in treatment mean personnel would not have been blindedBlinding of outcome assessment (detection bias) All outcomesLow riskQuote: \"Wound infection was determined by an epidemiology nurse blinded to treatment groups\" \"The diagnosis of intra‐abdominal abscess was determined by a radiologist blinded to the treatment groups\"\
Comment: outcome assessors were blindedIncomplete outcome data (attrition bias) All outcomesHigh riskQuote: \"Exclusion criteria were\... or an anastomotic leak in the postoperative course, which would represent a bias in the diagnosis of intra‐abdominal infection\"\
Comment: 5 participants were excluded from the analysis as they were considered to be at high risk of infection and represent a bias ‐ however it is not clear what bias they would introduce as their results are not reported.Selective reporting (reporting bias)Unclear riskComment: outcomes are not clearly reported as they are presented as percentages and do not clarify participant numbers.Other biasLow riskComment: there is no evidence of other bias.[@CD012234-bbs2-0043]Methods2‐arm RCT\
Setting: single breast unit at hospital in Spain\
Follow‐up: 2 weeks after surgeryParticipants40 female participants (mean age 54.8 (SD 13.7) years) undergoing axillary lymph node dissection\
Inclusion criteria: diagnosis of breast neoplasms and plans to undergo elective axillary lymph node dissection (ALND) of Berg's levels I and II due to axillary metastasis determined preoperatively by core biopsy or evidence of metastasis in the sentinel lymph node biopsy (SLNB) in the intraoperative or in the differed analysis.\
Exclusion criteria: chronic renal failure due to possible toxicity of gentamicin and participants undergoing a modified radical mastectomy.InterventionsGroup I (saline): lavage performed immediately prior to closure, after placement of drain and a first swab for microbiological culture. First lavage with 500 mL normal saline, which was aspirated and a second swab for culture obtained. Second lavage with 500 mL normal saline, which was aspirated prior to third swab for culture\
Group II (gentamicin): lavage performed immediately prior to closure, after placement of drain and a first swab for microbiological culture. First lavage with 500 mL normal saline, which was aspirated and a second swab for culture obtained. Second lavage with 240 mg gentamicin dissolved in 500 mL normal saline, which was aspirated prior to third swab for culture.\
Cointerventions: perioperative systemic antibiotics (single dose amoxicillin/clavulanic acid 2 g IV, within 30 min of incision) were administered in both groups. Redon drain was left in place and connected to a low pressure vacuum device, and removed when drainage volume was \< 30 mL/dOutcomes**Primary outcome: SSI** (\"wound infection\" ‐ not defined)\
Group I (saline): 0/20\
Group II (gentamicin): 0/20\
**Secondary outcome: length of hospital stay (median (range) d)**\
Group I: 3 (1‐3)\
Group II: 3 (1‐3)\
**Secondary outcome: mortality**\
Group I (saline): 0/20\
Group II (gentamicin): 0/20\
**Secondary outcome: adverse events (all types)**\
Group I (saline): 0/20\
Group II (gentamicin): 0/20NotesFunding: Fundación Navarro Tripodi***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"Patients were randomized by means of an Internet randomization module into 2 groups.\"\
Comment: sequence generation used an appropriate methodAllocation concealment (selection bias)Unclear riskQuote: \"Patients were randomized by means of an Internet randomization module into 2 groups.\"\
Comment: unclear whether randomisation schedule was concealed from staffBlinding of participants and personnel (performance bias) All outcomesUnclear riskQuote: \"Patients were blinded as to whether they received gentamicin or not.\"\
Comment: unclear whether staff were blinded to treatment allocationBlinding of outcome assessment (detection bias) All outcomesUnclear riskComment: no direct quote; no information on who performed outcome assessment or whether they were blinded to treatment allocationIncomplete outcome data (attrition bias) All outcomesLow riskComment: no evidence of attrition biasSelective reporting (reporting bias)Unclear riskComment: no evidence of selective reporting but not enough information to be certainOther biasUnclear riskComment: no evidence of other sources of bias, but reporting is not sufficient to be certain[@CD012234-bbs2-0044]Methods2‐arm RCT\
Setting: several hospitals in Spain and 1 hospital in UK (\"at our institutions\" ‐ not stated how many ‐ it isn\'t clear from authorship)\
Follow‐up: minimum 42 months post surgery (infection surveillance was for 30 d following discharge)Participants106 participants undergoing elective surgery for colon neoplasms (data only presented for 104 as 2 who died perioperatively were excluded). Mean (SD) age: Group I 69.1 (10.2) years, Group II 68.5 (10.2) years. Co‐morbidities included diabetes mellitus (Group I 33%, Group II 29%), high blood pressure (Group I 46%, Group II 50%), dyslipidemia (Group I 33%, Group II 29%), cardiopathy (Group I 23%, Group II 27%). Groups were balanced in terms of tumour stage and surgical technique used.\
Inclusion criteria: diagnosis of colon neoplasms, undergoing elective surgery with curative aims\
Exclusion criteria: pre‐operative diagnosis of renal failure, allergy to gentamicin or clindamycin, diagnosis of rectal cancerInterventionsGroup I: immediately prior to closure of the abdominal wall, lavage was performed with an antibiotic solution (gentamicin 240 mg and clindamycin 600 mg dissolved in 500 mL normal saline). The solution was allowed to sit in the abdominal cavity for 3 min, then aspirated (53 participants)\
Group II: as above but with 500 mL normal saline (53 participants)\
Co‐interventions: perioperative systemic antibiotics (ciproflaxin 400 mg and metronidazole 1500 mg, single dose given within 30 min of incision, additional dose after 4 h if surgery prolonged)Outcomes**Primary outcome: SSI**\
Incisional SSI (defined as the presence of a purulent discharge from the surgical incision and confirmed with microbiological culture)\
Group I (antibiotic): 3.8% (calculated as 2/52)\
Group II (saline): 13.5% (calculated as 7/52)\
Organ‐space SSI\
Group I (antibiotic): 0% (0/52)\
Group II (saline): 5.8% (calculated as 3/52)\
**Secondary outcome: length of hospital stay (median (range) d)**\
Group I (antibiotic): 6.5 (5‐14)\
Group II (saline): 6 (5‐32)\
**Secondary outcome: adverse events**\
Anastomotic leak\
Group I (antibiotic): 2/52\
Group II (saline): 3/52\
**Secondary outcome: mortality**\
1 participant from each group died perioperatively and was excluded from the analysis. Survival analysis is reported for remaining participants as the primary outcome of the study was disease‐free survival, but 30‐day survival is not reported.\
30‐day mortality\
Group I (antibiotic): 1/53\
Group II (saline): 1/53NotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"Patients were randomly assigned using a random number table\"\
Comment: appropriate method usedAllocation concealment (selection bias)Unclear riskComment: no mention of allocation concealmentBlinding of participants and personnel (performance bias) All outcomesUnclear riskComment: There is no mention of blinding of participants and personnel. It is unlikely that personnel were blinded but possibleBlinding of outcome assessment (detection bias) All outcomesLow riskQuote: \"Incisional SSI was determined by an epidemiology nurse blinded to the treatment groups\"\
Comment: outcome assessor was blinded (for SSI)Incomplete outcome data (attrition bias) All outcomesUnclear riskComment: 1 participant in each group died perioperatively and was excluded from analysis. This is unlikely to have biased results but no details about these participants are included so it is difficult to judge.Selective reporting (reporting bias)Low riskComment: there does not appear to have been selective outcome reporting and the primary outcomes of the study are reported in detailOther biasLow riskComment: there is no evidence of other bias[@CD012234-bbs2-0045]MethodsParallel‐group RCT\
Setting: single hospital in Spain\
Follow‐up: 30 d after dischargeParticipants80 participants undergoing laparoscopic sleeve gastrectomy (LSG) as a bariatric procedure. Mean age 43.1 years; mean BMI 47.8 kg/m^2^\
Inclusion criteria: BMI either \> 40 kg/m2 or \> 35 kg/m2 with comorbidities associated with obesity and undergoing laparoscopic sleeve gastrectomy (LSG) as a bariatric procedure.\
Exclusion criteria (preoperative): documented gastroesophageal reflux (these underwent laparoscopic Roux‐en‐Y gastric bypass), uncontrolled psychiatric disorders, active infection or malignant disease, and any other concomitant pathology considered to be a contraindication to bariatric surgery diagnosis of chronic renal failure. Post‐operative complications were also excluded from the analysis.InterventionsGroup I: intra‐abdominal lavage with 500 mL saline (40 participants)\
Group II: intra‐abdominal lavage with a gentamicin--clindamycin solution: gentamicin (240 mg) and clindamycin (600 mg) dissolved in 500 mL (40 participants)\
Cointerventions: Peri‐operative systemic antibiotics (cefuroxime 3 g; single dose pre‐operatively within 30 min of incision, repeated after 4 h when the surgery exceeded that time)Outcomes**Secondary outcome: mortality**\
Group I (saline): 1/40\
Group II (clindamycin‐gentamicin): 0/40\
**Secondary outcome: adverse events ‐ complications of surgery**\
Group I (saline): 2/40\
Group II (clindamycin‐gentamicin): 1/40NotesDeclaration of no competing financial interests, funding otherwise NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"The patients were randomized by means of an Internet randomization module into two groups\"\
Comment: appropriate means of randomisation sequence generation reportedAllocation concealment (selection bias)Unclear riskQuote: \"The patients were randomized by means of an Internet randomization module into two groups\"\
Comment: unclear if appropriate measures were taken to conceal allocationBlinding of participants and personnel (performance bias) All outcomesUnclear riskComment: there was no information on whether personnel and participants were blinded to group allocationBlinding of outcome assessment (detection bias) All outcomesLow riskQuote: \"Incisional SSI was determined by an epidemiology nurse blinded to the treatment groups. Infection surveillance was extended for 30 d after discharge. The diagnosis of organ‐space SSI and leak was determined by a radiologist blinded to the treatment group.\"\
Comment: outcome assessment was performed in a blinded mannerIncomplete outcome data (attrition bias) All outcomesLow riskExclusions due to postoperative complications (3 participants) from some analyses were fully reported and accounted for; all participants could be included in analysis of SSISelective reporting (reporting bias)Low riskOutcomes were clearly predefined and appeared to be fully reportedOther biasLow riskNo evidence of other sources of bias and reporting sufficient to suggest there were none[@CD012234-bbs2-0046]Methods3‐arm RCT\
Setting: 1 surgical unit in South Africa\
Follow‐up: at least 2 weeks after operationParticipants87 participants undergoing surgery for peritonitis (mean age 53 years, range 18‐91 years)\
Inclusion criteria: confirmed diffuse or localised intra‐abdominal infection\
Exclusion criteria: those with nonruptured, localised abscesses and those participants undergoing appendectomy through right iliac fossa incisions; those with diffuse fecal peritonitis, infected pancreatic necrosis, or postoperative peritonitisInterventionsGroup I (control): all peritoneal contamination was sucked out or picked out manually; the peritoneal cavity was then swabbed gently with large abdominal swabs (29 participants)\
Group II (saline): all peritoneal contaminants were sucked out, and the peritoneal cavity was generously irrigated with no less than 5 L of saline solution (29 participants)\
Group III (chloramphenicol succinate): all peritoneal contaminants were sucked out, and the peritoneal cavity was generously irrigated with no less than 5 L of saline solution; 2 g of chloramphenicol succinate was added to the last L of the lavage fluid (29 participants)\
Cointerventions: all participants received systemic antibiotics penicillin G potassium, amikacin sulfate and metronidazole. Therapy with antibiotics was started preoperatively and continued after operation for 24 hs and more, depending on the operative finding and each participant\'s clinical course. Intraperitoneal drains were placed only when abscesses were found.Outcomes**Primary outcome: SSI**\
\"Wound infection\" defined as a discharge of pus from the wound; considered to be minor in cases where no early removal of sutures was necessary and primary healing was achieved; considered to be major when wounds required premature removal of sutures and drainage of pus and that healed by secondary intention.\
Group I (control): 6/29 (4 minor, 2 major)\
Group II (saline): 5/29 (3 minor, 2 major)\
Group III (chloramphenicol succinate): 5/29 (3 minor, 2 major)\
**Secondary outcome: mortality**\
Group I (control): 6/29\
Group II (saline): 6/29\
Group III (chloramphenicol succinate): 3/29\
**Secondary outcome: adverse events**\
Surgical complications\
Group I (control): 3/29 (one pelvic abscess)\
Group II (saline): 7/29 (one pelvic abscess)\
Group III (chloramphenicol succinate): 2/29\
Medical complications\
Group I (control): 8/29\
Group II (saline): 9/29\
Group III (chloramphenicol succinate): 5/29\
**Secondary outcome: mean length of hospital stay**\
Group I (control): 13 d\
Group II (daline): 13 d\
Group III (chloramphenicol succinate): 10 dNotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"Patients were randomized into one of the following three treatment groups\...\"\
Comment: unclear how randomisation was performedAllocation concealment (selection bias)Unclear riskQuote: \"Patients were randomized into one of the following three treatment groups\...\"\
Comment: unclear whether randomisation schedule was concealedBlinding of participants and personnel (performance bias) All outcomesHigh riskComment: no direct quote; no information on whether participants or personnel were blinded to treatmentBlinding of outcome assessment (detection bias) All outcomesUnclear riskQuote: \"Patients were monitored closely after operation and followed up in the outpatient clinic for at least 2 weeks after the operation.\"\
Comment: Nno information on whether personnel performing outcome assessments were blinded to treatmentIncomplete outcome data (attrition bias) All outcomesLow riskComment: no evidence of attrition biasSelective reporting (reporting bias)Unclear riskComment: no evidence of selective reporting, but not enough information to be certainOther biasUnclear riskComment: no evidence of other sources of bias, but reporting not sufficient to be certain[@CD012234-bbs2-0047]Methods2‐arm RCT\
Setting: neurosurgical department in Japan\
Follow up: 10 d post surgeryParticipants20 participants (mean age 60 years) admitted for clipping surgery for unruptured cerebral aneurysms; indications for clipping surgery are age \< 70 years, no significant systemic risk for general anaesthesia, and aneurysm size \> 5 mm. In 2 participants, 2 aneurysms were clipped in one surgery.\
Inclusion criteria: age between 20 and 70 years; planned surgery for aneurysm(s) of the internal carotid artery territory through a unilateral pterional approach; no steno‐occlusive lesions (\> 50%) in cerebral arteries as evaluated by magnetic resonance (MR) angiography and/or conventional angiography; and aneurysms that presented no significant surgical difficulty\
Exclusion criteria: aneurysms presenting more surgical difficulty than usual; aneurysms suitable for approaches other than the pterional approach; aneurysms suitable for intravascular surgery; history of cerebrovascular diseases causing any disability (modified Rankin scale score 1 or worse); and significant medical problemsInterventionsGroup I (artificial CSF): brain surfaces and basal and sylvian cisterns irrigated during surgery with Artcereb, an artificial CSF (10 participants)\
Group II (saline): brain surfaces and basal and sylvian cisterns irrigated during surgery with physiological saline (10 participants)Outcomes**Primary outcome: SSI**\
NR\
**Secondary outcome: adverse events: (postoperative, all types, includes MRI findings)**\
Group I (artificial CSF): 2/10\
Group II (saline): 2/10 (2/10 participants with 2 events each)NotesPublished paper does not report any of specified primary outcomes for this review\
Funding: Nihon Medi‐Physics Co, Ltd, Tokyo, Japan, provided N‐isopropyl‐p‐\[123I\]iodoamphetamine and Otsuka Pharmaceutical Co., Tokyo, Japan, provided Artcereb. The study did not receive any other financial support.\
**Contacted lead study author to find out if there are any further data relating to our outcomes*Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"The patient was randomly assigned to irrigation fluid A or B during surgery to irrigate the basal and sylvian cisterns and the brain surface.\"\
Comment: unclear how randomisation was performedAllocation concealment (selection bias)Unclear riskQuote: \"A total of 20 bottles each containing 500 mL of Artcereb (Artcereb group, n = 10) or physiological saline (saline group, n = 10) were prepared. The bottles of Artcereb were labelled A, and those of physiological saline were labelled B, without the knowledge of the study participants. The assignment was kept in a shielded envelope and only opened after all study data were collected.\"\
Comment: unclear whether allocation sequence was concealedBlinding of participants and personnel (performance bias) All outcomesUnclear riskQuote: \"The bottles of Artcereb were labelled A, and those of physiological saline were labelled B, without the knowledge of the study participants. The assignment was kept in a shielded envelope and only opened after all study data were collected.\"\
Comment: unclear whether personnel were blind to treatment allocationBlinding of outcome assessment (detection bias) All outcomesUnclear riskQuote: \"All 20 patients were serially evaluated on postoperative days 1, 3 to 5, and 7 to 10.\" Potentially amend this after obtaining more information from study authors, as it may not specifically relate to assessment of wound.\
Comment: study author contacted to determine if this relates to wound assessmentIncomplete outcome data (attrition bias) All outcomesLow riskComment: no evidence of attritionSelective reporting (reporting bias)Unclear riskComment: no evidence of selective reporting, but not enough information to be certainOther biasUnclear riskComment: no evidence of other sources of bias, but reporting not sufficient to be certain[@CD012234-bbs2-0048]Methods2‐arm RCT\
Setting: a general hospital, UK\
Follow‐up: 6 weeks post surgery (close monitoring in post‐operative period, then outpatient review at 6 weeks) Also a 1‐year follow‐up (see notes)Participants159 patients undergoing elective or emergency transperitoneal intestinal surgery of various types and for a range of conditions (e.g. colorectal neoplasm, inflammatory bowel disease, diverticular disease). Mean (range) age: Group I (saline): 51 (16‐89) years, Group II (tetracycline): 50 (19‐85) years. Stratification 1) high risk and low risk operation category 2) IV antibiotic used (three regimes)\
Inclusion criteria: elective or emergency transperitoneal intestinal surgery (small bowel, colon and rectum)\
Exclusion criteria: allergy to penicillin or cephalosporinsInterventionsGroup I (saline): prior to closing the abdomen at the conclusion of the operation, peritoneal lavage was performed with 2 L 0.9% sterile saline. The lavage fluid was washed around the peritoneal cavity for at least 2 min and then sucked out with a sump sucker (74 participants)\
Group II (tetracycline): same method as above but with lavage fluid 2 L 0.9% sterile saline containing 2 g tetracycline (85 participants)\
Co‐interventions: all participants received IV antibiotic at the beginning of the operation (metronidazole 1.5 g and either gentamicin 120 mg (55 participants), ceftriaxone 2 g (55 participants), or mezlocillin 5 g (49 participants)). All participants had abdomen closed with a mass suture technique and primary skin closure with suction drainage to the pelvisOutcomes**Primary outcome: SSI**\
Wound infection was defined as a discharge of pus from the wound.\
(Abdominal minor/major and perineal infection, and IV antibiotic groups also reported separately)\
Group I (saline): 24/74\
Group II (tetracycline): 10/85\
**Secondary outcome: adverse events**\
Intra‐abdominal abscess\
Group I (saline): 10/74\
Group II (tetracycline): 11/85\
Septicemia\
Group I (saline): 0/74\
Group II (tetracycline): 2/85\
**Secondary outcome: surgical re‐intervention rate**\
Reoperation for adhesive obstruction within 1 year of surgery (reported in the discussion rather than results)\
Group I (saline): 0/74\
Group II (tetracycline): 3/85NotesSurgical re‐intervention rate was reported in the discussion rather than the results and is from 1‐year follow‐up.\
Funding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"Each patient was assigned a study number on a consecutive basis. The hospital pharmacist then dispensed\... according to a computed‐generated randomization code.\" \"Randomization was stratified so that patients classified as \'high risk\' or \'low risk\' were distributed equally between the two lavage groups and also among the three intravenous antibiotic regimens\"\
Comment: appropriate methods used to generate the sequenceAllocation concealment (selection bias)Low riskQuote: \"The hospital pharmacist then dispensed the intravenous antibiotics and the lavage fluid according to a computer‐generated randomization code. All drugs were in numbered ampoules, the pharmacist being the sole possessor of the code\"\
Comment: the allocation sequence appears to have been concealedBlinding of participants and personnel (performance bias) All outcomesUnclear riskQuote: \"The hospital pharmacist then dispensed the intravenous antibiotics and the lavage fluid according to a computer‐generated randomization code. All drugs were in numbered ampoules, the pharmacist being the sole possessor of the code\"\
Comment: suggests that there may have been blinding of participants and personnel but not explicitly statedBlinding of outcome assessment (detection bias) All outcomesUnclear riskQuote: \"All patients were monitored\... by assessors independent of the surgical team\"\
Comment: suggests they may have been blind to treatment but not explicitly statedIncomplete outcome data (attrition bias) All outcomesLow riskComment: all participants are included in the resultsSelective reporting (reporting bias)High riskComment: some outcomes were NR by group, or were only reported in the discussion (re‐operation rate) and it is not clear which outcomes were decided prospectivelyOther biasUnclear riskComment: no evidence of other bias but reporting insufficient to be certain[@CD012234-bbs2-0049]Methods2‐arm RCT\
Setting: single hospital in USA\
Follow‐up: 12 weeks post surgery (daily examination for 7 d, then at least weekly)Participants500 patients undergoing operative procedures (age reported as groups rather than mean ‐ there are participants of all age groups from \< 9 years to \> 80 years). Surgery categories included clean, potentially contaminated, contaminated and dirty.\
Inclusion criteria: elective or emergency surgery, abdominal and gastrointestinal procedures, oncologic procedures, vascular reconstructions, head and neck operations, thoracic procedures, genitourinary procedures, trauma operations\
Exclusion criteria: amputations for ischaemic disease, drainage of subcutaneous abscesses, skin grafting, anorectal procedures, a history of iodine sensitivity, thyroid disease or significant renal impairmentInterventionsGroup I (povidone‐iodine): following closure of the fascia, subcutaneous tissues were irrigated for 60 s with 10% povidone‐iodine solution (242 participants)\
Group II (saline): following closure of the fascia, subcutaneous tissues were irrigated for 60 s with saline solution (258 participants)\
Co‐interventions: wounds categorised as dirty had close system suction wound catheters placed in the subcutaneous space, which were removed 48 h postoperatively. Systemic antibiotics (clindamycin and gentamycin, or doxycycline for those with a history of allergy or suspected early impaired renal function) were given preoperatively to participants in potentially contaminated, contaminated, and dirty wound categories. If there were clinical indications of sepsis, systemic antibiotics were continued in some participants beyond 48 h postoperatively.Outcomes**Primary outcome: SSI**\
An incision was considered infected if any amount of pus was discharged within 12 weeks of operation. Serous drainage from questionable wounds was cultured and the wound was classified as infected if any bacterial growth was recovered.\
Group I (povidone‐iodine): 7/242\
Group II (saline): 39/258\
Results also reported by wound category (clean, potentially contaminated, contaminated, dirty) for both groupsNotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"\...eligible patients\...were randomly allocated into treatment and control groups\"\
Comment: there are no details on how participants were randomly allocatedAllocation concealment (selection bias)Unclear riskComment: there is no information about allocation concealmentBlinding of participants and personnel (performance bias) All outcomesUnclear riskComment: there is no mention of blindingBlinding of outcome assessment (detection bias) All outcomesUnclear riskQuote: \"All wounds were examined daily by a single observer\"\
Comment: there is no mention of blindingIncomplete outcome data (attrition bias) All outcomesLow riskComment: data from all randomised participants are included in the analysisSelective reporting (reporting bias)Low riskComment: the only outcome of interest was SSI and these data are fully reportedOther biasUnclear riskComment: there is not enough methodological detail to judge[@CD012234-bbs2-0050]Methods2‐arm equivalence RCT\
Setting: single hospital (2 sites) in Australia\
Follow‐up: 6 weeks by phone call and state‐wide record searchingParticipants83 adults with intraoperative finding of acutely inflamed appendix undergoing laparoscopy for suspected appendicitis. Mean age 20 years (suction only group) versus 32 years (irrigation and suction group)\
Inclusion criteria: adult patients (English‐speaking), \> 18 years, undergoing laparoscopy for clinically or radiologically suspected appendicitis meeting the following intra‐operative case definition: \"Intra‐operative finding of an acutely inflamed appendix, with suppuration or perforation localized to the right iliac fossa, paracolic gutter or pelvis, and when the surgery is completed via a laparoscopic approach.\"\
Exclusion criteria: pathology not satisfying the case definition, pregnant, interval appendectomy, appendectomy following percutaneous drainage for abscess, appendectomy for reasons other than appendicitis (for example, tumour)InterventionsGroup I: saline irrigation and suction. Median volume 675 mL (minimum 500 mL); irrigation deployment to contaminated areas at surgeon\'s discretion (41 participants allocated; 40 received intervention; 40 analysed)\
Group II: suction only (no irrigation) (42 participants allocated; 41 received intervention; 41 analysed)\
Cointerventions: all participants were treated with pre‐operative, IV, broad‐spectrum antibiotics. Continuation post‐operatively for purulent or perforated appendicitis, with transition to oral antibiotics recommended for 5 d but at the discretion of the treating surgeon: 17/41 vs 21/40 received theseOutcomes**Primary outcome: SSI**\
Group I (saline irrigation): 0/40\
Group II (no irrigation): 0/41\
**Secondary outcome: length of stay**\
Group I (saline irrigation): 2.0 (1 ‐ 3)\
Group II (no irrigation): 2.0 (1 ‐ 2.25)\
**Secondary outcome: adverse events ‐ abscess formation**\
Group I (saline irrigation): 2/40\
Group II (no irrigation): 2/41NotesFunding: no funding was received***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"Following enrolment, patients underwent simple randomization to either "suction only" (SO) or "irrigation and suction" (IS), with the use of computer‐generated random number sequencing.\"\
Comment: it appears that an appropriate method was used to generate the randomisation sequence.Allocation concealment (selection bias)Low riskQuote: \"Group allocation and data‐collection forms were stored in identical, opaque sealed envelopes\"\
Comment: it appears that an appropriate method was used to conceal the allocation sequence.Blinding of participants and personnel (performance bias) All outcomesHigh riskComment: personnel (surgeons) were aware of the allocation to intervention groups. It is unclear if participants were also aware of allocation.Blinding of outcome assessment (detection bias) All outcomesLow riskQuote \"Data collection was performed by an individual not involved in clinical treatment of enrolled patients.\"\
Comment: it appears that blinded outcome assessment was undertakenIncomplete outcome data (attrition bias) All outcomesLow riskQuote: \"All enrolled patients were accounted for in follow‐up through hospital medical records and searching the statewide admission database\"\
Comment: 1 participant in each group converted to open surgery and therefore did not receive the intended intervention. All other participants were included in the analysis.Selective reporting (reporting bias)Low riskComment: both primary and secondary outcomes were predefined and appear to be fully reportedOther biasLow riskThere were no other sources of bias apparent, and reporting was sufficiently detailed to be reasonably confident that this was the case.[@CD012234-bbs2-0051]Methods2‐arm RCT\
Setting: single study in USA\
Follow‐up: early follow‐up by clinic follow‐up or phone call at 2‐4 weeksParticipants220 children \< 18 years with perforated appendicitis undergoing laparoscopic appendectomy\
Inclusion criteria: children \< 18 years who were found to have perforated appendicitis. Perforation was defined as a hole in the appendix or fecalith in the abdomen\
Exclusion criteria: NRInterventionsGroup I: saline irrigation, minimum 500 mL volume plus suction, mean volume 867 (327) (110 participants)\
Group II: no irrigation, suction only (110 participants)\
Cointerventions: 50 mg/kg dose of ceftriaxone (maximum dose 2 g) and 30 mg/kg dose of metronidazole (maximum dose 1 g) before the operation. Once daily dosing of ceftriaxone and metronidazole continued postoperativelyOutcomes**Secondary outcome**: **adverse events ‐ abscess formation**\
Group I (saline irrigation): 20/110 (calculated from 18.3% of 110)\
Group II (no irrigation): 21/110 (calculated from 19.1% of 110)\
**Secondary outcome: length of stay**\
Group I (saline irrigation): 5.4 (2.7)\
Group II (no irrigation): 5.5 (3.0)\
**Secondary outcome: readmission**\
Group I (saline irrigation): 0/110\
Group II (no irrigation): 3/110\
**Secondary outcome: reoperation**\
Group I (saline irrigation): 0/110\
Group II (no irrigation): 1/110NotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"A computer‐generated individual unit of randomization was utilized in a nonstratified sequence in blocks of 10\"\
Comment: an appropriate method was used to generate the randomisation sequence.Allocation concealment (selection bias)Unclear riskQuote: \"After consent for study enrolment was obtained, the randomization sequence was accessed to identify the next allotment. The attending surgeon did not obtain consent and was blind to the allotment throughout the enrolment process.\"\
Comment: it seems that allocation concealment was used but procedures are not clear enough to be sure it was adequate.Blinding of participants and personnel (performance bias) All outcomesHigh riskComment: no specific quote but it appears that personnel could not be blinded; it is unclear whether participants were blinded.Blinding of outcome assessment (detection bias) All outcomesUnclear riskComment: no specific quote; no information on whether outcome assessors were blinded to treatment allocation. It is stated that \"Surgeons were not blinded during the postoperative course\" but it is unclear if they were performing the outcome assessment.Incomplete outcome data (attrition bias) All outcomesLow riskComment: all eligible randomised participants were included in the analysis. There were a large number of participants who consented but were excluded because of the intraoperative inclusion criterion. As this was prespecified this is unlikely to be a source of bias.Selective reporting (reporting bias)Unclear riskQuote: \"This was a definitive trial design using postoperative abscess as the primary outcome variable.\"\
Comment: only the primary outcome was prespecified in the methods so it is difficult to determine if all planned outcomes were fully reported.Other biasUnclear riskComment: there is no evidence of other sources of bias but the reporting is insufficiently detailed to be certain.[@CD012234-bbs2-0052]Methods2‐arm RCT\
Setting: a single centre in Japan\
Follow‐up: 3 months post surgery. (After the operation, there was wound inspection daily by nurses, once a week by an infection control nurse and surgeon during hospital stay, and at 4 week and 3 month post operative visits)Participants400 participants undergoing elective colorectal surgery for a variety of conditions (e.g. colorectal cancer, ulcerative colitis and Crohn\'s disease). 37 randomised participants were excluded for protocol violations (e.g. inappropriate bowel preparation, inappropriate antimicrobial prophylaxis, colon was not opened) therefore baseline data include 363 participants. Mean (SD) age: Group I (ESAAS) 51.8 (17.4) years, Group II (saline) 51.9 (17.7) years; diabetes 14/180 vs 13/183; colorectal cancer 82/180 vs 90/183\
Inclusion criteria: participants undergoing elective colorectal surgery\
Exclusion criteria: dirty/infected wound, emergency surgery, laparoscopic surgery, stoma creation without bowel resection, transrectal operation, use of antibiotics within 10 d preceding surgeryInterventionsGroup I (ESAAS): the surgical wound was irrigated with at least 500 mL of ESAAS (electrolysed strongly acidic aqueous solution, produced by the electrolysis of tap water containing 0.12% NaCl) after the completion of fascial suture (200 participants, of whom 20 excluded due to protocol violation)\
Group II (saline): the surgical wound was irrigated with at least 500 mL of saline solution after the completion of fascial suture (200 participants, of whom 17 excluded due to protocol violation)\
Co‐interventions: all participants received Magcorol P (68 g magnesium citrate) for bowel preparation, antimicrobial prophylaxis 30 min before surgery with 1 g of second generation cephalosporins IV. If surgery was \> 3 h, these were redosed. The same antibiotics were continued for 24 h after the operation (3‐4 doses). Povidone‐iodine was used for skin preparation.Outcomes**Primary outcome: SSI**\
Diagnosis based on guidelines issued by the National Nosocomial Infections Surveillance system. Infection had to occur within 30 d of the operation.\
Group I (ESAAS): 19/180\
Group II (saline): 29/183\
Incisional SSI\
Group I (ESAAS): 11/180\
Group II (saline): 21/183\
Organ/space SSI\
Group I (ESAAS): 8/180\
Group II (saline): 8/183\
**Primary outcome: wound dehiscence**\
Superficial wound dehiscence defined as \> 1 cm separation of the incision above the fascia with or without infection that required packing and healing by secondary intention. Fascial dehiscence involved disruption of the fascia. (Superficial incisions deliberately opened to treat SSI were excluded.)\
Group I (ESAAS): 17/180 (15 superficial; 2 fascial)\
Group II (saline): 12/183 (10 superficial; 2 fascial)\
**Secondary outcome: antibiotic resistance**\
MRSA\
Group I (ESAAS): 4/14\
Group II (saline): 8/24\
MSSA\
Group I (ESAAS): 0/14\
Group II (saline): 3/24\
(other organisms are reported but without sensitivity)NotesFunding: none reported***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"Computer generated sequence allocation was used\"\
Comment: approriate methods appear to have been usedAllocation concealment (selection bias)Low riskQuote: \"concealment was achieved by use of opaque envelopes opened at operating room by a third party\"\
Comment: appropriate steps were taken to conceal allocation with opaque envelopes and third partyBlinding of participants and personnel (performance bias) All outcomesHigh riskQuote: \"some surgeons could make the distinction between ESAAS and saline solution during application to the wound\"\
Comment: authors state that personnel were not blindedBlinding of outcome assessment (detection bias) All outcomesUnclear riskQuote: \"the diagnosis of SSI was made by our infection control team\"\
Comment: it is not clear whether personnel knew treatment allocationIncomplete outcome data (attrition bias) All outcomesHigh riskComment: 37/400 randomised participants were excluded at baseline due to protocol violation. This is a large number and it is possibly biased as personnel were not blinded, even though reasons for exclusion appear similar in the 2 treatment groups. No participants were lost to follow‐up.Selective reporting (reporting bias)Low riskComment: all results are reported for the stated outcomes of interestOther biasLow riskComment: there is no evidence for other sources of bias[@CD012234-bbs2-0053]Methods2‐arm RCT\
Setting: single centre in Japan\
Follow‐up: 4 weeks post surgeryParticipants193 participants undergoing elective liver resection surgery (200 randomised, 7 excluded due to complications during surgery). Median age 68.5 years (range 21‐87 years), mean age 66.4 (11.2) vs 66.8 (11.3) years. Diabetes mellitus co‐morbidity: Group I 24.0%, Group II 19.6%. Hepatocellular carcinoma: Group I 35/96, Group II 37/97. Cholangiocellular carcinoma: Group I 3/96. Group II 2/97. Liver metastases: Group I 45/96, Group II 52/96\
Inclusion criteria: elective liver resection without resection/reconstruction of the bile duct or intestine\
Exclusion criteria: resection/reconstruction of the bile duct and/or intestine, an operation designated Class III or higher according to CDC guidelines, detection of peritoneal dissemination of cancerInterventionsGroup I (lavage): after removal of resected liver and confirmation of haemostasis, irrigation with sterile saline (37º C) directed at the dissected area. 3000 mL was used in open surgery and 1000 mL in laparoscopic surgery (96 participants)\
Group II (no lavage): no intraoperative lavage performed (97 participants)\
Co‐interventions: prophylactic antibiotic (flomoxef sodium) 1 g IV 30 mins before surgery, 1 g every 3 h during surgery, 1 g 2h after surgery, then 2 g daily for 4 d. A closed suction drain was placed near the transection plane of the liver parenchyma for all participants, and wound washout was performed using sterile saline after fascial closure but before skin closureOutcomes**Primary outcome: SSI**\
Incisional infection (either superficial or deep) or organ/space infection. Incisional infection defined by clinically apparent cellulitis, induration, or purulent discharge from the closure site. Organ/space infection defined by radiologic evidence of a fluid collection necessitating drainage or antibiotic therapy.\
Total SSI\
Group I (lavage): 21/96\
Group II (no lavage): 13/97\
Superficial/deep SSI\
Group I (lavage): 7/96\
Group II (no lavage): 6/97\
Organ/space SSI\
Group I (lavage): 16/96\
Group II (no lavage): 7/97\
**Secondary outcome: mortality (90 d)**\
Group I (lavage): 2/96\
Group II (no lavage): 1/97\
**Secondary outcome: morbidity (post‐operative complications)**\
Group I (lavage): 37/96\
Group II (no lavage): 36/97\
**Secondary outcome: hospital stay (mean (SD) d)** (median (range) also reported)\
Group I (lavage): 15.2 (13.4)\
Group II (no lavage): 15.2 (13.1)NotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"..simple randomization was carried out by comparing a number within a sealed envelope with numbers in a computer‐generated random number table\"\
Comment: use of a random number tableAllocation concealment (selection bias)Unclear riskQuote: \"\...a number within a sealed envelope..\"\
Comment: it appears that steps were taken to conceal allocation in some way, but it is not known if envelopes were opaque and consecutively numberedBlinding of participants and personnel (performance bias) All outcomesHigh riskQuote: \"By its nature this study was unblinded\"\
Comment: no blinding of personnel, appears to state that participants were also unblindedBlinding of outcome assessment (detection bias) All outcomesHigh riskQuote: \"By its nature this study was unblinded\"\
Comment: no blinding of personnel, appears to state that outcome assessors were also unblindedIncomplete outcome data (attrition bias) All outcomesLow riskComment: all participants reported at baseline accounted for in analysis (but 7 excluded during surgery; probably too few to impact analysisSelective reporting (reporting bias)Low riskComment: all outcomes of interest appear to have been reported for all participantsOther biasLow riskComment: there is no evidence of other sources of bias[@CD012234-bbs2-0054]Methods3‐arm RCT\
Setting: a single hospital in Thailand\
Follow‐up: minimum 2 weeks post surgeryParticipants374 participants randomised in total, 252 in the 2 arms of interest. Mean age (range): Group I (control) 27 (15‐65) years, Group II (Savlon) 24.5 (15‐55) years\
Inclusion criteria: \> 15 years of age with acute appendicitis requiring emergency operation\
Exclusion criteria: known penicillin sensitivity, preoperative antibiotics received, microscopically normal appendices, periappendicitis due to inflammation elsewhereInterventionsGroup I (control): no local treatment during operation (124 participants)\
Group II (Savlon): each layer was irrigated with 1% solution of cetyl trimethyl ammonium bromide (Savlon) and possibly also chlorhexidine, but this is unclear; and swabbed dry before closure (128 participants)\
Co‐interventions: \"The use of peritoneal drainage and postoperative antibiotics was left to the surgeon\'s discretion\" drains were used for 4 participants in group I (control) and 8 in group II (Savlon), all but 1 were for participants with a perforated appendixOutcomes**Primary outcome: SSI**\
\"A wound was considered to be infected when there was a collection of pus which emptied itself spontaneously or after incision\"\
Group I (control): 3/108 participants with non‐perforated appendix, 9/16 participants with perforated appendix\
Total 12/124\
Group II (Savlon): 5/111 participants with non‐perforated appendix, 8/17 participants with perforated appendix\
Total 13/128NotesThere is an additional trial arm in which ampicillin powder is applied to wounds.\
Funding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)High riskQuote: \"At operation patients were randomly allocated into three groups by drawing cards\" \"randomisation may not have been adequate because more perforated appendices were found in the ampicillin group, which suggests that a large number of junior staff on rotation may have disregarded randomisation in what they took (rightly) to be the patient\'s interest\"\
Comment: it is not clear whether allocation was random, the study authors express doubtAllocation concealment (selection bias)High riskQuote: \"At operation patients were randomly allocated into three groups by drawing cards\" \"randomisation may not have been adequate because more perforated appendices were found in the ampicillin group, which suggests that a large number of junior staff on rotation may have disregarded randomisation in what they took (rightly) to be the patient\'s interest\"\
Comment: it is not clear whether allocation was random, the study authors express concernBlinding of participants and personnel (performance bias) All outcomesHigh riskComment: there is no information about blinding. The participants may have been blinded to treatment, but it is clear the personnel were not.Blinding of outcome assessment (detection bias) All outcomesUnclear riskComment: there is no information about blinding of outcome assessmentIncomplete outcome data (attrition bias) All outcomesLow riskComment: all randomised participants are accounted for in the resultsSelective reporting (reporting bias)Unclear riskComment: there is not enough information to judgeOther biasUnclear riskComment: there is not enough information to judge[@CD012234-bbs2-0055]Methods2‐arm RCT\
Setting: single hospital in Turkey\
Follow up: NRParticipants430 women undergoing elective caesarean section. Mean age was 27.7 years (irrigation group) vs 28.2 years (mean number of previous births was 1)39% vs 36% had a comorbidity such as asthma or thyroid dysfunction.\
Inclusion criteria: women with gestational age \> 38 weeks and elective cesarean delivery. Elective caesarean was defined as being performed before the presence of labour with or without previous history of caesarean delivery\
Exclusion criteria: women with emergency cesarean delivery, chorioamnionitis, type I diabetes, placenta previa, placenta accreta, maternal coagulopathy, or prior severe gastrointestinal diseaseInterventionsGroup I: saline irrigation of the abdominal cavity using 500 mL of warm normal saline after closure of the uterine incision but before closure of the abdominal wall. All blood clots, vernix, and other debris were evacuated from the paracolic gutters, anterior and posterior cul‐de sacs, and under the bladder flap when employed.\
Group II: no irrigation; all clots, vernix and other debris were left in place.\
Cointerventions: 5 IU IV bolus of oxytocin over 5--10 s when the umbilical cord was clamped. Then, 30 IU of oxytocin in 500 mL lactated Ringer solution administered at a rate of 125 mL/h, and continued for 4 h. A total of 1 g cefazolin diluted in 20 mL normal saline administered over a 5‐min periodOutcomes**Primary outcome: SSI** (partial or total separation of the incision, as well as the presence of purulent or serous wound discharge with induration, warmth, and tenderness)\
Group I (saline irrigation): 1/215\
Group II (no irrigation): 2/215NotesFunding: Departmental funds only***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"The participants were randomized to either an irrigation group or a control group. Assignment to one of the two treatment groups was determined using a random number table.\"\
Comment: an appropriate method was used to generate the randomisation sequenceAllocation concealment (selection bias)Low riskQuote: \"The assigned treatments were written on cards and sealed in secure opaque envelopes numbered in sequence.\"\
Comment: appropriate measures to ensure allocation concealment appear to have been followed.Blinding of participants and personnel (performance bias) All outcomesHigh riskQuote: \"The surgeons were not blinded to the procedure allocation. The allocated envelope was opened by the surgeon just before surgery, and the procedure allocation was recorded on each woman's chart.\"\
Comment: personnel were not blinded; unclear if participants were blindedBlinding of outcome assessment (detection bias) All outcomesUnclear riskQuotes: \"Postoperative physicians were blinded to group assignment to avoid any potential bias; however, the surgeon who performed the operative procedure cared for the patient in the postoperative period, thus, was not blinded to the study group.\"\
\"All data were recorded and analyzed by another researcher, who was blinded to the group assignments.\"\
Comment: some elements of outcome assessment were undertaken by a blinded assessor but it\'s not clear whether all assessment was.Incomplete outcome data (attrition bias) All outcomesLow riskComment: all randomised participants were included in the analysis.Selective reporting (reporting bias)Unclear riskQuote: \"The primary outcome measured was the rate of antiemetic drugs required in the postoperative period following cesarean delivery. Secondary outcome measures included the rate of PIM. Other outcomes evaluated were nausea and emesis occurring during the postoperative hospitalization.\"\
Comment: additional outcomes to those specified were also reported so it is difficult to determine whether all planned outcomes were assessed and reported.Other biasLow riskComment: there is no evidence of any other bias and reporting is detailed.[@CD012234-bbs2-0056]Methods3‐arm RCT\
Setting: a single hospital in Ireland\
Follow‐up: not statedParticipants131 participants undergoing appendectomy (age range 3.5‐74 years)\
Inclusion criteria: all participants undergoing appendectomy over a stated time period\
Exclusion criteria: NRInterventionsGroup I (Betadine): following appendectomy, participants were irrigated with 150 mL 1% Betadine (main constituent povidone iodine) solution intraperitoneally and 50 mL to the wound following closure of the peritoneum (49 participants)\
Group II (sterile water): participants were irrigated with approximately 150 mL sterile water intraperitoneally and 50 mL to the wound following closure of the peritoneum (31 participants)\
Group III (no irrigation): no irrigation following appendectomy (51 participants)Outcomes**Primary outcome: SSI**\
\"Wound infection was defined as the presence of pus either spontaneously or on probing. All infections were confirmed bacteriologically\"\
There were 17 wound infections among the 131 participants. Results are not given by trial arm. The authors state \"when broken down according to type of irrigation, there was no significant difference between the three groups\"\
**Secondary outcome: systemic antibiotic use**\
53/131 participants \"distributed evenly across the groups\"\
**Secondary outcome: length of hospital stay**\
Participants with infection: 10 d\
Participants without infection 6 d\
Results NR by groupNotesResults are only provided for the whole group, by appendix histology or for participants with infected wounds vs uninfected, not by treatment group.\
Funding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote: \"The randomization took place in theatre following induction of anaesthesia by selecting a disc from a box\"\
Comment: not enough information to judge whether this method was adequateAllocation concealment (selection bias)Unclear riskQuote: \"The randomization took place in theatre following induction of anaesthesia by selecting a disc from a box\"\
Comment: not enough information to judge whether this method was adequateBlinding of participants and personnel (performance bias) All outcomesHigh riskComment: no information provided about blinding. The participants may have been blinded but personnel would be aware of treatmentBlinding of outcome assessment (detection bias) All outcomesUnclear riskComment: no information provided about who performed outcome assessmentIncomplete outcome data (attrition bias) All outcomesUnclear riskComment: no participants appear to have dropped out of the studySelective reporting (reporting bias)High riskComment: results are not reported for study arms so there are no data provided to back up authors\' claim of no difference between groups.Other biasUnclear riskComment: not enough information to judge[@CD012234-bbs2-0057]Methods2‐arm RCT\
Setting: 25 centres in Europe\
Follow‐up: 4‐16 weeks post surgery (follow‐up laparoscopy)Participants498 participants randomised, of whom 72 were excluded from study before or during surgery due to failure to meet pre‐operative or intra‐operative inclusion criteria\
Inclusion criteria: female, aged 18‐45 years, undergoing primary removal of myomas or endometriotic cysts, using adequate contraceptive and not pregnant (negative test and agreement to use adequate contraception)\
Exclusion criteria (pre‐operative): pregnancy, serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase and/or bilirubin \> 20% above normal range and considered clinically significant; blood urea nitrogen and creatinine \> 30% above normal range and considered clinically significant; systemic corticosteroids, antineoplastic drugs and/or radiation; gonadotropin‐releasing hormone agonist/antagonist (except oral contraceptive) in 4 weeks prior to study; active pelvic/abdominal infection; known allergy to starch polymers; known/suspected intolerance to study materials; prior surgery for endometriotic cysts or myomas; non‐gynaecological surgical procedure planned during laparoscopic procedure; \> 4 myomas, largest myoma \< 2 or \> 8 cm diameter, or endometriotic cysts \< 3 or \> 7 cm on pre‐operative ultrasound; history of alcohol or other substance abuse within last year; use of another investigational agent; participation in another clinical trial within last 30 d; (at centres in France, diabetes mellitus was also an exclusion criterion)\
Exclusion criteria (intra‐operative and post‐operative): clinical evidence of cancer, pregnancy, rectovaginal endometriosis, endometriosis class III or IV other than endometrial cysts (American Fertility Society (AFS) classification), conversion to laparotomy, unplanned surgery involving opening of the bowel (excluding appendectomy), extensive pelvic adhesions (AFS scores moderate or severe), use during procedure of any anti‐adhesion agent, use of O~2~ enhanced insufflation, adhesions requiring lysing during planned myomectomy or planned endometrial cyst removal (other than those around the ovarian fossa), endometriotic cysts not removed and ovary not left open, suturing the ovarian capsule, pedunculated cysts, use of glue, peritoneum sutured to fascia, use of drains, and post‐operative ovarian histology consistent with a non‐endometriotic cystInterventionsAt surgery, the abdomen was washed with warm study solution and this washing/irrigation of the abdominal cavity was repeated/continued with a minimum of 100 mL at intervals of at least once every 30 min. At the end of surgery, after a final irrigation with a minimum of 100 mL and evacuation of intraoperative solution, a final 1000 mL was instilled from a fresh treatment bag.\
Group I (Adept): study solution was Adept, a 4% icodextrin solution (217 participants) (non‐antibacterial)\
Group II (LRS): study solution was lactated Ringer\'s solution (209 participants) (non‐antibacterial)\
Co‐interventions: none specifically mentioned. There was standardised surgical management and all trocar ports ≥ 10 mm were double sutured to the fascia to help minimise any leakage.Outcomes**Primary outcome: SSI**\
\'Wound infection\' listed in treatment‐related adverse events table VII\
Group I (Adept): 1/217\
Group II (LRS): 1/209\
\'Wound infection and vomiting\' listed in adverse events designated serious table VIII (none deemed treatment‐related)\
Group I (Adept): 2/217 (1 with faecal impaction)\
Group II (LRS): 0/209\
**Secondary outcome: mortality**\
Mentioned within adverse events section\
Group I (Adept): 0/217\
Group II (LRS): 0/209\
**Secondary outcome: adverse events**\
Group I (Adept): 71/217 of which 18 considered treatment‐related\
Group II (LRS):72/209 of which 15 considered treatment‐relatedNotesOutcomes: the objective of the study was to examine the effect of irrigation on adhesion formation hence this was the primary outcome and infection and mortality were only mentioned among adverse events and are reported for the designated safety population\
Funding: Shire Pharmaceutical Development Ltd was the original study sponsor, providing research funding to all hospital departments involved, and funding was also provided by Baxter BioSurgery (Shire and Baxter are the previous and current distributors of Adept)***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"Treatment was randomized through a 24‐h central randomisation telephone system\" \"Patients were stratified according to their diagnosis of either myomas or endometriotic cysts and were randomised in a 1:1 ratio to separate randomisation lists\" \"The system was administered by the study Clinical Research Organisation\"\
Comment: method of sequence generation is not explicitly stated but appropriate service and method for stratification appear to have been usedAllocation concealment (selection bias)Low riskQuote: \"The system was administered by the study Clinical Research Organisation\" \"the treatment pack assigned was not permitted for allocation to any other patient in the study\"\
Comment: use of 3rd party and other steps to conceal allocationBlinding of participants and personnel (performance bias) All outcomesLow riskQuote: \"Double‐blinding was possible as both fluids are clear and odourless solutions with similar viscosities to water and they were packaged identically\"\
Comment: adequate methods used to blind participants and personnelBlinding of outcome assessment (detection bias) All outcomesUnclear riskQuote: (referring to primary outcome) \"Reviewers were blinded to the study treatment assignment\"\
Comment: it appears steps were taken to blind outcome assessors for the primary outcome however blinding is not mentioned for safety assessment (our outcomes of interest)Incomplete outcome data (attrition bias) All outcomesUnclear riskQuote: \"The safety population consisted of all consenting patients who received randomized treatment\"\
Comment: 72/498 randomised participants were excluded from the study before (27) or during (45) surgery. There does not appear to be any bias in this exclusion but it is possible.Selective reporting (reporting bias)Unclear riskComment: our primary outcome of interest (infection) is not clearly defined or reported as it not a primary outcome of the study.Other biasUnclear riskComment: the study was funded by pharmaceutical companies which may have influenced reporting of safety data.[@CD012234-bbs2-0058]Methods3‐arm RCT\
Setting: 2 hospitals in the UK\
Follow‐up: 3, 7, 10 d, and 1 month post‐surgeryParticipants53 participants undergoing operations for generalised purulent or faecal peritonitis. Mean (range) age: Group I 56.1 (10‐84) years, Group II 49.7 (10‐83) years, Group III 56.0 (18‐79) years\
Inclusion criteria: generalised purulent or faecal peritonitis confirmed at laparotomy\
Exclusion criteria: NRInterventionsFollowing completion of surgical procedure, participants were given a thorough peritoneal toilet and lavage until solutions ran clear with the following protocols:\
Group I (saline): warm saline solution lavage, with a further 100 mL saline inserted into the abdominal cavity before wound closure (20 participants)\
Group II (chlorhexidine): warm chlorhexidine gluconate (Hibitane) 1:5000 solution lavage, with 100 mL inserted before wound closure (19 participants)\
Group III (PVP‐I): warm saline solution lavage, with 100 mL PVP‐I solution (\'Betadine\' peritoneal lavage solution) inserted before wound closure (14 participants)\
Co‐interventions: broad spectrum antibiotics (metronidazole and either gentamicin or cefuroxime) were given pre‐operatively and continued for at least 5 d postoperatively. Abdominal drains were inserted in all participants as required by the focus of primary sepsis or nature of surgery performedOutcomes**Primary outcome: SSI**\
Wound abnormalities indicative of infection presented (can be added as each participants is only counted once)\
Pus in wound\
Group I (saline): 5/16\
Group II (chlorhexidine): 4/16\
Group III (PVP‐I): 4/13\
Sero‐sanguinous discharge\
Group I (saline): 4/16\
Group II (chlorhexidine): 6/16\
Group III (PVP‐I): 5/13\
Inflammation or induration\
Group I (saline): 1/16\
Group II (chlorhexidine): 2/16\
Group III (PVP‐I): 2/13\
Summed data\
Group I (saline):10/16\
Group II chlorhexidine): 12/16 Group III: (PVP‐I): 11/13\
**Secondary outcome: mortality**\
12 participants died, 8 within 4 d of the operation (data below), and 4 died 8‐52 d postoperatively but group assignment was not reported. Authors state \"all deaths were due either to the severity of the presenting disease or co‐existing complicating conditions\"\
Mortality (within 4 d of surgery)\
Group I (saline): 4/20\
Group II (chlorhexidine): 3/19\
Group III (PVP‐I): 1/14\
**Secondary outcome: length of hospital stay**\
Mean (SD) d (unclear on numbers of participants in groups (see mortality) 41 survivors included in total)\
Group I (saline): 11.4 (4.4)\
Group II (chlorhexidine): 9.3 (4.3)\
Group III (PVP‐I): 12.6 (3.8)NotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Unclear riskQuote \"Patients were randomized to receive\...\"\
Comment: no details about method of randomisationAllocation concealment (selection bias)Unclear riskComment: no information in reportBlinding of participants and personnel (performance bias) All outcomesUnclear riskComment: no information in reportBlinding of outcome assessment (detection bias) All outcomesUnclear riskComment: no information in reportIncomplete outcome data (attrition bias) All outcomesHigh riskComment: 12/53 participants died, thus removing some outcome data e.g. length of hospital stay. Causes of death were reported and there was no attrition for other reasons.Selective reporting (reporting bias)High riskComment: details of deaths are provided but it is not reported which groups some of these participants were assigned to. Outcomes are not fully reported and may have been selectively reported.Other biasHigh riskQuote: \"the random allocation of patients to the different lavage groups resulted in an uneven distribution of the causes of peritonitis between the groups\"\
Comment: due to small numbers of participants and broad inclusion criteria the groups may be too different to demonstrate a treatment effect.[@CD012234-bbs2-0059]MethodsParallel‐group RCT\
Single hospital in the USA Follow‐up: NRParticipants236 women undergoing caesarean section\
Inclusion criteria: \"pregnant English‐speaking women, ≥ 18 years, presenting for labour or scheduled cesarean delivery\
Exclusion criteria: \"declining consent or urgent and emergent clinical situations in which the staff caring for the patient determined the time required for the consent process could adversely affect the potential participant's clinical care\"InterventionsGroup I: lavage with 500‐1000 mL warm saline after closure of the hysterotomy, but before the closure of the abdominal wall (110 participants)\
Group II: no lavage (126 participants)\
Cointerventions: blood clots and other debris manually evacuated. 1 g cefazolin IV as antibiotic prophylaxis before the start of surgery. Participants with cefazolin allergy received 900 mg clindamycin.Outcomes**Secondary outcome: length of stay** (reported as day of discharge)\
Group I (saline lavage): 3 d\
Group II (no lavage): 3 dNotesFunding: NR***Risk of bias*BiasAuthors\' judgementSupport for judgement**Random sequence generation (selection bias)Low riskQuote: \"Assignment was performed by opening a sequentially numbered opaque envelope containing computer‐randomized individual allocations\"\
Comment: appropriate method of sequence generation reportedAllocation concealment (selection bias)Low riskQuote: \"Assignment was performed by opening a sequentially numbered opaque envelope containing computer‐randomized individual allocations\"\
Comment: appropriate method of allocation concealment reportedBlinding of participants and personnel (performance bias) All outcomesHigh riskQuote: \"The original randomization was performed by research staff before the initiation of the study using a random number table generator, and the participants were blinded to treatment once assigned.\" \"The envelope was opened by the circulation nurse in the operating room and silently viewed by the surgeons after closure of the hysterotomy.\"\
Comment: participants were blinded to the treatment allocation but personnel were not.Blinding of outcome assessment (detection bias) All outcomesHigh riskQuote: \"This was recorded by nursing staff not blinded to the randomization\....Postoperative nursing staff were blinded to group assignment to avoid any potential bias; however, the surgeon who performed the operative procedure cared for the patient in the postoperative period and, thus, was not blinded to the study group\".\
Comment: some outcome assessors were not blinded.Incomplete outcome data (attrition bias) All outcomesLow riskComment: all randomised participants were included in the analysis.Selective reporting (reporting bias)Unclear riskComment: outcomes assessed were clearly prespecified and mostly fully reported but measures of variance were not given for some outcomes.Other biasUnclear riskQuote \"Our study was stopped halfway through to allow for planned midpoint data analysis for resident research day\"\
Comment: unclear if the study was stopped early and if so whether this was on the basis of a specific stopping rule. No evidence of other sources of bias and reporting sufficient to be reasonably confident of this.[^9]

Characteristics of excluded studies \[ordered by study ID\] {#CD012234-sec2-0023}
===========================================================

StudyReason for exclusion[@CD012234-bbs2-0060]Different indication: healing by delayed primary or secondary intention in some or all participants[@CD012234-bbs2-0062]Quasi‐randomised RCT[@CD012234-bbs2-0061]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0063]Different indication: healing by delayed primary or secondary intention in some or all participants[@CD012234-bbs2-0064]Different indication: healing by delayed primary or secondary intention in some or all participants[@CD012234-bbs2-0065]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0066]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0067]Quasi‐randomised RCT[@CD012234-bbs2-0068]Quasi‐randomised RCT[@CD012234-bbs2-0069]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0070]Different indication: used for anaesthesia purposes[@CD012234-bbs2-0071]Ineligible population: some or all participants did not undergo surgery[@CD012234-bbs2-0072]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0073]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0074]Ineligible intervention: extremely small volume of liquid[@CD012234-bbs2-0075]Different intervention: lavage was not the intervention of interest[@CD012234-bbs2-0076]Different indication: healing by delayed primary or secondary intention in some or all participants[@CD012234-bbs2-0077]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0078]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0079]Different indication: healing by delayed primary or secondary intention in some or all participants[@CD012234-bbs2-0080]Ineligible intervention: differences in lavage procedure were not the only difference between the groups[@CD012234-bbs2-0081]Different indication: used for anaesthesia purposes[@CD012234-bbs2-0082]Quasi‐randomised RCT[@CD012234-bbs2-0083]Ineligible population: some or all participants did not undergo surgery[@CD012234-bbs2-0084]Ineligible population: some or all participants did not undergo surgery[@CD012234-bbs2-0085]Different indication: used for anaesthesia purposes[@CD012234-bbs2-0086]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0087]Ineligible population: some or all participants did not undergo surgery[@CD012234-bbs2-0088]Ineligible indication: healing by delayed primary or secondary intention in some or all participants[@CD012234-bbs2-0089]Different indication: used for anaesthesia purposes[@CD012234-bbs2-0090]Ineligible indication: healing by delayed primary or secondary intention in some or all participants[@CD012234-bbs2-0091]Quasi‐randomised RCT[@CD012234-bbs2-0092]Ineligible intervention: extremely small volume of liquid[@CD012234-bbs2-0093]Different indication; study author contact confirmed that no relevant outcome data were collected and purpose of study was to evaluate pain and WBC[@CD012234-bbs2-0094]Quasi‐randomised RCT[@CD012234-bbs2-0095]Quasi‐randomised RCT[@CD012234-bbs2-0096]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0097]Ineligible intervention: extremely small volume of liquid[@CD012234-bbs2-0098]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0099]Ineligible intervention: extremely small volume of liquid[@CD012234-bbs2-0100]Ineligible population: some or all participants did not undergo surgery[@CD012234-bbs2-0101]Quasi‐randomised RCT[@CD012234-bbs2-0102]Ineligible indication: healing by delayed primary or secondary intention in some or all participants[@CD012234-bbs2-0103]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0104]Different indication: used for anaesthesia purposes[@CD012234-bbs2-0105]Ineligible population: some or all participants did not undergo surgery[@CD012234-bbs2-0106]Quasi‐randomised RCT[@CD012234-bbs2-0107]Quasi‐randomised RCT[@CD012234-bbs2-0108]Quasi‐randomised RCT[@CD012234-bbs2-0109]Use of peri‐operative irrigation/lavage was not the difference between the groups[@CD012234-bbs2-0110]Ineligible indication: healing by delayed primary or secondary intention in some or all participants[@CD012234-bbs2-0111]Different indication: used for anaesthesia purposes[@CD012234-bbs2-0112]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0113]Quasi‐randomised RCT[@CD012234-bbs2-0114]Ineligible population: some or all participants did not undergo surgery[@CD012234-bbs2-0115]Quasi‐randomised RCT[@CD012234-bbs2-0116]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0117]Different indication: used for anaesthesia purposes[@CD012234-bbs2-0118]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0119]Ineligible indication: healing by delayed primary or secondary intention in some or all participants[@CD012234-bbs2-0120]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0121]Ineligible intervention: extremely small volume of liquid[@CD012234-bbs2-0122]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0123]Ineligible indication: healing by delayed primary or secondary intention in some or all participants[@CD012234-bbs2-0124]Ineligible indication: healing by delayed primary or secondary intention in some or all participants[@CD012234-bbs2-0125]Quasi‐randomised RCT[@CD012234-bbs2-0126]Quasi‐randomised RCT[@CD012234-bbs2-0127]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0128]Ineligible population: some or all participants did not undergo surgery[@CD012234-bbs2-0129]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0130]Quasi‐randomised RCT[@CD012234-bbs2-0131]Use of peri‐operative irrigation/lavage was not the only systematic difference between the groups[@CD012234-bbs2-0132]Different indication: used for anaesthesia purposes[^10]

Characteristics of studies awaiting assessment \[ordered by study ID\] {#CD012234-sec2-0024}
======================================================================

[@CD012234-bbs2-0133]Methods2‐arm RCTParticipants20 women undergoing surgery for endometriosisInterventionsGroup I: lavage performed routinely\
Group II: lavage performed until liquid was clearOutcomesPrimary outcome: C‐reactive protein concentration\
White blood cell count\
Temperature\
ComplicationsNotesWe have contacted study author who confirms relevant outcome data were collected; these are currently unpublished although a publication is being prepared. Study author unable to supply data in advance of publication[@CD012234-bbs2-0134]Methods2‐arm RCTParticipants80 people receiving knee or hip replacement surgeryInterventionsGroup I: iodophore irrigation of wound during surgery (40 participants)\
Group II: physiologic salt solution irrigation of wound during surgery (40 participants)OutcomesPrimary outcome: contamination of suction device used during surgery\
Group I: 13/40\
Group II: 14/40Notes2 records for this study; one in Dutch. Notes from translator on methodology, \"The authors say it is randomised, however there is no description as to how this was done and the allocation is not reported\" \"Very low quality, bad methodology, baseline not clearly described\"\
Unclear whether any relevant outcomes were collected. Unable to contact study author to date[@CD012234-bbs2-0135]Methods2‐arm RCT\
Setting: \"private hospital\" in Turkey\
Follow‐up: 40 d\
Duration of study: 2004‐2007Participants1272 women undergoing cesarean section\
Loss to follow‐up: 17 participants were lost from follow‐up\
Age range: 23.1‐33.7 years\
Inclusion criteria: women undergoing cesarean section\
Exclusion criteria: coincident remote site infections or colonisation, diabetes, cigarette smoking, systemic steroid use, obesity (\> 20% ideal body weight), excessive subcutaneous scar tissue due to previous operations, perioperative transfusion of blood products and altered immune response were excluded from the study (33 women). Operation time, \> 2 h or blood loss \> 1 L or having premature rupture of membrane \> 6 hs were discharged from the study (26 women)InterventionsGroup I: povidone‐iodine 10% was used for preoperative antisepsis of skin and after closure of skin (600 participants)\
Group II: povidone‐iodine was used in the same way but also subcutaneous tissue was irrigated with rifamycin SV/ 250 mg, before closure of subcutaneous tissue (596 participants)\
Amount of irrigation fluid: not stated\
Cointervention: single dose of 1 g ceftriaxone was given to all participants for prophylaxis in perioperative period after clamping of umbilical cordOutcomesPrimary outcome: SSI\
Group I: 12/600. All of them were superficial incisional SSI\
Group II: 0/596\
Secondary outcome: cost \[costs were given in dollars, we have assumed these to be USD\]\
Group I: total cost of 12 participants with SSI was USD 5386 Group II: total cost of the rifamycin SV used for washing of subcutaneous tissue was USD 876.12\
P value: not stated for cost alone\
When groups were compared, surgical site infection and cost were significantly lower in study group ( P \<0.05)NotesFunding: not stated\
Not clear whether randomisation was adequate. Study author contact attempted but so far unsuccessful[@CD012234-bbs2-0136]Methods2‐arm RCT\
Setting: appears to be single hospital in Spain\
Follow‐up: 1 yearParticipants79 Participants with orthopaedic (hip and knee) implant infection undergoing surgery for the infectionInterventionsGroup I: low‐pressure pulsatile lavage\
Group II: high‐pressure pulsatile lavage\
Cointerventions: after open debridement, a broad‐spectrum intravenous antimicrobial regimen was started and maintained until obtaining definitive microbiological results. The definitive oral antibiotic treatment was selected according to the antibiogram. The duration of intravenous and oral antibiotics was not standardised and this was decided according to the clinical manifestations and the C‐reactive protein values of each caseOutcomesRemission of infection; relapse of infection; retention of prosthesis; reinfection; success rateNotesThe source of funding did not play any role in the investigation. Unclear whether any relevant outcomes were reported. Study author contact attempted but so far unsuccessful.[@CD012234-bbs2-0137]Methods2‐arm RCT\
Setting: single UK hospital\
Follow‐up: none reportedParticipants44 participants undergoing hip fracture fixation\
Inclusion and exclusion criteria not reportedInterventionsGroup I: 0.05% chlorhexidine jet lavage (number of participants not reported)\
Group II: no intervention (number of participants not reported)\
Co‐interventions: not reportedOutcomesAir bacterial counts and mean operating timesNotesUnclear whether any relevant outcomes were reported. Unable to contact study author to date\
No funding reported[^11]

Characteristics of ongoing studies \[ordered by study ID\] {#CD012234-sec2-0025}
==========================================================

[@CD012234-bbs2-0138]Trial name or titleDoes Peritoneal lavage influence the rate of complications in paediatric laparoscopic appendicectomy? A prospective randomised clinical trialMethodsParallel‐group (2‐arm) RCTParticipantsChildren with perforated appendicitisInterventionsPeritoneal lavage with 0.9% saline then suction\
No lavage (suction only)OutcomesLength of hospital stay in days, including any days of re‐admission\
Intra‐abdominal abscessStarting date20 May 2010Contact informationCharles Keys\
Department of Paediatric Surgery\
Southern Health\
Monash Medical Centre\
246 Clayton Road\
Clayton\
Vic 3168\
AustraliaNotesNo updates registered[@CD012234-bbs2-0139]Trial name or titleDilute Betadine lavage in the prevention of postoperative infectionMethodsParallel‐group (2‐arm) RCTParticipantsPeople who are scheduled to undergo a revision total knee arthroplastyInterventionsBetadine lavage: dilute Betadine lavage prior to surgical closure for 3 min followed by 2000 mL of sterile saline irrigation\
Saline lavage: (2000 mL) prior to closureOutcomesInfectionStarting date2 August 2010Contact informationDarren R Plummer, BBA, MBA; [darren.plummer\@rushortho.com](darren.plummer@rushortho.com)\
Rush University Medical Center\
Chicago, Illinois, United States, 60612NotesCurrently recruiting[@CD012234-bbs2-0140]Trial name or titleAntibiotic irrigation for pancreatoduodenectomyMethodsParallel‐group (2‐arm) RCTParticipantsAdults undergoing pancreatoduodenectomy (Whipple procedure)InterventionsAntibiotic irrigation via peritoneal lavage (polymyxin B (500,000 U) in 1 L of 0.9% normal saline)\
Placebo irrigation via peritoneal lavage (0.9 % normal saline)OutcomesInfections\
FistulasStarting date1 July 2014Contact informationMichael G. House, Associate Professor of Surgery, Indiana University\
Indianapolis, Indiana, United States, 46202\
[michouse\@iupui.edu](michouse@iupui.edu)NotesRecruiting[@CD012234-bbs2-0141]Trial name or titleIncidence of surgical site infection after irrigation of surgical pocket with 0.05% chlorhexidine compared with triple antibiotic solution in post‐mastectomy breast reconstructionMethodsIntra‐individual (split‐body) (2‐arm) RCTParticipantsWomen with breast cancer undergoing bilateral breast reconstructionInterventions0.05% chlorhexidine solution (IrriSept®) commercially prepared in 450 mL bottles\
Triple antibiotic solution will contain 1 g of cefazolin, 50,000 U of bacitracin, and 80 mg of gentamicin in 500 mL of normal saline\
Each participant will receive triple antibiotic solution on one breast and the chlorhexidine on the other breastOutcomesSurgical site infectionStarting date17 March 2015Contact informationKent Higdon, MD 615‐936‐0160\
[kent.higdon\@vanderbilt.edu](kent.higdon@vanderbilt.edu)\
Vanderbilt University Medical Center\
Nashville, Tennessee, United States, 37232NotesRecruiting[@CD012234-bbs2-0142]Trial name or titleBacterial contamination: iodine vs saline irrigation in pediatric spine surgeryMethodsParallel (2‐arm) RCTParticipantsChildren aged 3‐18 years undergoing surgery for diagnosis of spinal deformityInterventionsPovidone‐iodine ‐ 0.35% povidone‐iodine (Betadine)\
Normal saline ‐ sterile sodium chloride (NaCl) solutionOutcomesPostoperative infectionStarting date7 August 2015 (received), anticipated start date February 2017Contact informationPrincipal investigator: Michael Glotzbecker, MD; Boston Children's HospitalNotesNot yet open to recruitment[@CD012234-bbs2-0143]Trial name or titleWater and saline head‐to‐head in the blinded evaluation study trial (WASHITBEST)MethodsParallel‐group (2‐arm) RCTParticipantsParticipants diagnosed with acute appendicitis aged at least 6 yearsInterventionsIrrigation of the abdomen during surgery with normal saline\
Irrigation of the abdomen during surgery with sterile waterOutcomesPostoperative deep space organ infection as defined by the Surgical Infection Society (time frame: 30 d)\
Infection after surgery within the peritoneal space\
Temperature \> 38.5º C (time frame: 30 d)\
\> 2 d to return of bowel function as evident by either flatus or bowel movement (time frame: 30 d)\
Length of hospital stay (time frame: 30 d)Starting date8 March 2016 (information received). Study start date April 2013Contact informationArthur Rawlings, MD\
University of Missouri‐ColumbiaNotesCompleted[^12]
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[^1]: Editorial Group: Cochrane Wounds Group.

[^2]: ^1^Downgraded once for risk of bias in one or more domains other than performance bias in studies that account for more than 50% of the analysis weight; downgraded once for imprecision because confidence intervals include both benefit and harm. Publication bias could not be clearly ruled out but was not additionally downgraded for as the evidence was unclear. ^2^Downgraded twice for imprecision because confidence intervals are wide and fragile and include the possibility of both benefit and harm. There is also uncertainty as to whether the analysis was correctly adjusted for a split‐body design. ^3^Downgraded once for imprecision and once for high risk of detection bias in the study with 77% of the analysis weight. ^4^Downgraded once for imprecision.

[^3]: ^1^Downgraded once for risk of bias due to high risk of bias for at least one domain in studies contributing over 50% of the weight and once for probable publication bias. We did not further downgrade for inconsistency because the inconsistency present appeared due to the difference between larger and smaller studies and hence was accounted for by the downgrade for potential publication bias. ^2^Downgraded once for inconsistency due to study with highest weight showing effect in opposite direction to other included studies, once for high risk of bias and twice for imprecision, due to confidence intervals being wide and fragile, and including both benefit and harm. ^3^Downgraded twice for imprecision due to wide and fragile confidence intervals, which included both benefit and harm, as well as no difference between interventions. ^4^Downgraded once for risk of bias in studies with the majority of the weight and twice for imprecision due to wide and fragile confidence intervals, which included both benefit and harm, as well as no difference between interventions.

[^4]: ^1^Downgraded twice for high risk of bias in multiple domains for study contributing most of the weight. ^2^Downgraded twice for imprecision due to wide and fragile confidence intervals, which include both benefit and harm.

[^5]: ^1^Three‐armed trial; not all participants relevant to this comparison. ^2^Five‐armed trial; not all participants relevant to this comparison.

    CI: confidence interval; RCT: randomised controlled trial; RR: risk ratio; SSI: surgical site infection

[^6]: ^1^Elliott is a 4‐armed trial with a factorial design, arms with and without intravenous antibiotics are combined

    CI: confidence interval; CSF: cerebrospinal fluid; NR: not reported; RR: risk ratio

[^7]: CI: confidence interval; RR: risk ratio

[^8]: More details of interventions can be found in [Table 8](#CD012234-tbl-0008){ref-type="table"} and Characteristics of included studies

    1 Elliott is a four‐armed trial with a factorial design, arms with and without iv antibiotics are combined

    CI: confidence interval; CSF: cerebrospinal fluid; MRI: magnetic resonance imaging; MRSA: methicillin‐resistant *Staphylococcus aureus*; RR: risk ratio; SSI: surgical site infection

[^9]: BMI: body mass index; CABG: coronary artery bypass graft; CDC: Centers for Disease Control and Prevention; CSF: cerebrospinal fluid; ITT: intention‐to‐treat; IM: intramuscular; IV: intravenous; MRI: magnetic resonance imaging; MRSA: methicillin‐resistant *Staphylococcus aureus*; MSSA: methicillin‐susceptible *Staphylococcus aureus*; NR: not reported; PP: per‐protocol; PVP: polyvinyl pyrrolidine; RCT: randomised controlled trial; SSI: surgical site infection

[^10]: RCT: randomised controlled trial; WBC: white blood count

[^11]: RCT: randomised controlled trial

[^12]: RCT: randomised controlled trial
